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ABSTRACT
Dihydrolipoamide dehydrogenase (DHlipDH) has been shown to be present in 
isolated plasma membrane fractions from mitochondrially inactive bloodstream 
T.brucei (Danson et al, 1987) and has been shown, by subcellular fractionation, to 
have a unique plasma membrane location in these mitochondrially inactive cells 
(Jackman et al, 1990).
Two synthetic peptide epitopes (DLD1 and DLD2) were chosen from an 
antigen prediction profile of bloodstream T.brucei DHlipDH. Both peptides were 
successfully synthesised by the F-moc solid phase method and used to raise 
polyclonal antisera. ELISA analysis confirmed that anti-DLDl and anti-DLD2 were 
peptide specific. Anti-DLDl antisera was shown to cross-react with procyclic T. 
brucei sonicate on western blot, forming bands in the MW range of 47-65 kD. This 
suggested some cross-reactivity of DLD1 antiserum with denatured T.brucei 
DHlipDH. Immunoprecipitation experiments showed some cross-reactivity of DLD1 
antiserum with native T. brucei DHlipDH, although reactivity appeared weak. 
Immunofluorescence studies confirmed weak cross-reactivity of anti-DLDl with 
native DHlipDH antigen, indicating that the raised antiserum was unsuitable for use in 
immunocytochemical localisation studies.
DHlipDH was assayed and partially characterised in sonicates of Crithidia 
fasciculata and Phytomonas sp. The discovery of DHlipDH in mitochondrially 
inactive Phytomonas sp., in the absence of mitochondrial multienzyme complexes 
with which it is normally associated, was unexpected and an investigation of a 
possible plasma membrane location was undertaken by cell fractionation. Assays of 
potential enzyme organelle markers for use in subcellular fractionation studies were 
performed and their suitability discussed. Plasma membrane isolates were prepared 
from Crithidia fasciculata and Phytomonas sp. and fraction purity gauged by 
morphological examination under the electron microscope. A two fold increase in 
DHlipDH specific activity over homogenate was observed in an isolated plasma 
membrane fraction from Crithidia fasciculata , while a five-fold increase was 
observed in Phytomonas sp.
Preliminary evidence for an extramitochondrial DHlipDH in Phytomonas sp. is 
presented and the implications of a possible plasma membrane location discussed.
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20GDHC 2-Oxoglutarate dehydrogenase complex
ABC Avidin: Biotinylated enzyme complex
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ADP Adenosine - 5’-diphosphate
ATP Adenosine-5 ’ -triphosphate
ATPase Adenosine triphosphatase
AV-17 Acid Violet -17
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BSA Bovine serum albumin
CNS Central nervous system
DCCI Dicyclohexylcarbodiimide





DLD1 Synthetic peptide (1) derived from bloodstream T.brucei DHlipDH primary sequence










EDTA Ethylene diamine tetraacetic acid
EGTA Ethyleneglycoltetraacetic acid
FAD Flavin adenine dinucleotide
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LS Long slender
NAD+ Nicotinamide adenine dinucleotide (oxidised form)
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Organisms belonging to the order kinetoplastda are flagellated single-celled 
eukaryotic protozoa. Kinetoplastids are the most primitive eukaryotic group to contain 
mitochondria (Sogin, 1991). These cells are characterised by the possession of a 
unique organelle called the kinetoplast, a dense structure at the base of the flagellum 
that contains the DNA of the organism’s single mitochondrion. Other features of 
kinetoplastids include a surface membrane which has been adapted in various ingenious 
ways to repel host defences, a cytoskeleton reinforcing the body surface, and a 
flagellar apparatus with associated flagellar pocket that represents an important site of 
traffic into and out of the parasite.
1.2. The Trypanosomatidae family
1.2.1 Introduction
The Trypanosomatidae family belongs to the order Kinetoplastida and consists 
of seven common genera of monoflagellates parasitic in invertebrates (leeches and 
arthropods) and vertebrates. The genera of the family Trypanosomatidae show a 
variety of developmental stages which are based mainly on the position of the 
kinetoplast relative to the nucleus, the degree of flagellar development and the position 
at which the flagellum emerges from the body (Hoare and Wallace, 1966) (Fig. 1).
The following six distinct body types, each representing a genus, are recognised:
1. The amastigote ( representative of the genus Leishmania) - a small rounded or 
oval body without a flagellum
2. The promastigote (representative of the genus Leptomonas)- characterised by the 
slender, spindle-shaped body with a free flagellum The kinetoplast is near the
1
anterior end of the body. There is no undulating membrane The genus Leptomonas 
is morphologically indistinguishable from Phytomonas living in plants.
3. The choanomastigote (representative of the genus Crithidia) - small, flagellated 
body with broad end, a truncated anterior and a rounded posterior. The flagellum 
emerges from the funnel-shaped reservoir. There is no undulating membrane. The 
kinetoplast is anterior and lateral to the nucleus.The choanomastigote does not 
appear in the life cycle of any other genus..
4. The opisthomastigote ( representative of the genus Herpetomonas) - characterised 
by the kinetoplastid being posterior to the nucleus and the axoneme runs through 
almost the entire length of the body. There is no undulating membrane.
5. The epimastigote (representative of the genus Blastocrithidia) - the kinetoplast is 
positioned near the anterior margin of the nucleus. A short undulating membrane is 
present.
6. The trypomastigote (representative of the genus Trypanosoma) - the kinetoplast is 
near the posterior end of the body and an undulating membrane runs the frill length 
of the parasite. There may or may not be a free flagellum Only in the genus 
Trypanosoma does a trypomastigote appear.
These stages are typical of the mature stage of the genus listed with it. The life 
cycles of these genera may include several of the morphological stages.
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b. choanom astigote c. promastigote d. opisthom astigote e. epim astigote f. trypom astigote
Figure 1: Developmental stages in the life-cycles of trypanosomatid flagellates ( Modified from Hoare 
and Wallace, 1966).
1.2.2 Classification
The taxonomy of the Trypanosomatidae family is based on a combination of the 
morphological features and the life cycles of the genera (McGhee, 1968). There are six 
types of bodies (Fig. 1) and two basic types of life cycles.
The monogenetic cycle is completed in a single invertebrate host with the final 
parasite form being different and characteristic of the genus. Monogenetic 
Trypanosomatids include Leptomonas, Herpetomonas, Crithidia, and Blastocrithidia. 
In the digenetic cycle, there are two hosts, one an invertebrate and the other either a 
plant or a vertebrate. The genus Phytomonas completes its cycle in milkweed bugs and 
milkweed plants. Genera occurring in vertebrates include Trypanosoma, requiring 
leeches or bloodsucking insects as the invertebrate hosts and vertebrates of various 
kinds as the alternate host.
1.2.3 Phylogeny of the trypanosomatid flagellates
The family Trypanosomatidae is a diverse group of monogenetic and digenetic taxa 
( Vickerman, 1976; Molyneaux, 1983). Speculation on phylogenetic relationships 
within the Trypanosomatidae are largely centred around the ancestry of the digenetic 
parasites of mammals; the trypanosomes and leishmanias. Until recently, the history of
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the kinetoplastids has been reconstructed from comparative studies on morphology, 
life cycles and host distribution. Novel techniques of molecular sequencing - especially 
of small subunit ribosomal RNA (SSU rRNA) genes - have now provided a means of 
assessing genetic distances between organisms.
Early speculation regarding the phylogeny of the trypanosomes was essentially 
divided between two very different view points. The first, favoured by Hoare (1972) 
saw the monogenetic trypanosomatids of non-bloodsucking insects as the progenitors 
of the digenetic parasites now transmitted by haematophagous insects. The transition 
to haematophagy allowed the insects to infect vertebrates, and the parasites to adapt to 
life in the bloodstream or to the intracellular habitat. The second theory, however, 
states that digenetic parasites originated from free living invaders and secondarily gave 
rise to monogenetic parasites (Wallace, 1966). Hence, the original trypanosomatids 
were parasites of vertebrates; later they invaded the blood and were transmitted by 
blood-sucking invertebrates.
The introduction of molecular sequencing techniques into phylogenetic studies 
has revealed some interesting patterns of phylogenetic descent. Comparisons of 
mitochondrial (kinetoplast) rRNAs (Vickerman, 1976) produced a tree that broadly 
confirmed Hoare’s view and suggested that the genera Crithidia, Leptomonas, 
Leishmania and Trypanosoma diverged successively, with the digenetic life-style 
originating once before the separation of Leishmania. The principle problem with this 
study, however, was lack of use of an outgroup to root the tree and so the tree’s 
direction of evolution was in doubt.
By using the free-living kinetolplastid Bodo caudatus as an outgroup in a 
comparison of both small and large ribosomal RNA gene sequences of several 
trypanosomatids, Fernandez et al (1993) constructed a very different tree in which 
T.brucei represented the most ancient lineage, then T.cruzi. The Blastocrithidia and 
Phytomonas lineage’s branched off next after the trypanosomes, with Crithidia and 
Leptomonas some time later. Leishmania and Endotrypanum separated most recently 
of all. This appeared to indicate that the unrooted tree of Lake et al was infact upside 
down. Maslov et al (1994) published a very similar tree to Fernandez et al (1993) 
based on aligned 18S nuclear ribosomal RNA sequences and using Euglena gracilis as
4
an outgroup to root the tree. Evidence supporting this revised tree comes from a 
variety of other molecular comparisons (Fernandez et al, 1993), but in particular from 
comparative studies on RNA editing and on surface structure in different 
trypanosomatids. This was confirmed by Maslov et al (1996) who constructed a 
phylogenetic tree using maximum likelihood, maximum parsimony and evolutionary 
parsimony tree in which T. brucei and T. cruzi diverge before the lineage leading to 
Phytomonas, and then Crithidia and Leishmania (Fig. 2). The tree was rooted using 
rRNA sequences from two species from the suborder Bodonina. All methods showed 
that the mammalian parasite, T.brucei, constitutes the earliest divergent branch while 
the remaining trypanosomes formed a monophyletic group.







p  Trypanosoma avium 
L Trypanosoma cruzi
r  T rypanosoma boissoni 
"L  Trypanosoma triglae
-  T rypanosoma carassii 
~  Trypanosoma rotatorium
Trypanosoma brucei
T rypanosoma borreli 
  Bodo caudatus
Figure 2: Majority consensus (50%) parsimony tree of Kinetoplastid species constructed from the 
SSU rRNA dataset (Maslov et al, 1996).
However, a recent report by Lukes et al (1997) presents evidence for the monophyly 
of trypanosomes. This is contrary to previous results in which trypanosomes were 
found to be paraphyletic with T.brucei representing the earliest diverging lineage. This 
work implies that the adaptation to invertebrate vectors plays a more important role in 
the trypanosome evolution than the adaptation to vertebrate hosts. Hence, the exact 
nature of the phylogenetic relationship among members of the family 
Trypanosomatidae is at present clearly open to contention.
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1.2.4 Pathogenicity of Trypanosomatid flagellates
Digenetic members of the trypanosomatid family are being intensively studied as they 
are causative agents of serious and widespread diseases in man and animals. The most 
important trypanosomatids from the point of view of public health are 1) the 
leishmanias, causing several forms of leishmaniasis, some of which can be fatal (the 
visceral leishmaniasis or kala azar) and grossly disfigure (the mucocutaneous 
leishmaniasis or espundia) or be relatively mild, localised and in some cases self-healing 
(some forms of cutaneous leishmaniasis); 2) the African trypanosomes, which cause 
sleeping sickness in humans (.Trypanosoma brucei gambiense, T.b. rhodesiense) and 
diseases of cattle (nagana: T.b.brucei, T. congolense, T.vivax) or of horses and camels 
(surra: T. evansi) that are of considerable economic importance ; 3) Trypanosoma 
cruzi, the agent of the American trypanosomiasis Chagas disease, which is endemic in 
most of Latin America. There are also trypanosomatid parasites of plants ( the genus 
Phytomonas, which has plant juice-sucking insects as vectors) and trypanosomatids 
that infect only insects, such as those belonging to the genuses Leptomonas and 
Crithidia. In 1909, Lafont reported a trypanosomatid in the latex of Euphorbia 
pilulifera, calling it Leptomonas davidi.( Lafont, A., 1909). These observations were 
confirmed in the same year by Donovan (1909). Donovan proposed the creation of a 
new genus Phytomonas in the family Trypanosomatidae in order to differentiate plant 
from animal trypanosomatids.
1.2.4.1 An animal -infecting trypanosome : Pathogenicity of African trypanosomes (T. brucei) 
African trypanosmes are digenetic parasites living alternately in the 
bloodstream and tissues of their host and the gut of their tsetse fly (Glossina spp.) 
vector. Epimastigotes, procyclic trypomastigotes, and metacyclic trypomastigotes are 
present in the tsetse-fly whereas long, slender and short, stumpy trypomastigotes are 
present in the bloodstream of the mammalian host (Fig. 3). The long slender forms are 
replicative, as are the procyclic trypomastigotes and the epimastigotes present in the 
vector.
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Figure 3: T.brucei - a schematic representation of developmental cycle in a mammal and in the tsetse 
fly vector. Stages with the variable antigen coat are shown on the nght, uncoated forms on the left. 
The tubular mitochondrion is depicted partly in section to show changes in its cristae. The 
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no essential part in tne cycle. Division occurs in asterisked stages. (From ‘Introduction to animal 
parasitology by JD Smyth, adapted from Vickerman, 1985)
The genus Trypanosoma is split into two divisions (Stercoraria and Salivaria ) that 
differ primarily in their course of development in their vectors. The first division, 
Stercoraria, consists of species in which development is completed in the terminal gut 
and where transmission is by faeces from the vector e.g. T. cruzi. The other division, 
Salivaria, is composed of species in which development is completed in the anterior 
part of the vector’s digestive tract and where transmission is via vector saliva. The 
African trypanosomes belong to this division and are called salivarian trypanosomes.
1.2.4.1.1 African trypanosomiasis
Although the number of human deaths occurring annually because of African 
sleeping sickness is relatively low, the African trypanosome is considered by the World 
Health Organisation to be one of the most important parasites affecting the people of 
the Third World (Trigg, 1979). The reasons for this are that the disease caused by this 
parasite is usually chronic and debilitating in humans and significantly decreases the 
availability of cattle for food. Up until 1979 there were some 10,000 new cases 
recorded each year (Barry and Emery, 1984). The disease has been on the increase in 
the last decade with more than 20,000 new cases reported each year, although the true 
incidence is likely to be much higher because of inadequate reporting. Recent estimates 
suggest that 50 million people are exposed to the risk of infection in Africa.
1.2.4.1.2 Human trypanosomiasis
There are two forms of human trypanosomiasis, West African or Gambian 
sleeping sickness, and East African or Rhodesian sleeping sickness (Greenwood,
1982). The trypanosomes causing these diseases are both subspecies of T. brucei; 
Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. T. b. 
gambiense is distributed mostly in West and Central Africa, while T. b. rhodesiense is 
found mostly in Southern and East Africa. The parasites are indistinguishable 
morphologically. The infections are distinguished from each other by their locale and 
clinical course. If untreated, human sleeping sickness is inevitably fatal because of the 
invasion and destruction of the central nervous system The duration of the illness 
ranges from weeks to months in T. rhodesiense infections and from months to years 
with T. gambiense.
The disease progresses through three stages: the initial stage in which the 
parasite is localised to the site of the tsetse fly bite ; the early or systemic stage in 
which the trypanosomes are widely distributed by the bloodstream throughout the 




Closely related to human trypanosomiasis is nagana, trypanosomiasis in 
livestock. While the human disease is important because of the threat of epidemic 
outbreaks, animal trypanosomiasis presents a constant economic problem in Africa.
This disease renders 4 million square miles of land in sub-Saharan Africa unfit for 
livestock production. In addition to denying the expanding human population this 
needed source of animal protein, the lack of cattle restricts crop production because 
there is a shortage of draught animals and animal manure.
The course of African trypanosomiasis in domestic livestock is similar to the 
early stages of the disease in humans. However, the two main livestock pathogens, T. 
congolense and T.vivax rarely invade the central nervous system Thus while in the less 
common livestock infections with T. b. brucei CNS pathology can occur, in livestock 
trypanosomiasis it is the parasite-induced anaemia and cachexia leading to weakness 
and inability to forage for food that causes most deaths.
1.2.4.2 An insect-infecting trypanosome : Pathogenicity of Crithidia (Crithidia fasciculata)
Species of Crithidia are common parasites of the alimentary canal of many 
different types of insect. Although generally considered non-pathogenic, occasional 
deaths of their arthropod hosts have been attributed to Crithidia sp. (Molyneux and 
Ashford (1983)
Crithidia fasciculata occurs naturally in the intestines of mosquitoes, 
specifically in Anopheles maculipennis and Culex incidens mosquitoes (Whitfield,
1979), although the flagellates may be easily cultured in vitro. Choanomastigotes from 
Crithidia fasciculata have hence been widely used for metabolic studies as an 
innocuous model for human trypanosome pathogens. Crithidia sp. exists in the 
choanomastigote stage and what might be called a semiamastigote stage (McGhee and 
Cosgrove, 1980) Within the mosquito, the amastigote forms (3 to 4 p long by 2 to 4 p 
wide) of Crithidia fasciculata are attached to the mid and hindgut intestinal mucosa.
The swimming choanomastigote form (free-living stage) (Clark, 1959) is 6 to 8p long 
by 2 to 3 p wide.
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1.2.4.3 A plant- infecting trypanosome : Pathogenicity of Phytomonas sp.
Phytomonas are fusiform promastigotes, characterised by a slender, elongated 
cell body twisted two or three times around their longitudinal axis.(Sanchez-Moreno 
et al, 1995) They measure 10 - 20pm in length, have a width of about 1.5 pm and the 
free ( anterior) flagellum measures 10-15 pm
Trypanosomatids of the genus Phytomonas are associated with diseases of 
coffee, coconut and oil palm, being transmitted to the plant host by feeding hemipteran 
insects. Phytomonas populations differ in the types of tissue or cell which they 
colonise ( latex, phloem or fruit) (Dollet, 1994). In plants they parasitize the 
laticiferous tubes that contain the milky substance known as latex and the phloem and 
xylem of palm trees and other plants where they may exert a pathogenic effect 
( Stahel, 1931; Parthasarathy et al, 1976; Dollet et al, 1977; Dollet, 1984).
Although initially considered not particularly damaging to most laticiferous plants, it 
has been shown that infection with intraphloemic flagellates can have devastating 
consequences on economically important plants occurring in Latin America, causing 
diseases such as hartrot of coconut (Parthasarathy et al, 1976.) marchitez sorprisiva of 
oil palm (Dollet et al, 1977); and phloem necrosis of coffee ( Parthasarathy et al, 1976; 
Dollet et al, 1977; 1984 )
Other plant trypanosomatids parasitize plants and fruits without inducing a 
pathological syndrome in the plant. The parasite has been observed in some varieties of 
garden vegetables and legumes, including beans and soybeans, although nothing is 
known about the pathogenicity on these crop s. ( Dollet et al, 1982 ; Jankevicius et al, 
1988)
1.2.5 Life cycles of Trypanosomatid flagellates
The life cycle of parasites is frequently complex, often utilising a sequence of 
different hosts, with each host providing habitats which may vary markedly in their 
physico-chemical characteristics. Even within the same host, parasites may experience 
a wide range of environments and nutrients available for their episodes of extensive 
growth and differentiation. The metabolic resources required to sustain growth may be 
derived from endogenous host reserves or exogenous nutrients. It is obviously
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essential that the different life cycle stages of a parasite are able to exploit the 
environment for the nutrients they require.
1.2.5.1 The life cycle of African trypanosomes (T. brucei)
The life cycle of T. brucei is the most widely studied of all the African 
trypanosomes. T.b. brucei has a digenetic life cycle, undergoing a cyclical transmission 
from mammal to mammal effected by their insect vector, the tsetse fly. Different 
developmental stages of the life-cycle are accompanied by markedly different 
morphological stages (Fig. 3). There are also corresponding biochemical adaptations. 
Most notable amongst these changes are those of the mitochondrion and the surface of 
the flagellate, which must undergo alterations in order for the parasite to survive in the 
two very different environments of the mammalian host and the insect vector 
(Vickerman 1965 and 1985).(see section 1.2.6.1 ‘Energy (carbohydrate) metabolism 
in T. brucei ’)
Infection of the mammalian host is initiated by injection into the skin of the 
metacyclic trypomastigote forms in the vectors saliva. These parasites differentiate into 
a pleomorphic population of bloodstream forms, ranging from the long slender (LS) 
form, which has a free flagellum at its anterior end, to the short stumpy (SS) form, 
which has no free flagellum (Vickerman 1965).
It is the LS form which is the most abundant when parasitaemia is rising as it is 
able to divide rapidly with a generation time of 4-6 hours. It is this form which evades 
the host immune system by antigenic variation of its surface coat (Tanner, Jenni, 
Hecker and Brun, 1980). Each cell is ensheathed in a surface coat composed of a 
matrix of a single glycoprotein (Cross, 1975). Parasitaemia occurs in waves, with each 
peak appearing to coincide with the expression of one specific antigenic variant. As 
trypanosomes bearing a particular variant antigen are eliminated from the population 
by the host immune system, a new variant type arises to take its place as the principal 
surface antigen (Boothroyd, 1985). The mitochondrion of the LS form is poorly 
developed as the parasite has a plentiful supply of blood glucose, and is therefore able 
to meet all of its energy requirements through glycolysis, thus obviating the need for a 
citric acid cycle.
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During periods of low parasitaemia, the SS form predominates. SS forms are 
thought to be a pre-adaptation to life in the insect, mainly because of the state of its 
mitochondrion, which is intermediate between those of the LS and procyclic insect 
forms. With ingestion into the gut of the feeding tsetse fly, bloodstream form 
trypanosomes undergo differentiation to become parasites that can survive in the 
vector. The adapted parasite is known as the tsetse fly midgut form (Shapiro et al, 
1986) or procyclic stage. This form of the parasite lacks the variable surface coat 
characteristic of bloodstream forms and is not infective for mammalian hosts. The 
uncoated trypanosomes successfully grown in vitro are considered analogous to this 
stage.
Some of the tsetse fly procyclic trypanosomes migrate back up to the fly mouth 
parts and salivary glands where they differentiate into the epimastigote stage (Hoare, 
1970). This is the only time in the African trypanosome life cycle when the parasite 
assumes the characteristic epimastigote morphology seen in other members of the 
family Trypanosomatidae; in this form the kinetoplast is anterior to the nucleus. 
Epimastigotes in turn differentiate into metacyclic trypomastigotes. When inoculated 
into the new environment of the mammalian host (as the tsetse feeds) they transform 
into proliferating long slender bloodstream forms and establish the mammalian 
infection (Jenni and Bran, 1977 and Bran, 1977).
1.2.5.2 The Life-cycle of Crithidia {Crithidia fasciculata)
Crithidia exhibit a monogenetic life cycle, having only a single invertebrate 
host, the mosquito. Anopheles maculipennis and Culex incidens mosquitoes become 
infected by ingesting Crithidia amastigotes that have been deposited in faeces on 
flowers by previously feeding mosquitoes harbouring the infective parasite in their mid 
and hindgut intestinal mucosa (Clark et al, 1964; Brooker, 1971)
Infected mosquitoes flying or blown over marshes, pond, pools, or other 
aquatic habitats, contaminate them with their faeces and dead bodies.
Choanomastigote forms so released may then be ingested by larval mosquitoes present 
in the aquatic environment..
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1.2.5.3 The Life cycle of Phytomonas sp
Phytomonas resembles the monogenetic genus Leptomonas of insects and the digenetic 
Leishmania of mammals in having an amastigote and a promastigote in its life cycle 
(Sanchez-Moreno et al, 1995; Jankevicius et al, 1988). Phytomonas might hence be 
considered as a transitional form between the monogenetic species in invertebrates and 
. the digenic ones, which have an alternation of hosts between insects and vertebrates.
The life cycle of Phytomonas is still not completely understood although it is 
generally assumed that parasites in the latex of infected plants, mostly in the form of 
promastigotes, are transmitted by feeding phytophagous insects (Dollet, 1984, 1987). 
When ingested by feeding insects, multiplication of the flagellates ceases temporarily 
and no growth takes place in the oesophagus and crop. Upon arriving in the pylorus 
and midgut, rapid growth begins, producing giant promastigotes. These large forms 
leave the digestive tract for the haemocoel, where growth continues. From here, they 
go into the salivary glands. In these organs, reproduction is resumed with the 
formation of a few amastigotes and numerous small promastigotes. Insects sucking 
latex from plants inject the parasites with the salivary secretions. Inside the plant, the 
parasites remain small, being 13.5 p long by 2.5 p wide, but they proliferate rapidly, 
forming both promastigotes and amastigotes. At first they are localised in the area of 
the bites but the infection soon spreads, becoming generalised, with the flagellates 
distributed throughout all parts of the plant.
1.2.6 Energy metabolism in Trypanosomatids
Trypanosomatids - T. brucei in particular - have been the subject of many 
studies during the last 15 years due to a number of morphological and biochemical 
peculiarities unique to this family. These include features such as branched respiratory 
chains with an unusual cytochrome c, the presence of a glycosome organelle and the 
aerobic fermentation of glucose.( Opperdoes, 1991 ). The glycosome is an unusual, 
non-DNA containing organelle that houses the enzymes of the glycolytic chain, which, 
unusually, are mostly absent from the cytosol
Bloodstream trypomastigotes of T. brucei are among the eukaryotic cells with 
the highest rates of glucose consumption, at least 10-fold higher than that of their
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mammalian host. However, most other trypanosomatids also present high rates of 
glucose utilisation irrespective of the carbohydrate contents in their natural habitat 
(Cazzulo, 1992). There is a good correlation between glucose consumption rates and 
environmental carbohydrate contents in bloodstream forms and insect procyclic forms 
of T. brucei, the latter being an order of magnitude lower (Opperdoes, 1987; Darling 
et al, 1988 ). On the other hand, the insect parasite Crithidia fasciculata , which lives 
in the mosquito’s gut, an environment of low carbohydrate contents, presents 
nevertheless a rate of glucose consumption of the same order as that shown by 
bloodstream African trypanosomes (Cazzulo et al, 1988)
Another interesting feature of glucose utilisation by trypanosomatids is the lack 
of a ‘Pasteur effect’ (Cannata and Cazzulo, 1984; Darling et al, 1987). In most 
organisms the transition from anaerobiosis to aerobiosis is accompanied by a rapid and 
considerable decrease in the rate of glucose utilisation. This inhibition of glycolysis by 
oxygen (the Pasteur effect) is lacking in trypanosomatids which seem to be adapted to 
consume as much glucose as is able to enter the cell ( Cazzulo, 1992). Present 
evidence suggests that subcellular compartmentation is the major factor involved in the 
regulation of glycolysis in trypanosomatids ( Opperdoes, 1987). The high rate of 
glucose consumption seems to be due to the very high concentration of glycolytic 
enzymes and intermediates inside the glycosome (Opperdoes, 1986).
1.2.6.1 Energy (carbohydrate) metabolism in Trypanosoma brucei
The activities of the trypanosome mitochondrion are modulated during the 
developmental cycle to take advantage of the changing environmental conditions.
While the bloodstream parasite can rely on an abundant supply of host-derived 
carbohydrates for its relatively inefficient aerobic metabolism, the parasite taken into 
the gut of the tsetse fly vector must become more efficient to survive in this 
environment which is poorer in carbohydrates (Vickerman, 1971).
To remain functional, all glycolytic systems must have an efficient system for 
the reoxidation of the NADH generated in the glyceraldehyde-3-phosphate 
dehydrogenase reaction ( Fig. 4). Under aerobic conditions, this system is usually the 
respiratory chain.
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1.2.6.1.1 Long slender (LSI bloodstream forms
LS mitochondria do not contain spectrally detectable cytochromes, have little 
or no NADH dehydrogenase, and lack several key en2ymes of the citric acid cycle 
(pyruvate dehydrogenase , a- ketoglutarate dehydrogenase, citrate synthase, and 
succinate dehydrogenase) (Ryley, 1956; Vickerman, 1965; Bowman et al, 1972; 
Brown et al, 1973; Flynn and Bowman, 1973; Bienen et al, 1991). Consequently, 
glucose can only be metabolised by glycolysis as far as pyruvate which is then excreted 
into the surrounding medium (Fairlamb and Opperdoes, 1986). Most of the enzymes of 
the glycolytic pathway and an NAD-dependent glycerol-3-phosphate dehydrogenase 
enzyme are localised in the glycosome (Fairlamb and Opperdoes, 1986; Hannaert and 
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Figure 4. Subcellular compartmentation of the enzymes involved in glucose catabolism in T.brucei. 
Abbreviations of metabolites : Glu-6-P, glucose-6-phosphate; Fru-6-P, fructose-6-phosphate; Fru-1,6- 
diP, fructose 1,6-bisphosphate; DHAP, dihydroxyacetone phosphate, PEP, phosphoenolpyruvate; 
GAP, glyceraldehyde-3-phosphate; G-1,3-diP, 1,3 diphosphoglycerate; 3-PGA, 3-phosphoglyerate; 2- 
PGA, 2-phosphoglycerate, G-3-P, glycerol-3-phosphate; ALA, L-alanine. G-1,3-diP and 3-PGA are 
shown inside a dotted box to indicate that enzyme (9) is present inside the glycosome of the 
bloodstream trypomastigote of T.brucei and in the cytosol of the procyclic trypomastigote. The 
mitochondrion on the left corresponds to the cristae-less tubular mitochondrion of bloodstream 
trypomastigotes; the mitochondrion on the right corresponds to the cristae-containing mitochondrion 
of procyclic trypomastigotes. The enzymes involved are: glycerol-3-phosphate oxidase (1); glycerol-3- 
phosphate dehydrogenase (2); glycerophosphate phosphatase (3); glycerol kinase (4); glyceraldehyde 
isomerase (8); phosphoglycerate kinase (9); phosphoglycerate mutase (10); enolase (11); pyruvate 
kinase (12); alanine aminotransferase (13); NAD-linked glutamate dehydrogenase (14); NADP-linked 
glutamate dehydrogenase (15); malic enzyme (16); pyruvate dehydrogenase complex (17); citrate 
synthase (18); aconitase (19); 2-oxoglutarate 3-phosphate dehydrogenase (5); PEP carboxykinase (6); 
malate dehydrogenase (7); triosephosphate dehydrogenase complex (20); fumarate reductase (21); 
succinate dehydrogenase (22); fumarase (23). The possible participation of both glutamate 
dehydrogenases in the formation of L-alanine linked to NADH reoxidation is indicated only for the 
cytosol, but the same pathways are possible inside the mitochondrion (Duschak and Cazzulo, 1991).
Diagram adapted from Cazzulo, 1992.
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In the absence of tricarboxylic acid cycle enzymes and cytochromes, the 
bloodstream trypanosomes use a unique system in aerobio sis for the reoxidation of the 
NADH generated in the glyceraldehyde-3-phosphate dehydrogenase reaction. 
Regeneration of NAD+ from NADH is required for continuous glycolysis, and this is 
mediated by a glycerol-3-phosphate shuttle to the mitochondrion. In the glycosome, 
glycerol-3-phosphate dehydrogenase reduces dihydroxyacetone phosphate (DHAP) to 
glycerol-3-phosphate (G-3-P) and regenerates NAD+ from NADH. Glycerol-3- 
phosphate shuttles to the mitochondrion where it is oxidised to dihydroxyacetone 
phosphate by a novel cyanide insensitive L-glycerol-3-phosphate oxidase in which form 
it returns to the glycosome. This reoxidation allows the quantitative conversion of 
glucose to pyruvate and the maintenance of redox balance in the cell. The reducing 
equivalents delivered to the mitochondrion ultimately reduce molecular oxygen to 
water.
Under anaerobic conditions, or in the presence of glycerophosphate oxidase 
inhibitors e.g. salicylhydroxamic acid (SHAM) (Flynn and Bowman, 1973; Clarkson et 
al, 1981), glucose is converted to equimolar amounts of pyruvate and glycerol 
(Fairlamb and Opperdoes, 1986). Glycerol production seems to be accompanied by 
ATP synthesis by reversal of the glycerol kinase reaction.
1.2.6.1.2 Short stumpy bloodstream form
Later in the course of infection, a non-dividing short stumpy trypanosome form 
predominates. Like the long slender form, short stumpy form cells metabolise glucose 
to pyruvate and utilise the glycerophosphate oxidase system to regenerate NAD+. 
Unlike the long slender form, short stumpy form cells are also capable of metabolising 
a-ketoghitarate to succinate (Vickerman, 1965; Bowman et al., 1972; Flynn and 
Bowman, 1973). The mitochondrion of these forms contains a more complete citric 
acid cycle in that pyruvate dehydrogenase and a-ketoglutarate dehydrogenase are 
present (Bowman et al., 1972; Flynn and Bowman, 1973). Cytochromes are not 
present in SS form cells, but inhibitor studies suggest the presence of a functional 
NADH dehydrogenase complex (Bowman et al., 1972; Flynn and Bowman, 1973; 
Bienen et al., 1991).
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1.2.6.1.3 Insect (or procyclic form)
The transmission of the bloodstream form cells to a tsetse fly along with a 
bloodmeal induces the development of a cristate mitochondrion with functional 
cytochrome mediated electron transport and a complete citric acid cycle together with 
a shift to the use of proline as the preferred energy source (Brown et al., 1973). 
Proline, which is the major catabolisable substance in the fly’s hemolymph (Fairlamb 
and Opperdoes, 1986), is used by the insect as an energy source for flight (Vickerman, 
1985). There is partial attenuation of the glycerophosphate oxidase, which may still 
account for up to 30% of terminal oxidation in procyclics (Opperdoes, 1985 ; Fairlamb 
and Opperdoes, 1986). As indicated by the increased cyanide sensitivity of this form, 
the insect midgut procyclic form utilises a conventional cytochrome c oxidase as the 
terminal enzyme of electron transport (Hill, 1976; Bienen et al, 1983).
Procyclic cells divide rapidly in the fly midgut before migrating to the salivary 
glands of the fly. The salivary gland stages of the trypanosome are not well studied at 
the biochemical level, but it is believed that mitochondrial activity is repressed before 
the organisms become infective for a new mammalian host. This is based on the 
observation that the mitochondria of the infective metacyclic form have the 
unbranched, noncristate appearance that is characteristic of the bloodstream form 
(Vickerman, 1985).
1.2.6.2 Energy (carbohydrate) metabolism in Crithidia fasciculata 
In contrast to bloodstream T. brucei (and, more recently, Phytomonas sp.) , Crithidia 
fasciculata, together with all other studied trypanosomatids to date, seem to NADH 
deoxidise generated in the glyceraldehyde-3-phosphate dehydrogenase reaction, at 
least partially, through the respiratory chain. This oxidation is linked to 
phosphorylation which, as in all other known systems, is mediated by a mitochondrial 
oligomycin- sensitive Mg2+-ATPase. However, oxidation through the respiratory chain 
does not seem to be enough to maintain the high levels of glycolysis attainable and 
glucose oxidation is incomplete, with the parasites producing, even in the presence of 
oxygen, reduced catabolites such as succinate and ethanol (Cazzulo, 1992). This type 
of metabolism, characterised by a nearly complete lack of Pasteur effect, has been 
called aerobic fermentation by von Brand (von Brand, 1979).
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For Crithidia fasciculata the final products of aerobic catabolism are C02, 
succinate and ethanol with minor amounts of glycerol and acetate (Cazzulo et al, 1985, 
1988). The final products of anaerobic glycolysis are mainly succinate, ethanol and 
glycerol with minor amounts of L-malate and acetate.(Cazzulo, 1988; De los Santos et 
al, 1985). The general outline of the pathways leading to the formation of end products 
succinate, ethanol and glycerol is depicted in Fig. 5 ( over).
The degradation of glucose by Crithidia fasciculata follows the classical 
Embden-Meyerhof path of glucose degradation up to the level of phosphoenolpyruvate 
followed by its carboxylation to oxaloacetate. The latter is then converted into 
succinate by the action of malate dehydrogenase, fumarase and fumarate reductase. 
Glycerol is produced in small amounts and reflects the role of the glycerol-3-phosphate 
dehydrogenase system which is probably important as a shuttle to transport reducing 
equivalents into the mitochondrion for re-oxidation through the respiratory chain 
(Bacchi et al, 1968). The absence of L-alanine production (Cazzulo et al, 1988) 
appears not to be due to a lack of transaminase activity, but rather reflects the high 
effectiveness of the pathway for ethanol synthesis through the action of pyruvate 
decarboxylase and alcohol dehydrogenase (Cazzulo et al, 1988), which would leave 
little pyruvate available for transamination. Pyruvate kinase activity in Crithidia 
fasciculata appears to be very low, and the malic enzyme reaction is probably the 
major one involved in the formation of pyruvate necessary for ethanol production.
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Figure 5 : Pathways for glucose fermentation by Crithidia fasciculata (Cazzulo, 1992). Glu-6-P, 
glucose-6-phosphate; Fru-6-P, fructose-6-phosphate; Fru-1,6-diP, fructose 1,6-bisphosphate; DHAP, 
dihydroxyacetone phosphate; PEP, phosphoenolpyruvate. The enzymes involved are: phosphoenol 
pyruvate carboxykinase (1); malate dehydrogenase (2); fumarase (3); fumarate reductase (4); 
glycerokinase (5); glycerophosphate phosphatase (6); pyruvate kinase (7); pyruvate decarboxylase 
(8); alcohol dehydrogenase (9); pyruvate dehydrogenase (10); malic enzyme (11).
1.2.6.3 Phytomonas sp.
In contrast to other trypanosomatids, little has been known about the biology 
of these protozoa until very recently, mainly due to the lack of an in vitro culture until 
1984 when Dollet succeeded in establishing axenic cultures of parasites isolated from 
both the phloem and latex fluids of plants. (Dollet, 1984 ; Menara et al, 1988). This 
breakthrough has led to the study of carbohydrate metabolism of the typical 
promastigote stage of Phytomonas, with many metabolic studies being performed on 
culture promastigotes of Phytomonas from Euphorbia characias. More recently, such 
studies have been extended to a range of different Phytomonas isolates and it has been 
found that the energy catabolism follows the same general pattern in all species of 
Phytomonas studied to date (Femandez-Becerra, 1997).
Phytomonas promastigote cells, isolated in the early stationary phase of 
growth, have been analysed for their capacity to utilise plant carbohydrates for their 
energy requirements and were found to contain a number of cellulose degrading 
enzymes including invertase ( Sanchez-moreno et al, 1992). These flagellated protists, 
shown to utilise glucose, fructose and mannose as major energy substrates (Chaumont 
et al, 1994; Sanchez-Moreno et al, 1992) are also capable of utilising plant sucrose due 
to the presence of invertase. They have been shown to exhibit a glycolytic energy 
metabolism similar to T.brucei bloodstream forms, where these sugars are converted to 
pyruvate by aerobic fermentation according to the Embden-Meyerhof pathway. Citric- 
acid cycle activity, cytochromes and oxidative phosphorylation are absent in 
Phytomonas sp. and consequently oxygen consumption is insensitive to the classical 
inhibitors of mitochondrial respiration, such as antimycin and potassium cyanide. 
However, respiration is totally sensitive to salicylhydroxamic acid (SHAM), an 
inhibitor of the trypanosome glycerol-3-phosphate oxidase system, indicating that a 
mitochondrial glycerol-3-phosphate oxidase system, similar to the one described for 
bloodstream T.brucei (Opperdoes, 1987) is present and active in these organisms.
The absence of detectable cytochromes and the fact that respiration is not 
inhibited by the classical inhibitors of the mitochondrial respiratory chain in any strain
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of Phytomonas sp. studied to date (Femandez-Becerra et al, 1997) indicates that the 
glycolytic pathway serves as the major, if not the only, source of ATP within the cell.
1.3 Dihydrolipoamide dehydrogenase (DHlipDH) in bloodstream T.brucei
Dihydrolipoamide dehydrogenase (DHlipDH) is an essential component of the 
pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, branched chain 2-oxoacid 
dehydrogenase and glycine cleavage system, which are multienzyme complexes located 
in mitochondria of most eukaryotic organisms. With the bloodstream form of T.brucei 
having a highly repressed mitochondrion containing no detectable 2-oxo acid 
dehydrogenase complexes, it was a surprise when Danson et al (1987) discovered 
DHlipDH in these cells. Further intrigue was added to this discovery when they found 
that this DHlipDH co-purified with bloodstream T.brucei plasma membranes.
A complete subcellular fractionation of T.brucei, and comparison with marker 
enzymes, performed by Jackman et al (1990) indicated that the DHlipDH was located 
over the entire inner surface of the plasma membrane of the bloodstream form only and 
was not located elsewhere in the bloodstream cell. Furthermore, a study of the latency 
of the enzyme suggests that it is located on the cytoplasmic surface of the plasma 
membrane (Jackman et al, 1990).
Interestingly, a DHlipDH in E.coli has been found to be functionally distinct 
from those of the pyruvate and 2-oxoglutarate dehydrogenase complexes and has been 
implicated in the binding-protein-dependent transport of galactose and maltose 
(Richarme, 1989) , suggesting a plasma membrane location.
These findings point to the possibility of a plasma membrane associated 
DHlipDH present in an evolutionary diverse range of species. Such a membrane 
associated DHlipDH may have an important function, possibly related to solute 
transport in and out of the trypanosome cell, and consequently be of therapeutic 
interest as a possible drug target.
1.3.1 Dihydrolipoamide dehydrogenase
The enzyme dihydrolipoamide dehydrogenase (DHlipDH) is a flavoprotein 
member of a group of disulphide oxidoreductase enzymes that include glutathione
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reductase and trypanothione reductase. It employs FAD to catalyse the oxidation o f  
dihydrolipoamide (DHlip) to lipoamide (lip) using NAD+ as the final electron acceptor 
in the oxidation as shown in the reaction below:
Dihydrolipoamide + NAD+ ^  Lipoamide + NADH + FT 
DHlipDH has been isolated from many species. It is a homodimeric 
enzyme, with subunit sizes varying from 49 Kda in Pseudomonas putida to 61 Kda in 
Saccharomyces cervisiae. Each active site consists o f two binding sites which act as 
channels for NAD+ and lipoamide, separated by the flavin moiety, and a redox-active 
disulphide bridge.
Various biochemical and spectroscopic studies have revealed that the reaction 
proceeds via a ping-pong mechanism in which the enzyme goes from an oxidised to a 
semi-reduced state, where in the latter the reactive disulphide bridge is open and one o f  
the two cysteine residues forms a charge transfer complex with the flavin. NAD+ 
accepts the electrons from this complex, and, in being reduced to NADH, re-oxidises 
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Figure 6 : NAD+-dependent oxidation of dihydrolipoamide catalysed by dihydrolipoamide 
dehydrogenase. Catalysis proceeds via alternate oxidation and reduction of an intrachain disulphide 
bond and a base (B) on the enzyme. In the reduced enzyme, the electrons are shared between the 
active site dithiolate anion and a molecule of FAD (Danson, 1988).
1.3.2 Trypanothione reductase
Trypanothione reductase (TR) is a flavoenzyme which is o f particular interest as a 
target molecule for antitrypanosomal therapy. Like other members o f the disulphide
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oxidoreductase class of flavoproteins that includes glutathione reductase, 
dihydrolipoamide dehydrogenase and mercury reductases (Williams et al, 1992), 
trypanothione reductase contains a cysteine disulphide bridge in the active site, which 
undergoes reduction by the pyridine dinucleotide co-factor as an obligatory step in the 
overall reaction mechanism (Shames et al, 1986).
TR has been found only in parasitic protozoa of the order Kinetoplastida where 
it is a key enzyme of the parasite’s thiol metabolism, catalysing the NADPH-dependent 
reduction of glutathionylspermidine conjugates which serve as the parasites main 
thiols. TR and DHlipDH have a number of structural features in common, and exhibit 
an unusually high one-electron-reducing capacity (Krauth-siegel and Schoneck, 1995).
1.3.3 Role of DHlipDH in multienzyme complexes
DHlipDH performs its catalytic role as part of the pyruvate dehydrogenase 
complex (PDHC), 2-oxoglutarate dehydrogenase complex (20GDHC), branched chain 
2-oxoacid dehydrogenase complex (BCKDHC) and the glycine cleavage system (GCS) 
(Yeaman, 1989). All of these complexes have been found in prokaryotic systems, and 
are intramitochondrial in eukaryotes. They consist of multiple copies of several 
component enzymes, designated E l, E2 and E3. Each complex is situated at a key 
position in carbon and energy metabolism and they are of particular importance 
because the PDHC, 20GDHC and BCKDHC catalyse irreversible catabolic steps 
(reviewed by Perham, 1991)
1.3.3.1 Pyruvate dehydrogenase complex
The pyruvate dehydrogenase complex is the most studied of the 2-oxo acid dehydrogenase 
complexes and catalyses the following enzyme reaction:
Pyruvate + CoA + NAD+ ^  Acetyl CoA+ CO2 + NADH + HT1- 
The PDHC has a pivotal role in the utilisation of pyruvate by most cells, producing 
acetyl CoA for energy or biosynthesis. It consists of 3 catalytic components, E l, E2 
and E3, which have similar properties in all species:
El(pyruvate decarboxylase) catalyses the decarboxylation of pyruvate to a 
hydroxyethyl group followed by reductive acetylation of the lipoamide coenzyme of E2
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E2 (dihydrolipoyl transacetylase) E2 hands the acetyl group, derived from 
pyruvate , to CoA using a swinging arm, with a lipoamide coenzyme bound to the 
end, which rotates among the catalytic centres of the 3 component enzymes (Guest, 
1978; Perham, 1991)
E3 (dihydrolipoamide dehydrogenase) oxidises the reduced lipoamide
coenzyme in preparation for receiving another acetyl group, and hands the reducing
+
equivalents to NAD .
1.3.3.2 2-Oxoglutarate dehydrogenase complex
The 2-Oxoglutarate dehydrogenase complex is of the same basic structure as 
the PDHC, but is not regulated by phosphorylation. The 20GDHC is part of the citric 
acid cycle of the cell, in which it catalyses the irreversible oxidative decarboxylation of 
2-oxoglutarate to succinyl-CoA in a reaction analogous to that of the PDHC.
1.3.3.3 Branched-chain 2-oxoacid dehydrogenase complex
The BCKDHC catalyses the oxidative decarboxylation of branched-chain 
amino acids, the general reaction being:
R-CO-COOH + Co A + NAD+ ----->  R-CO-CoA + C 0 2 + NADH + H*
The eukaryotic BCKDHC is similar in structure to the PDHC and is also 
regulated by phosphorylation. Its metabolic importance is as the first committed step in 
branched- chain amino acid catabolism Acyl CoA products are fed into the citric acid 
cycle through acetyl CoA or succinyl CoA In oxidising the branched chain amino 
acids, it is able to prevent their otherwise toxic effects on the cell. The complex is 
found in eukaryotic systems and in those bacteria that utilise branched chain amino 
acids (e.g. Pseudomonasputida)
1.3.3.4 Glycine cleavage system
The glycine cleavage system (GCS) consists of four protein components: P- 
protein (pyridoxal-phospate containing glycine decarboxylase), H- protein (lipoyl
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bearing aminomethyltransferase), T-protein (N^ > methylene tetrahydrofolate 
synthetase) and L-protein (DHlipDH) (Kikuchi and Hiraga, 1982). It catalyses the 
pyridoxal phosphate-dependent decarboxylation of glycine:
glycine + H^folate + NAD+ ^  5, lO-methylene-KLj-folate + NH3 + CO2 + NADH + H+
This complex is also capable of glycine synthesis in the reverse of the above 
reaction, and is in contrast to the 2-oxoacid dehydrogenase complexes which catalyse 
an irreversible reaction.
The GCS forms the major pathway for the catabolism of glycine and serine in 
vertebrates (Kikuchi and Hiraga, 1982) and for the breakdown of glycine by certain 
anaerobic glycine-utilising bacteria, including Clostridium cylindrosporum (Dietrichs 
and Andreesen, 1990)
1.3.4 Lipoic acid
Investigations into the role of DHlipDH in the bloodstream form of T. b. brucei have 
involved looking for its presumed substrate, lipoic acid, in these cells (Jackman et al,
1990)
O
U poicacid  (Ionized fo rm )
The presence of lipoic acid in any DHlipDH - containing cell would suggest that the 
enzyme may be performing an analogous role to that in the 2-oxo acid dehydrogenase 
complexes, in catalysing the interconversion of reduced and oxidised lipoic 
acid/hpoamide. If it were absent, then the enzyme would have a different substrate in 
vivo, and be able to catalyse the oxidation of dihydrolipoamide as a secondary reaction 
in vitro. The presence of lipoic acid in a cell would therefore seem to indicate that 
DHlipDH would use it as a substrate in vivo.
There are a number of different methods that have been developed for the 
quantitative determination of lipoic acid in biological systems. Following release of the
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cofactor from protein by acid or base hydrolysis, lipoic acid has been assayed a) 
manometrically using Streptococcus faecalis (strain 10C1) (Gunsalus and Razzell, 
1957), b) Polarographically using the lipoic acid mutant of Escherichia coli K12, 
W1485///?2, (Herbert and Guest, 1968; 1970 and 1975) or by turbidimetric assay using 
Escherichia coli K12, W1485/zp2 (Herbert and Guest, 1975).
1.4 Study aims
There is overwhelming evidence to suggest the existence of an unusual 
extramitochondrial DHlipDH in the mitochondrially repressed bloodstream T. brucei. 
No such investigation has been extended to Trypanosomatidae family members 
possessing a similarly repressed mitochondrion e.g. Phytomonas sp. and one aim of 
this study is to investigate the presence and location of DHlipDH in cultured 
Phytomonas sp. promastigote cells..
Jackman et al (1990) demonstrated substantially higher levels of DHlipDH in 
the procyclic form of T.brucei (13 - fold higher in the procyclic compared to the 
bloodstream form) which is almost certainly due to DHIipDH-containing multienzyme 
complexes present in the active mitochondrion, but they were unable to determine 
conclusively if any remained at the plasma membrane. Similarly, as would be expected 
in the mitochondrially active Crithidia fasciculata, there is evidence for at least one 
mitochondrially located DHlipDH in the form of the pyruvate dehydrogenase complex 
(Diaz and Komuniecki, 1995). However, no research has been done to investigate a 
possible plasma membrane location in Crithidia fasciculata .
It is hence the immediate aim of this study to investigate whether a plasma 
membrane DHlipDH occurs in procyclic T. brucei by immunolocalisation studies. 
Polyclonal antibodies to selected antigenic peptide sequences derived from the 
bloodstream T.brucei DHlipDH gene sequence (Else et al, 1993) are to be raised. 
Characterisation of raised polyclonal peptide antisera is to be achieved by western blots 
of procyclic T. brucei cell sonicates and specificity for native DHlipDH gauged by 
immunoprecipitation of DHlipDH activity from procyclic T. brucei cell sonicates. If 
the raising of a tightly binding peptide antisera specific for native DHlipDH is 
successful, preliminary immunofluoresence studies may be followed by more sensitive 
immunogold localisation studies to determine unequivocally whether a plasma mebrane
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location exists in procyclic T. brucei cells. Such studies may then be extended to other 
members of the Trypanosomatid family, namely Crithidia fasciculata and Phytomonas 
sp.
If the raising of a native DHhpDH-specific peptide antiserum is unsuccessfiil, 
DHlipDH localisation studies may be carried out in Crithidia fasciculata and 
Phytomonas sp. using cell fractionation techniques. Isolated plasma membrane 
fractions may be assayed for DHlipDH activity and compared to cell homogenate 
DHlipDH activity in order to gauged any DHlipDH enrichment in plasma membrane 
fractions. Determination of the purity of plasma membrane fractions would be 
imperative for interpretation of any findings, and purity may be assessed by the 
measurement of ‘marker’ enzymes for other cell organelles, or else by morphological 
examination under the electron microscope.
28
CHAPTER 2
MATERIALS AND GENERAL METHODS
(A) MATERIALS
All chemicals used in this work were of analytical grade or the finest grade 
commercially obtainable.
2.1 CELL CULTURE
2.1.1 General cell culture
All solvents and chemicals used in cell culture work were obtained from BDH 
Chemicals Ltd., Poole, Dorset. HEPES was obtained from the Aldrich Chemical Co., 
Gillingham, Dorset. L-glutamine (200 mM), penicillin/streptomycin (5000 I.W./ml and 
5000 mg/ml), phosphate buffered saline (Dulbecco’s formula) tablets were obtained 
from Flow laboratories, Irvine, Scotland.
All chemicals used in preparation of SDM-79 medium were obtained from Sigma 
Chemical Co., Poole, Dorset except Dulbecco’s modified Eagle medium powder, 
mediuml99, MEM amino acid solution (X50 concentration), MEM non-essential 
amino acids (X100 concentration), and Gentamycin which were obtained from Life 
technologies Ltd., Paisely, together with tissue culture medical flasks (25 cm2). Bovine 
serum albumin ( fraction V), triethanolamine, and haemin used in the preparation of 
Crithidia fasciculata culture medium were supplied by Sigma. Foetal calf serum was 
obtained from Globe Pharm, Esher, Surrey. Yeast extract, tween 80 and tryptone 
(‘bacto-tryptone) were supplied by Difco. Grace medium (without haemolymph) used 
in preparation of Phytomonas sp. growth medium was supplied by Gibco.
2.1.2 Organisms
Established procyclic cultures of T.brucei 427 were a gift from Dr. W. Gibson, 
Department of Pathology, University of Bristol Cultures of Phytomonas sp. f isolated 
from Euphorbia pinea) and Crithidia fasciculata (clone H56) were a gift from A. M 
Page, Department of Biochemistry, Royal Holloway University of London.
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2.2 PEPTIDE SYNTHESIS
All amino acid derivatives (table 1) and resin used for peptide synthesis were 
purchased from Milhgen (manufactured by Cambridge Research Biochemical Ltd). 
Piperidine (98%), 4-dimethylaminopyridine (DMAP,99%), 1-hydroxybenzotriazole 
hydrate (HOBT), dicyclohexylcarbodiimide (DCCI), and t-amyl alcohol (99%) were 
supplied by Aldrich (Gillingham, Dorset)
Trifluoroacetic acid (TFA) was supplied by Fluorochem, and distilled at atmospheric 
pressure for use in HPLC solvents.
Freeze-drying o f samples was achieved by solution in water, freezing in an acetone- 
solid CO2 bath, and vacuum evaporation on an Edwards Modulyo freeze-dryer.
Table 1; The amino acid derivatives used in peptide synthesis
Ala Fmoc-L-Ala-OPfp
Arg Fmoc-L-Arg(Mtr)-OPfp











Boc: tert -butylaxycarbanyl. 
tBu: tert -butyl.
Mtr: rnethoxytrimethylbenzene sulphonyl
OtBu: tert -butyl ester
CDhbt: 3, 4-dihydro-3-hydroxy-4-axD-l, 2,3-benzotriazol ester 
OPfp: pentafluorcpheny 1 ester
A polydimethylacrylamide resin was used for the synthesis o f  peptide DLD1, while a 
polyethyleneglycol polystyrene resin was used for the synthesis o f  DLD2. Both resins 
were supplied by Milhpore, UK
2.3 PREPARATION OF ANTI-PEPTIDE ANTIBODIES
Maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) and keyhole limpet 
haemocyanin (KLH) were supplied by Pierce (Chester). Sodium borohydride, 5,5’-
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dithio-bis-(2-nitrobenzioic acid) (DTNB) and dithiothreitol (DTT) were supplied by 
Sigma.
2.4 ENZYME- LINKED IMMUNOSORBENT ASSAY (ELISA)
Enzyme substrate, tetramethyl benzidine (TMB) was supplied by Sigma. Anti rabbit 
IgG-peroxidase was supplied by^mersham.
2.5 IMMUNOBLOTTING
Nitrocellulose strips were supplied by Millipore corporation, Bedford. Free peptide 
was synthesized according to sections 2.20 and 2.21 (The amino acid sequences of 
peptides DLD1 and DLD2 are detailed in section 2.20) and conjugated KLH-peptide 
was produced as described in section 2.18.2.
2.6 SDS POLYACRYLAMIDE GEL ELECTROPHORESIS
SDS, N,N’methylenebisacrylamide, acrylamide, TEMED, ammonium persulphate 
(AMPS) and bromophenol blue were supplied by BDH chemicals, Poole, Dorset, UK 
Molecular weight markers were obtained from Sigma.
2.7 IMMUNOLOGICAL DETECTION OF PROTEINS
Biotinylated goat(gt) anti-rabbit IgG was supplied by Sigma.
Vectastain ABC kit was supplied by Vector Labs, Peterborough . The kit utilizes a 
preformed Avidin:Biotinylated enzyme Complex (ABC) principle. Each kit is 
composed of biotinylated affinity purified primary antibody, Reagent A (Avidin DH 
solution) and Reagent B (biotinylated horseradish peroxidase).
2.8 IMMUNOPRECIPITATION
Goat anti-rabbit IgG, Protein A (non-viable Staphylococcus aureus) and polyethylene 
glycol (PEG) 6000 were supplied by Sigma. Microtitre wells (polystyrene) were 
supplied by Labsystems ( Life sciences International), Hampshire. High purity triton X- 
100 was from Pierce and Warriner (UK), Chester. Dihydrolipoamide was prepared by 
Keith Jolly at the University of Bath Biochemistry Department.
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2.9 IMMUNOFLUORESCENCE
Goat anti rabbit IgG-FITC conjugate, poly-L-lysine, rabbit anti-mouse IgG-FITC 
conjugate, normal rabbit serum and normal goat serum were supplied by Sigma. 
Vectorshield mounting fluid was supplied by Vector laboratories, Peterborough.
ROD1 monoclonal antibody was kindly donated by Prof Keith Gull, University of 
Manchester.
2.10 ISOLATION OF CRUDE PLASMA MEMBRANE FRACTIONS FROM 
CRITHIDIA FASCICULATA AND PHYTOMONAS SR
Tris, EDTA (disodium ethylene diamine tetra-acetic acid), PMSF 
(phenylmethylsulphonylfluoride) and leupeptin (synthetic hemisulphate) were supplied 
by Sigma. Tris - EDTA buffer consisted of 0.5 M Tris-HCl and 0.1 M EDTA and pH 
adjusted to pH 7.8 at 4°C using sodium hydroxide. Leupeptin (2pg/ml) was dissolved 
in methanol and added to buffers with vigorous stirring, and PMSF (in 100 pi of 
dimethyl sulphoxide) added to warmed buffers, including sucrose solutions used in 
sucrose density gradient ultracentrifiigation, with vigorous stirring to give a final 
concentration of 1 mM. Silicon carbide abrasive grain, -400 mesh was supplied by 
Aldrich Chemical Company, Inc. Analar sucrose was supplied by Fisons PLC. Sucrose 
solutions were prepared by dissolving sucrose in warmed Tris-EDTA buffer containing 
PMSF (ImM). All sucrose solutions were chilled on ice before use
2.10.1 Protein determination of isolated plasma membrane fractions
Plasma membrane protein concentration was found using a protein assay k it, supplied 
by Sigma ( Cat. No. P5656), based on Peterson’s modification of the micro-Lowry 
method (Peterson, 1977). Interference in the direct Lowry procedure is caused by 
commonly used chemicals including tris, EDTA and sucrose. The procedure with 
protein precipitation, which uses DOC (deoxycholate) and TCA (trichloroacetic acid), 
eliminates all these interferences. Lowry reagent solution (Cat. No. L1013) and Folin 
and Ciocalteu’s Phenol reagent (Cat. No. F9252) were supplied by Sigma.
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2.10.2 Marker enzyme assays to determine purity of plasma membrane fractions 
DL-isocitrate, dihydroxyacetone phosphate, potassium chloride and magnesium 
chloride were supplied by Sigma Chemical Co. (Poole, Dorset). Phosphoenol pyruvate 
(PEP, monohexylamine salt) and disodium adenosine diphosphate (ADP), were 
purchased from BDH Chemical Co. Nicotinamide adenine dinucleotide (oxidised and 
reduced forms, NAD+ and NADH respectively) and lactate dehydrogenase (pig heart,
300p/mg protein, 5mg protein/ml) were supplied by Boehringer Mannheim, Germany. 
Analar sucrose and triethanolamine hydrochloride (TEA), were purchased from Fisons 
Pic., and Ultrapure Triton X-100 from Pierce Chemical Co., U.S.A. Dihydrolipoamide 
was a gift from Keith Jolly, Bath University, Bath, United Kingdom Adenosine 
monophosphate, [3H] labelled in the adenosine moiety (250pCi; specific activity 18.9 
CM mmole) was obtained from Amersham for use in the 5’ nucleotidase assay. A stock 
solution was prepared by addition of 50 % ethanol to give a final volume of 2 ml, and 
was stored at -20°C. Piperazine, magnesium chloride hexahydrate and f3- 
glycerophosphate were supplied by Sigma. Non-labelled AMP was supplied by 
Boehringer Mannheim
2.10.3 Electron microscopical examination of plasma membrane fractions
Electron microscopy grade reagents ( uranyl acetate, lead citrate) and copper grids 
were supplied by the University of Bath Electron Microscopy Unit. Epoxy resin (Taab 
premix, medium hardness) and osmium tetroxide (OSO4) were supplied by Taab 
laboratories Ltd., Aldermaston, Reading, Berkshire. Glutaraldehyde and plastic truffs 
were supplied by Agar Aids Ltd.. Analar grade cacodylate (sodium dimethyl arsenic 
acid) was supplied by Sigma Chemical Co., Poole, Dorset. Thin sectioning was 
performed on a Reichert Om U3 ultramicrotome supplied by Reichert-Jung Ltd., 
Slough, Berkshire. Electron microscopy was carried out on a JEOL 100CX 




All equipment such as bottles, tubes, Pasteur pipettes, plastic tips and solutions 
such as HEPES and PBS were sterilised by autoclaving at 15 lb/in^ for 20 minutes. 
Freshly prepared medium was filter sterilised using Millip ore 0.22 pM filter units. All 
experiments requiring sterile conditions were performed in a bench laminaflow hood.
2.13 PREPARATION OF CULTURE MEDIA
2.13.1 T.brucei culture medium
Procyclic forms of T.b.brucei were grown in SDM-79 medium ( table 2).
Table 2: SDM-79 Medium for the growth of procvclic forms of T. b. brucei
(Bran and Shoenberger, 1979)
Ingredients per litre
Dulbecco’s modified Eagle medium powder 7.0 g
Medium 199 powder 2.0 g
MEM amino add solution 8.0 ml
















D(+)Glucosamine HCL 50 mg
Folic add 4 mg
p-Aminobenzoic add 2 mg
Biotin 0.2 mg
Penidllin solution 12 ml
Gentamycin 20 mg
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All the ingredients were dissolved in 1/4 of the final volume, then both MEM amino 
acid solutions were added, and the pH adjusted with 4 M NaOH to pH 7.3. The 
medium was adjusted to final volume and filter sterilised with Millip ore 0.22 pM filter 
units. To this solution was then added 2 ml of filter sterilised haemin solution (2.5 
mg/ml in 50 mM NaOH) and the whole stored at -20°C in 100 ml quantities. Before 
use the medium was supplemented with 10% v/v sterile foetal calf serum (heat 
inactivated) and glutamine (10 mM).
2.13.2 Phytomonas sp. culture medium
Stock solutions of bovine serum ( BSA fraction V ), yeast extract, HEPES and 
antibiotic (0.3 g penicillin and 0.5 g streptomycin) were made up using double distilled 
water and then filter sterilised.
100 mis of growth medium was prepared aseptically as follows:
Grace’s medium*(without haemolymph ) 83 ml
BSA fraction V 1% w/v 5 ml
Yeast extract 1 % w/v 2.5 ml
Foetal calf serum 10% v/v 10 ml
HEPES (1M) 1% v/v 1 ml
Penicillin 500 IU/ml & Streptomycin 500 mg/ml 1 ml
The complete medium was stored at -20 °C.
* Ref. Grace, (1962)
2.13.3 Crithidia fasciculata culture medium ( Shim and Fairlamb, 19SS)
A culture medium was prepared by autoclave sterilising a mixture containing 
5g yeast extract, 4g tryptone, 15g sucrose, 2.5g triethanolamine and 5g tween 80, 
made up to 1 litre with distilled water. The pH was adjusted to 8.00 if necessary. An 
antibiotic stock solution of 200 mg per ml streptomycin, plus a 2 mg per ml solution 
of haemin (with a drop of 880 ammonia), were made up in distilled water. Both 
antibiotic and haemin stocks were filter sterilised. A 1 ml aliquot of each stock 
solution was added to the medium, upon cooling after autoclaving, to give a final
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concentrations of 0.2 mg per ml streptomycin and 2pg per ml haemin. The complete 
medium was stored at 4 °C.
2.14 IN VITRO CELL CULTIVATION
2.14.1 In Vitro Culture Of T. brucei Procyclic Trypomasigotes
Procyclic trypomastigotes were stored in liquid nitrogen under sterile 
conditions at a density of about 0.5 - 1 x 107 cells/ml in a 1.8 ml volume. When 
required, the tube containing the procyclics was thawed quickly and added to a culture 
flask containing 10 ml of warmed complete SDM-79 medium The culture was 
incubated at 27°C in an incubator. Once in culture, they grew very quickly and reached 
a density of 2-3 x 107 cells /ml. They were then subcultured at a density of 1-5 x 105 
cells/ml. The procyclics could be subcultured continuously for many months.
2.14.2 In vitro culture of Phytomonas sp. promastigotes
Frozen Phytomonas sp. isolates were prepared asceptically. 3 ml of culture 
(approximate density of 1 x 107 cells per ml) was spun for lOmins at 2000g and 
resuspended in 900 pi of fresh sterile medium 100 pi of filtered DMSO was then 
added. Isolates were frozen for 48 hours at - 80 °C before being transferred to liquid 
nitrogen. When required, a tube containing the Phytomonas sp. isolate was thawed 
quickly and added to a culture flask containing 20 ml of warmed complete Graces 
medium The culture was mixed gently and then incubated at 28 °C . The 
promastigotes grew quickly, reaching a maximum density of 1 - 1.4 x 107 cells per ml. 
This cell density signified the end of the parasites’ log phase growth. They were then 
subcultured at a density of lx 104 cells per ml and continually passaged into fresh 
medium on reaching a cell density of around lxlO7 cells per ml (approx. every 5 days).
2.14.3 In vitro culture of Crithidia fasciculata choanomastigotes
Crithidia fasciculata cells at a density of 5 x 108 cells per ml were stored at 
4°C for up to 4 weeks. They were then passaged into warmed complete medium in a 
ratio of 1:1000 of inoculum to medium The culture was mixed gently and placed in 
an incubator at 28°C where growth was very rapid, achieving a density of around 
5xl08 cells per ml in about 48 hours. Cells were passaged typically every 48 hours.
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2.15 PROTEIN ESTIMATION 
The Bradford dye-binding method
Protein determination was carried out using Coomassie brilliant blue (G-250). 
150 mg Coomassie G-250 was dissolved in 250 mis of 0.3M perchloric acid (PCA) 
and the reagent then filtered using whatman No. 1 filter paper. Assays were carried out 
in 3 ml cuvettes, to which 50pl sample, 0.95 mis phosphate buffer (pH 7.2) and 1 ml 
reagent were added. Protein content was assessed by measuring absorbance at 595 nm 
between 10 min and 1 hr after mixing by inversion. Cell samples were suspended in 
200 pi PBS and 200 pL of 0.3M NaOH to lyse the cells prior to assay. A blank, of 1 
ml dye reagent plus 1 ml PBS, was used in each assay. A standard curve, using BSA ( 
stock concentration of 1 mg/ml) was set up for each assay, using BSA in the range of 
5-50 pg/ml.
2.16 PEPTIDE SYNTHESIS
Two synthetic peptides, each of 15 amino acid residues (DLD1 and DLD2, 
corresponding to residues 130-144 and 228-242 of the bloodstream DHlipDH 
sequence respectively) were chosen ( section 3.2) and synthesised as described below. 
The exact amino acid sequence of both peptides were as follows:
DLD1 (130-1441
130 144





2.16.1 Assembly of peptide
The solid resin supports used (PepSyn-KA or PEG-PS) were commercially available 
with the C-terminal residue already attached via a benzyl ester linkage and the amino 
group protected by an Fmoc group. After solvation of the Fmoc protected C-terminal 
residue attached to the resin support with dimethylformamide (DMF), the reaction 
column was packed and the resin washed with DMF. The Fmoc-protecting group was 
removed by treatment with 20% piperidine for 9 minutes, followed by removal of 
piperidine and the protecting group reaction product with DMF. The next activated 
Fmoc-amino acid was dissolved in a solution of 5% w/v 1-hydroxy-benzotriazole 
(HOBT), 0.25% w/v Acid Violet-17 (AV-17), and 0.07% v/v diisopropylcarboiimide 
(DIEA), made up in DMF. The HOBT acted as a catalyst for the formation of a 
peptide bond between the activated ester group of the new Fmoc amino acid and the 
deprotected amine group of the amino acid linked to the soluble support. The AV-17 
and the DIEA were included to check completion of the coupling reaction prior to 
deprotection by spectrophotometric monitoring of the synthetic cycles. The activated 
Fmoc amino acid was added to the polymer support and allowed to circulate through 
the reaction column. After subsequent washing away of excess reagent and co­
products, the Fmoc protecting group of the new terminal amino acid was removed by 
treating with piperidine. This cycle was repeated for every amino acid in the chain. 
Elongation of the peptide chain was performed stepwise until the N-terminal amino 
acid was reached. Before cleavage of the peptides from the resins, both peptides were 
extended with two more amino acid residues using the same Fmoc technique. The 
additional amino acids were glycine, which was used as a spacer, and cysteine. The 
cysteine residue was added to the amino terminus of the peptides to allow coupling to 
a protein carrier.
After complete assembly of the extended peptide, final deprotection 
was carried out using 20% piperidine in DMF. The column was removed from the 
peptide synthesiser and the contents of the column (peptide-resin) were washed serially 
with 40ml each of t-amyl alcohol, acetic acid, t-amyl alcohol, dichloromethane and 
diethyl ether, after which the resin was dried using nitrogen gas.
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2.16.2 Cleavage of the assembled peptide from resin and deprotection of side chain 
protecting groups
The processes of cleavage of peptide from the resin support and removal of 
side chain protecting groups were combined. The benzyl ester linkage of peptide to 
resin can be easily cleaved by 90% trifluoroacetic acid (TFA). However this acidic 
cleavage can lead to the generation of carbocations, which may react with electron-rich 
amino acid side chains. In order to reduce the potential risks these carbocations posed, 
carbonium ion scavengers were added to the cleavage reagent. Hence the cleavage 
reagent was made up of a mixture of 90% TFA, 5% thioanisole, 3% ethanedithiol, and 
2% anisole under an atmosphere of nitrogen to prevent oxidation. The required 
amount of peptide-resin was weighed out and suspended in 1 ml freshly prepared 
cleavage reagent and allowed to react at room temperature.
In order to test the suitability of the chosen cleavage conditions, the cleavage 
was first performed on a 50 mg sample of the resin dissolved in 1 ml of cleavage 
reagent The process was monitored by removal o f200 pi samples at time intervals of 1 
hr, 2hr and 4hr for DLD1 and 2 hr, 4hr and 8 hr for DLD2. All the peptidic 
components were isolated with two rounds of washing with petroleum ether, followed 
by two rounds of di-ethyl ether washing, and the resulting white precipitates were 
suspended in 500pl 5% acetonitrile + 1% TFA. Analytical HPLC was then performed 
on the samples.
Once the optimum conditions for the cleavage and deprotection had been 
elucidated, the process could be scaled up to a more significant quantity of the peptide- 
resin (approx. lg) ie. a preparative run could be performed. The preliminary analytical 
HPLC run (see chapter 3) showed that DLD1 and DLD2 existed in both monomer 
and dimer forms and so had to be reduced into the monomer form using DDT (500 pg 
/ ml for DLD1, 250 pg / ml for DLD2) overnight prior to the preparative purification 
by HPLC.
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2.17 REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Analytical HPLC was carried out on a LKB Bromma Analytical HPLC under 
anaerobic conditions to ensure collection of peptide in the reduced form. Preparative 
HPLC was performed using a Millipore Waters system Separations were effected on 
VYDAL C18 wide pore reversed phase columns (300A pore size, 5pi particle size). 
Analytical runs were performed on columns 4.9mm by 25 cm at a flow rate of 0.7ml / 
min. Preparative HPLC was performed on columns 25mm by 25cm at a flow rate of 10 
ml / min using a 0.1%TFA / acetonitrile solvent.
As with the cleavage / deprotection step, a trial run was initially performed to 
determine the acetonitrile : water ratio at which the peptide peak would elute from the 
HPLC column. Prior to loading the crude preparation onto the HPLC column, it was 
filtered to remove any insoluble particles that would disrupt the chromatography and 
the peptide was eluted from the column with a linear gradient (from 5% to 95%) of 
acetonitrile in 0.1% TFA. The preparatory HPLC was then run using all of the 5% 
acetonitrile solvated peptide and when the peak came off fractions were collected 
every 20 seconds. Fractions from the start and finish of the peak and two from the 
middle of the peak were then re-analysed using the analytical HPLC. Clean fractions 
were pooled and then freeze dried under nitrogen overnight to remove TFA. Rotary 
evaporation under water pump vacuum without heating was then performed to remove 
acetonitrile. The dry purified peptide was stored at -20°C.
2.18 PREPARATION OF ANTI-PEPTIDE ANTIBODIES
The extended peptides were coupled to the carrier protein keyhole limpet 
haemocyanin (KLH).The carrier protein was activated with N-maleimidobenzoyl-N- 
hydroxysuccinimide ester (MBS) and subsequently coupled to the peptide through its 
cysteine residue (Green et al, 1982).
For optimum peptide - carrier coupling to occur, it was essential that the 
peptide to be coupled had a fidly reduced terminal cysteine group, so avoiding the 
tendency towards dimerisation which was observed in the preliminary HPLC run ( 
chapter 3).This was achieved by purifying both peptides, following reduction with 
DTT, by HPLC under anaerobic conditions, Le. using nitrogen purged reagents and 
performing all operations under nitrogen gas. (section 2.17)
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2.18.1 Conjugation method
1 ml KLH was dialysed (20 mg/ml'1) in 10 mM potassium phosphate pH 7.2 
overnight against 20 ml 10 mM potassium phosphate pH 7.2 at 4°C. The concentration 
was adjusted to 16 mg KLH ml'1 prior to use. For each peptide, 4 mg KLH in 250pl of 
10 mM potassium phosphate buffer (pH 7.2) was reacted with 0.7 mg MBS 
(dissolved in 50 -70 pi dry DMF) which was added dropwise with stirring for 30 min 
at room temperature. 300 pi of the reaction product was added to a characterised P-30 
Biorad column (1.5 x 13 cm , void volume 3.2 mis), equilibrated with 50 mM sodium 
phosphate buffer, pH 6.0, to remove free (unreacted) MBS. The KLH - MBS 
conjugate was recovered by pooling fractions from the first peak of the column eluate 
(monitored by absorbance at 280nm ) and then reacted with peptide (5 mg dissolved in 
1 ml phosphate buffer pH 7.2). The pH was adjusted to pH 7-7.5 and the reaction was 
stirred for 3 hr at room temperature. Solid NaCl was added to a final concentration of 
0.9%. The peptide conjugate was stored in 0.5 ml aliquots (1 mg peptide/ml) at - 
20°C.
2.19 IMMUNISATION METHOD
A total of four rabbits were used, two for each peptide-carrier conjugate. Each 
conjugate aliquot (0.5 mis) was mixed 1:1 with an aluminium hydroxide based 
adjuvant (Pierce Imject Alum) by gently vortexing for 10 min. Rabbits were immunised 
subcutaneously with 1ml of immunogen (500 pg protein) at 5 sites both for the original 
injection and for all booster injections according to the following schedule:
day 0 1st injection
week 4 1st booster injection
week 8 2nd booster injection
week 16 3rd booster injection
A test ear-bleed of 10-15 ml was taken 10 days after each boost.
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2.20 PREPARATION OF ANTISERA
Fresh rabbit blood was left for 4-5 hr at room temperature, then overnight at 
4°C for clotting. The clots were removed (and any free serum collected) and then 
centrifuged at 2000g for 15 mins at 4°C. Serum so obtained was pooled with the free 
serum already collected and was given a second centrifuge at 1 lOOOg (10,000 rpm) for 
15 mins. Serum was collected and stored in aliquots at -20°C.
2.21 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
A standard ELISA assay was performed based on the method of Engvall, (1980). 
Reagents for the assay were made up as follows:
(i) Solutions:
a) Coating buffer : 0.05M sodium carbonate buffer, pH 9.8
b) PBS / tween : PBS with 0.1 % v/v tween-20
c) Acetate buffer : 50 mM sodium acetate/citric acid pH 6
(ii) Substrate:
Stock solution: Tetramethyl benzidine (TMB) 10 mg/ml in dimethylsulphoxide 
(DMSO)
Enzyme substrate solution (freshly prepared prior to immediate use): 50 mM 
sodium acetate/citric acid pH6 + 0.1 mg/ml TMB (diluted from 10 mg/ml stock) +
0.006% hydrogen peroxide.
(iii) Enzyme -antibody Conjugate:
Anti - rabbit IgG-peroxidase. Stock conjugate was stored at -20°C as a 1:1 
dilution of commercially obtained antibody in glycerol.
The anti-rabbit IgG peroxidase was used as a suspension in PBS / tween ( 10 
mis of diluted stock antibody conjugate per plate).
In this assay, the antigen was immobilised by direct attachment to a solid plastic 
96- well support. Wells were coated with a solution of peptide / protein (lOpg protein 
/ ml) in coating buffer (lOOpl per well) for 18 hrs at 4°C. The wells were washed at 
room temperature with three successive portions of PBS/tween and then each well
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was blocked by incubation with 250-300pl of 1% (w/v) casein in PBS / tween for 1 hr 
at room temperature followed by two washes with PBS / tween. Serial dilutions of the 
test antisera in PBS / tween were performed (the highest dilution being 1/50, then 
1/100, 1/200 and so on). The plates were incubated for 2 hrs at room temperature and 
then each well washed three times with PBS / tween. To each well was added 100 pi 
anti rabbit-IgG-peroxidase conjugate (stock diluted 1 in 1000 in PBS/tween) and the 
wells were left to incubate for 2 hrs at room temperature. After washing three times 
with PBS / tween and then twice with PBS, lOOpl of the enzyme substrate (TMB) 
solution was added and the resulting colour allowed to develop for between 5-15 mins 
at room temperature. The reaction was stopped by adding 50pl of 1.84M sulphuric 
acid and the colour produced was read using a ‘Titertek Uniskan” microtitre plate 
reader with a 405nm filter.
2.22 PREPARATION OF CELLS FOR ENZYME ASSAY
Two 10 -15 ml aliquots of cell suspension were removed into 15 ml falcon 
tubes and cooled to 4°C on ice for 5 minutes. The cells were then pelleted by 
centrifugation at 2000 g for 10 minutes. The supernatant was removed and the cells 
were washed by alternately suspending and pelleting in fresh PBS using a bench 
mictofuge. After washing in PBS was complete, each pellet was suspended in 1ml PBS 
and the pellets combined in one tube. The number of cells per ml was determined using 
a haemocytometer and 1 ml aliquots typically containing between lxlO7 and lx 108 
cells in PBS were placed in plastic eppendorf tubes for sonication.
2.23 PREPARATION OF SONICATED CELL LYSATE
Sonic extracts of procyclic T.brucei, Crithidia fasciculata and Phytomonas sp. 
were prepared by sonicating cells in eppendorf microfuge tubes for 3 x 30 seconds at 
40w using a 3mm probe. Sonication tubes were incubated at 4°C to minimise heating 
effects, and each 30 second sonication was separated by a 30 second time period to 
allow maintainance of the temperature at 4°C. Cellular debris, observed as a small 
insoluble pellet, was removed by microfuging for 5 minutes at 10,000g and the 




Nitrocellulose paper was cut into strips of 4cm by 10cm The strips were 
washed by floating in approximately 20 ml of distilled water and then dried at room 
temperature. The strips were spotted with 5 pi of protein (see table 3) and allowed to 
dry for 30 minutes at room temperature.
Dot No. Protein Amount, protein per dot
1 KLH-peptide Ipg
2 Free peptide lOpg
3 Sonicated cell lysate 5 x 10 6 cells
4 KLH Ipg
Table 3: Protein antigens used in immunoblot experiments for testing cross-reactivity of raised 
immune and preimmune sera. Sonicated cell lysates were prepared as detailed in section 2.24
Strips were washed by floating in 20 ml PBS and then incubated with blocking 
agent ( 10 % v/v foetal calf serum in PBS/tween) for 2 hrs at room temperature with 
gentle agitaton. The strips were washed in 20 ml PBS/tween and then incubated with 
antiserum/pre-immune serum by immersing in 20 mis of serum (diluted 1/100 in PBS/ 
tween) at 4°C overnight with gentle agitation.. Controls received fresh PBS/tween 
only. Antibody binding was detected as described below.
2.24.2 Immunological detection of protein blots
The method of detection employed is described by Towbin et al, 1979.
The method used labeled antibodies to increase the size of the immune complex, 
leading to increased sensitivity. In this case, biotinylated horseradish peroxidase was 
mixed with avidin ( Hsu et al, 1981; Kendall et al, 1983). Because avidin is 
tetravalent, the biotinylated enzyme and avidin can associate to form large biotin 
binding enzymatically active complexes. These complexes can then be used to bind to 
the antigen through a biotinylated anti-immunoglobulin antibody.
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Washed electrophoretic blots were soaked in blocking agent (PBS containing 
1% v/v Tween-20 and 10% v/v foetal calf serum) for 1 hr at room temperature to 
saturate additional protein binding sites. The blots were then rinsed in PBS/Tween-20 
and incubated with probing antibody ( immune serum from rabbits immunised with 
synthetic peptide DLD1, diluted 1/100 in 0..1 % v/v tween 20/PBS) and then left to 
incubate overnight at 4° C with constant agitation. Controls were performed using 
preimmune rabbit serum similarly diluted.
Following this, the strips were washed four times in 20 ml 0.05% PBS/Tween- 
20, to remove non-specifically bound antibodies or serum proteins, and were then 
incubated in a recommended (Sigma) dilution ( 1 in 500 in PBS/tween) of biotinylated 
anti-rabbit IgG. In parallel with this, the avidin ( reagent A) and biotinylated 
horseradish peroxidase (reagent B) were each dilured 1/500 in PBS/tween and 
incubated together in a ratio of 1:1 for 1 hour according to Vectastain kit instructions.
Strips were incubated in 20 mis of the resulting avidin-biotinylated Horse 
radish peroxidase for 1 hr at room temperature. The strips were then washed four 
times ( for 5 min) in PBS / Tween-20 and then once in PBS.
2.25.3 Staining procedure
4-Chloro-l-Naphthol (0.3% (w/v)) in methanol was diluted with PBS, to give 
a final concentration of 0.06% w/v. 30% hydrogen peroxide (0.5 pl/ml) was added and 
strips were incubated in the substrate solution. A positive result was indicated by the 
development of an insoluble blue product spot in the exact location of the origional 
antigen spot. This was clearly visible within 30 mins of substrate incubation. Colour 
development was terminated by several washes in 20 ml distilled water followed by 20 
ml PBS. Finally, the nitrocellulose pieces were dried between filter papers.
2.25 WESTERN (PROTEIN) BLOTTING
2.25.1 SDS Polyacrylamide Gel Electrophoresis
2.25.1.1 Resolving and stacking gels: Slab gels were prepared by using a
vertical slab gel apparatus (Biorad Proteam TMN). The chemical compositions of the
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resolving and stacking gels used in the sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) are listed in table 3:
Table 4: Chemical compositions of resolving and stacking gels
Chemicals Resolving gel Stacking gel (ml)
Acrylamide stock (25% (w/v) in H20; 
24.4% acrylamide in H20, 0.6% (w/v) bis 
acrylamide in H20
(ml) 16 2
1M Tris/HCl, pH 8.8 15 -
1M Tris/HCl, pH6.8 - 1.25
distilled H20 7 1-25 6.3
6.3
The above reagents were mixed in the ratios described and then degassed and the 
following reagents were then added:
Resolving gel (ml) Stacking gel (ml)
10% SDS (w/v) in H20 0.4 0.1
N,N,N’ ,N’-T etramethyl- 
ethylene
diamine (TEMED) in H20
0.025 0.01
1.5% (w/v) ammonium- 
persulphate in H20
0.9 0.35
The addition of ammonium persulphate and TEMED resulted in polymerisation of the 
gels.
2.25.1.2 Electrophoresis buffer for SDS-PAGE, contained 0.13 M glycine,
0.025M Tris and 0.1% (w/v) SDS at a final pH 8.3. Approximately 2.5L of buffer 
were used to run each gel.
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2.25.1.3 Sample buffer : 0.125 M Tris-HCl pH 6.8 containing 50% w/v glycerol, 
10% (w/v) SDS, 10% (w/v) 2-mecaptoethanol and 0.01% (w/v) bromophenol blue. 
Samples were diluted in sample buffer and then boiled for 2 minutes to ensure 
complete denaturation.
2.25.1.4 Protein standards for SDS gels
1. 150 pi sonicated cell lysate (containing 4xl06 cells) per lane (section 2.4)




Phosphorylase B 97.4 kD
Galactosidase 116kD
Myosin 205kD
2.25.2 Running of SDS-PAGE
SDS gels (stacking gel (5% w/v polyacrylamide), resolving gel (10% w/v 
acrylamide) were prepared according to the method of Laemmli (1970)
Protein samples were prepared in sample buffer and boiled as detailed in 
section 2.26.1.3 and then loaded onto the stacking gel and run at 70 volts (15 mA/gel) 
until the bromophenol blue dye bands reached the resolving gel. The voltage was then 
increased to 170 volts (30mA/gel) for the remainder of the run ie. until the 
bromophenol blue reached the bottom of the gel.
2.25.3 Electroblotting
Electrophoresis was used to transfer the proteins from the polyacrylamide gels to 
nitrocellulose sheets ( Tsang et aL, 1983)
The gel was placed on top of a sheet of filter paper (Whatman, 3 mm) already 
saturated in blotting buffer (25 mM Tris buffer, pH8.3, containing 192 mM glycine and 
methanol to a final volume of 20%). A nitrocellulose sheet, which was also saturated in 
blotting buffer, was then placed on top of the gel, followed by a second filter paper 
sheet. This sandwich was placed between two sponge pads and supported between 
parallel electrodes in a reservoir tank filled with blotting buffer (Bio Rad transblot 
vertical tank). The sandwich was positioned so that the nitrocellulose sheet was
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between the gel and the anode. A current of 30 volts ( 0.1 amps) was passed through 
overnight at 4 °C , resulting in the transfer of proteins from gel to nitrocellulose sheet.
2.25.4 Staining of proteins on nitrocellulose paper using Ponceau S stain
Following the transfer of proteins, the nitrocellulose sheet was stained with 
Ponceau S to facilitate visualisation of the transferred protein bands ( Klein et a l, 1995 
). Electrophoretic blots were washed with PBS, pH 7.3 for 15 mins, then rinsed twice 
with PBS and stained in Ponceau S ( 0.1% (w/v) in trichloroacetic acid) to visualise 
the transferred bands which appeared within 20 mins and the nitrocellulose sheet was 
cut into appropriate sections. The nitocellulose blots were then quickly washed four 
times with 20 ml PBS ( approximately 5 mins each wash) to remove the stain. 
Immunological detection of protein blots was performed as detailed in section 2.24.2.
2.26 IMMUNOFLUORESCENCE
The entire procedure was carried out employing sterile technique and using sterilised 
materials and was based on the method detailed by Sherwin et al (1987).
13 mm diameter glass covershps were placed in plastic welled plates. The 
coverslips were prepared by coating with poly-L-lysine solution (5 pg/ml in 100 mM 
borate buffer, pH 8.2 ) for one and a half hours at room temperature. T.b.brucei 
procyclic cells, grown to a cell density of 3xl06 cells / ml were harvested by 
centrifugation at 2000g in a bench centrifuge for 3 minutes. Cells were washed twice in 
PBS by low speed centrifugation and the cells suspended in PBS to give a final cell 
density of 3 x 106 cells/ml PBS. 250 pi of the trypanoso'mal cell suspension was added 
to each well containing a polylysine-coated coverslip and the cells were allowed to 
settle for 1 hr at 25 °C.
The cells, now bound to the covershps, were then fixed in methanol at -20 °C 
for 1 hr, after which they were rehydrated by washing three times in PBS (0.5 mis per 
well). Cells were blocked using 0.5 mis 10% v/v FCS in PBS/tween per well for 1 hr at 
room temperature to reduce any non-specific serum protein binding and then incubated 
with various dilutions of antiserum / preimmune serum (in PBS/tween ) for 1 hr at 26 
°C. The coverslip-containing wells were then washed three times with PBS/tween (10
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mins per wash). Secondary antibody, goat antirabbit-FITC conjugate , diluted to an 
appropriate working dilution (determined to be 1/100) in PBS/tween was added to the 
cells ( 250 pi per well) for 1 hr at room temperature. Slides were washed three times 
in PBS ( 10 mins per wash ) before adding 10 pi of Vectorshield mounting fluid. 
Coverslips were then viewed using an inverted fluorescent microscope.
2.27 ISOLATION OF CRUDE PLASMA MEMBRANE FRACTIONS FROM
CRITHIDIA FASCICULATA AND PHYTOMONAS SP.
Many of the techniques that are used for the isolation and characterisation of 
plasma membranes have been reviewed by DePierre and Kamovsky (1973). The most 
critical part of the preparative procedure has been found to be at the cell 
homogenisation step (Voorheis et al, 1979) where it was important to lyse cells while 
retaining the microtubule-pellicular membrane association characteristic of 
trypanosomatid flagellates. Various methods of trypanosomal cell disruption have been 
reported in the literature, although no one type of method has been shown to be 
satisfactory. For example osmotic lysis yielded resealed ‘ghosts’ (Voorheis et al, 1979) 
with many trapped organelles that made further fractionation difficult, while even mild 
sonication gave rise to small vesicles that lacked the characteristic morphological 
feature ( microtubular array) of plasma membranes in trypano somes. The 
homogenisation procedure employed in this study to prepare plasma membrane sheets 
used a combination of two different techniques, osmotic stress and mild mechanical 
force. The procedure involved cell swelling followed by manual grinding with silicon 
carbide in a pestle and mortar as described by Toner and Weber (1972).
2.27.1 General procedure
The plasma membrane isolation process employed in this study was based on 
that developed by Dwyer et al (1980) and Voorheis et al (1979) and culminated in the 
isolation of a plasma membrane band by discontinuous density-gradient 
ultracentrifugation
C. fasciculata and Phytomonas sp. cells, at a cell density of 1.5 x 108 cells per 
ml, were rapidly chilled on ice and then harvested by centrifuging for 10 minutes at
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lOOOg. Cells were washed twice in ice cold PBS , centrifuging for 8 minutes at 1600g 
between washes. The washed, pelleted cells were weighed and resuspended in 1 ml 
chilled isolation buffer ( tris-EDTA buffer (pH 7.8) containing leupeptin (2pg/ml) and 
PMSF (ImM)) and then transferred to a chilled mortar. Chilled silicon carbide abrasive 
grain was added to the mortar (approximately 60:40 gm carbide/ gm wet weight) and 
the cell paste was ground manually using a chilled pestle until light microscopic 
examination showed that approximately 90% or more o f the cells were lysed 
(Opperdoes et al, 1977). The suspension was diluted with 5 ml chilled isolation buffer 
and spun for 3 minutes at 120 g to remove the carbide. The supernatant was carefully 
removed and centrifuged for a further 10 minutes at 4,000 g at 4 °C. The pelleted 
material was suspended in 6 ml 0.146 M sucrose solution (dissolved in tris-EDTA 
containing 1 mM PMSF) and the pellet disrupted by 2 passages through a 22 gauge 
needle. The suspension was then overlaid onto a discontinuous sucrose gradient 
consisting o f  a 1.61 M sucrose cushion (5ml) and a 1.17M sucrose layer (15 ml), and 
spun in a Beckman L5-50B ultracentrifuge at 27,000 rpm (4 °C ), for 2 hours using an 
SW27 rotor ( Dwyer, 1980)
A dense ‘plasma membrane4 band formed at the 1.61 M / 1.17M interface 
( Fig. 7) and was collected by careful removal o f gradient layers using a pipette. This 
was diluted to approximately 10% (v/v) sucrose with Tris-EDTA buffer and 
ultracentrifuged for a further 2 hours at 27,000 rpm. The resulting pelleted membranes 
were washed twice in PBS by centrifugation as described above and finally suspended 
in 1 ml PBS for analysis.
Fig. 7 Isolation o f  plasma membrane fraction on discontinuous sucrose gradient














2.27.2 Protein determination of isolated plasma membrane fractions
Protein was determined by Peterson’s modification of the micro-Lowry method 
(Peterson, 1977). 1 ml deoxycholate solution (1.5 mg per ml in double distilled water) 
(see materials, section 2.10.1) was added to tubes containing protein standard 
solutions or protein sample diluted to 1 ml with double distilled water. Tubes were 
mixed well and allowed to stand for 10 mins at room temperature. Precipitation of the 
trypanosomal proteins with 7.2% (w/v) trichloroacetic acid was followed by the 
resuspension of the precipitated pellet in 1 ml Lowry reagent solution (see materials, 
section 2.10.1). After a 20 min incubation at room temperature, 0.5 ml Folin and 
Ciocalteu’s Phenol reagent was added to each tube. Colour was allowed to develop for 
thirty minutes and absorbance readings taken at 750 m  Readings were completed 
within 30 mins. Bovine serum albumin ( Fraction V, Sigma) was used as a protein 
standard and sample protein concentrations determined from a standard calibration 
curve performed each assay.
2.27.3 Enzyme Assays
2.27.3.1 Dihydrolipoamide dehydrogenase (DHlipDH)
DHHpDH was assayed by following the oxidation of dihydrolipoamide to lipoamide, 
with the concurrent reduction of NAD+ to NADH, resulting in an increase in 
absorbance at 340 m
dihydrolipoamide + NAD + _^yfa°lip°an]ide lipoamide + NADH + H +
dehydrogenase
The assay took place in a 1 ml cuvette containing 50 mM potassium phosphate (pH
7.0) , 2 mM EDTA, 0.14 mM dihydrolipoamide, 1 mM NAD+ and 0.1% triton x-100. 
The assay was started with the addition of 5 - 100 pi enzyme-containing sonicated cell 
lysate (depending on the particular experiment) and progress was monitored by the 
increase in absorbance at 340 nm.
2.27.3.1.1 ‘No dihydrolipoamide’ controls
Control assays were routinely performed in the absence of dihydrolipoamide substrate. 
Any observed increase in absorbace at 340nm, due to endogenous enzyme activity, 
was subtracted from experimental rates.
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2.27.3.1.2 Alcohol dehydrogenase control
Alcohol dehydrogenase activity was assayed for in 50 mM potassium phosphate buffer 
pH 7, 2mM EDTA, ImM NAD and 20pl of absolute ethanol in a final volume of 1 ml.
2.27.3.2 NADH oxidising activity
A NADH oxidase assay was performed on both Phytomonas sp. and 
Crithidia fasciculata cell sonicates to ensure that any enzyme activity, observed as a 
decrease in A340, was due to the activity of the enzyme of interest as opposed to 
endogenous NADH oxidase activity. The assay was carried out by the addition of 
sonicated cell extract to a 1ml cuvette containing 50 mM potassium phosphate (pH
7.0) , 2mM EDTA and 0.14 mM NADH. Any endogenous NADH oxidase activity 
was detected by a decrease in absorbance at 340 nm.
2.27.3.3 Marker enzyme assays to determine purity of plasma membrane fractions 
Fractions taken from the plasma membrane isolation procedure were originally to be 
assayed for organelle marker enzymes to determine the purity of the plasma membrane 
fraction. The enzymes to be assayed were NAD-dependent isocitrate dehydrogenase 
(mitochondrial marker), NAD-dependent glycerol - 3 - phosphate dehydrogenase 
(glycosomal marker), pyruvate kinase (cytosolic marker) and 5 ’nucleotidase (plasma 
membrane marker).
Preliminary enzyme assays were performed on Phytomonas sp. and Crithidia 
fasciculata cell sonicates to determine the suitability of each enzyme assay as an 
organelle marker in these cell types.
All assays were carried out at 30°C, in the presence and absence of 0.1 % (w/v) 
Triton X-100 and initiated by addition of sample to the reagents at the concentrations 
below. All samples were assayed for background and endogenous rates, which were 
subtracted where necessary. Control NADH oxidase assays were performed where 
indicated.
A unit of enzyme activity is defined as that amount that catalyses the 
conversion of 1 pmole of substrate per minute at 30 °C .
5 2
2.27.3.3.1 NAD-dependent Isocitrate dehydrogenase (ICDH1 
Isocitrate was reduced by the activity of ICDH in the presence of NAD+ producing 2- 
oxoglutarate and NADH. The subsequent rise in absorbance at 340 nm allowed the 
reaction to be followed.
iso citrsito
isocitrate + NAD + — dehydrogenase— ^  2-oxoglutarate + NADH + H +
100 pi sample was added to a 1 ml cuvette containing 0.2 mM NAD, 5 mM DL- 
isocitrate and made up to 1 ml with TME buffer ( 20 mM Tris-HCl, 10 mM MgCk, 1 
mM EDTA) pH 8.
2.27.3.3.2 NAD - dependent glycerol - 3 - phosphate dehydrogenase (G-3-P PHI 
(Panes, 1988)
Dihydroxyacetone phosphate (DHAP) was reduced by the activity of G-3-P DH in the 
presence of NADH producing a-glycerol phosphate and NAD+. The subsequent loss in 
absorbance at 340 nm allows the reaction to be followed.
DHAP + NADH + H + L-glycero1-3-phosphate >  giyCerol phosphate + NAD
dehydrogenase ^  ° J r  r
5-50 pi sample were added to a 1 ml cuvette containing 0.14 mM NADH, 1 mM 
dihydroxyacetone phosphate and made up to 1 ml with 50 mM TEA (pH 7.6).
2.27.3.3.3 Pyruvate kinase tRergemever. 19741
Pyruvate released by the activity of pyruvate kinase was reduced to lactate by lactate 
dehydrogenase, whilst NADH was oxidised to NAD+. The reaction was followed by 
the loss in absorbance at 340nm
Phosphoenolpyruvate + ADP Pyruvale ^  pyruvate + ATP
kinase
lactatepyruvate + NADH + H + ------------------------------- lactate + NAD
dehydrogenase
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5 - 25 pi sample was added to a 1 ml cuvette containing 0.5 mM PEP, 5 mM ADP, 
lOOmM potassium chloride, 5 mM magnesium chloride, 0.14 mM NADH, 50pg 
lactate dehydrogenase and made up to 1 ml with 50 mM TEA (pH 7.6).
2.27.3.3.4 5’ nucleotidase assay
5’ nucleotidase activity of Crithidia fasciculata whole cell sonicate and isolated 
plasma membrane was determined using tracer amounts of radio-labeled 5’-AMP in an 
assay method adapted from that of Avruch and Wallach (1971). Following incubation with 
reaction mixture containing [3H]AMP, hydrolysis of the radiolabeled nucleotide was 
estimated by measuring released radiolabeled adenosine following addition to the reaction 
mixture of ZnS04 and Ba(OH)2. The reaction was carried out at pH 9.0 to inhibit acid 
phosphatase activity, while the incorporation of (3-glycerophosphate, an alkaline 
phosphatase substrate, into control assays provided a control by which the extent of any 
nonspecific alkaline phosphatase hydrolysis of AMP could be gauged
Working substrate solution was freshly prepared each assay and comprised 60 
mM piperazine - HC1 buffer (pH 9.0) containing 0.1 % Triton X-100, 24 mM 
magnesium chloride hexahydrate, 12 mM [3-glycerophosphate (to inhibit non-specific 
alkaline phosphatases), 0.12 mM non-labelled AMP (Boehringer Mannheim) and 1.3 
pi stock [3H] AMP solution per ml working substrate solution.
Sonicated cell extract (10pl) was added to 0.5 mis of working substrate 
solution for various time periods (see individual experiments in results section) at 
37°C. The reaction was stopped by addition of 0.2 ml of 0.15M zinc sulphate.
Samples were vortexed and the tubes placed on ice. Three 10 pi samples were taken 
and counted in optiphase (for determination of a total cpm value). 0.5 mis of 0.15 M 
barium hydroxide solution was added and the samples vortexed again. After standing 
on ice for 30 minutes, the tubes were microfuged at 13,000 rpm at 4°C for 10 minutes. 
Three 10 pi aliquots of supernatant (containing the reaction product, free [3H] 
adenosine) were taken and [3H] counted in optiphase as previously described. The 
release of adenosine was calculated in relation to the measured [3H]activity of the 
working substrate solution.
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Various modifications of this basic procedure were carried out as detailed in the results 
section.
2.27.4 Preparation of plasma membranes for examination by electron microscopy
The trypanosome plasma membranes were fixed with both osmium tetroxide
and glutaraldehyde. Osmium tetroxide was used primarily to bind lipid double bonds 
and hence cross-link neighbouring lipid molecules, but also to fix proteins via 
sulphydryl groups and side chain amino groups.
Glutaraldehyde was used for more efficient fixation of the plasma membrane 
proteins via side chain amino groups. More importantly glutaraldehyde preserved 
microtubules (Weakley, 1981) important for plasma membrane identification.
Lead acetate was used to increase the contrast of the plasma membranes by 
binding the reduced osmium and also sulphydryl, tyrosyl, carboxyl (anion form) and 
ionised phosphate groups. Uranyl acetate was used to bind phosphate and carboxyl 
groups and was particularly useful in visualising the plasma membranes (Hayat, 1981). 
Cacodylate buffer replaced phosphate buffer to prevent precipitation of lead citrate 
stain.
The washed plasma membrane pellet, obtained following sucrose density 
gradient centrifugation, was immediately fixed in 4% glutaraldehyde overnight and 
then processed according to the schedule in Fig. 8 (over) prior to examination under 
the electron microscope. When required, plasma membrane sheets were collected at 
7,500g, 30 seconds, throughout the procedure. Thin sections were stained 45 minutes 
in uranyl acetate, followed by 4 minutes in lead citrate.
2.27.5 Determination of the Michaelis Menten constant and maximum velocity of 
the plasma membrane associated DHlipDH in Phytomonas sp.
Cuvettes were prepared containing 50 mM potassium phosphate buffer (pH
7.2) with excess NAD (10 mM) , 0.1 % triton and various concentrations of 
dihydrolipoamide (DHlip) ( 0.5 - 0.05 mM). 50 pi of sonicated cell extract was added 
to each cuvette (each containing a different DHlip concentration ) to give a final 
















Suspended in 4% v/v glutaraldehyde, 0.1M 
cacodylate buffer pH 7 .2 ,12h, 20 degrees 











Pellet washed thrice with 0.1 M cacodylate 
buffer pH7.2, twenty degrees centigrade
Pellet resuspended in 1% (w/v) OsCh, 1 h 
twenty degrees centigrade, centrifuged and 
washed thrice with DDH2O, twenty degrees 
centigrade, to remove OsCh, and cacodylate 
buffer, the latter to prevent precipitation of 
uranyl acetate.
Pellet resuspended in 1% (w/v) aqueous 
uranyl acetate, lh,twenty degrees centigrade, 
in the absence of light to prevent 
precipitation of uranyl acetate, washed twice 
with DDH2O, then collected by centrifugation.
Dehydrated, 20 degrees centigrade, in 30 % 
(v/v) acetone twice (10 min), 70% (v/v) 
acetone twice (10 min) and 100% thrice, then 
collected by centrifugation.
Pellet suspended in 50:50 (v/v) acetone/TAAB 
resin, stood 20 degrees centigrade, 12h. Acetone/ 
resin replaced by 100% resin, stood 48h, 
replaced by 100% resin 12 h, and then 




Thin sections taken from resin blocks with a 
glass knife and Reichart OM U3 cutting 
microtome, were placed on copper grids and 
stained with a saturated ethanolic solution of 
uranyl acetate, 5min (absence of light to 
prevent precipitation), followed by lead citrate 
(absence of CO2 to prevent precipitation), 10 
min. Excess stain was washed off in DDH2O.
yStained sections
Sections studied under Jeol 1WCX electron 
microscope.




CHAPTER 3 (A): SELECTION AND SYNTHESIS OF PEPTIDE
ANTIGENS
3.1 Prediction Of The Epitopes Of DHlipDH
3.1.1 Introduction
Recently, as more DNA sequences and their corresponding protein sequences 
have become known, synthetic peptides have been used to prepare antibodies specific 
for previously uncharacterised proteins. Peptides are normally synthesised using the 
solid-phase techniques pioneered by Merrifield (1963).The synthetic peptides are 
purified and coupled to carrier proteins, and these conjugates are then used to 
immunise animals. Peptide-carrier conjugates seldom fail to elicit a response because of 
tolerance. Consequently, the peptides can usually be seen as epitopes, and high-titred 
antisera commonly are prepared. Characteristically, these antibodies will bind well to 
denatured proteins, but may or may not recognise the native protein.
Assays that need or benefit from anti-native antibodies will succeed only when 
the peptide sequence is displayed on the surface of the native molecule in a 
conformation similar to the peptide-carrier conjugate. Therefore, the successful 
production of anti-peptide antibodies is often determined by the ability to predict the 
location of certain peptide sequences in the three-dimensional structure of the protein.
3.1.1.1 Choosing the appropriate peptide sequence
Much work has been undertaken to find a predictive approach for 
locating the sites on a protein which are antigenically important. Following correlation 
studies of known protein antigenic structures (found by experimental means) with 
various physical parameters, using computer analysis, selection of peptides may now 
be based on the use of algorithms that predict potential antigenic sites. These 
predictive methods are, in turn, based on predictions of hydrophilicity, surface 
probability, flexibility, and secondary structure.
3.1.1.1.1 Hvdrophilicitv
Early work suggested that peptides containing hydrophilic amino acids (Hopp 
and Woods 1981,1983; Kyte and Doolittle 1982) and proline residues were more likely 
to be exposed on the surface of the native protein than other sequences, and many 
peptides have been prepared using these criteria Each amino acid has been assigned a 
numerical value (hydrophilicity index) based on the polarity of its side chain with the 
data largely coming from the solvent parameters of Levitt, 1976. Repetitively
5 7
averaging these values for overlapping sets of 6 residues along the chain and plotting 
them against the residue number of the leading residue gives a hydrophilicity profile, 
where a positive value indicates an above average hydrophilicity.
However, although hydrophilicity is required, it is not sufficient to predict the 
surface location of a particular sequence. Many strongly hydrophilic amino acid 
sequences are buried in water pockets or form inter- or intramolecular bonds and are 
thus excluded from interactions with anti-native antibodies
3.1.1.1.2 Surface probability (accessibility)
Molecular surface calculations can be performed on a protein of known 
structure by mathematically rolling a solvent water molecule over the van de Waal’s 
surface of the protein (Hubbard and Ivatt, 1981). Scales of accessibility are based on 
the study of proteins of known three-dimensional structure, and are constructed by 
measuring the accessible surface of all the residues in a number of proteins.
3.1.1.1.3 Side-chain Flexibility
In view of the observed link between antigenicity and segmental mobility 
(Westhof et al, 1984), Karplus and Shultz developed a method for predicting mobility 
of protein segments on the basis of the known temperature B factors of the a-carbons 
of 31 proteins of known structure. Amino acids could be separated into 2 classes 
comprising 10 flexible and 10 rigid residues. The rigid residues (Ala, 
Leu,His,Val,Tyr,Ile,Phe,Cys,Trp, and Met) possessed average B values lower than 1. 
The authors derived three scales for the amino acids called , BNORMO,BNORM1, 
and BNORM2 corresponding to different degrees of rigidity in the neighbouring 
residues. BNORMO is the scale that applies when none of the neighbouring residues is 
rigid; BNORM1 is the scale applying when one neighbouring residue is rigid while 
BNORM2 applies when the two neighbours are rigid. As a result, the prediction takes 
into account not only the propensity of single residues to rigidity, but also the flexible 
nature of a stretch of residues.
3.1.1.1.4 Secondary structure
Scales of secondary structure are based on the prediction of turns and loops 
obtained from statistical analysis of proteins of known structure. Since the knowledge 
of the secondary structure of a protein is very useful for predicting antigenicity, a 
number of algorithms for predicting secondary structure have been applied to the 
prediction of epitopes.
The core of proteins usually contains a combination of helices and sheets, 
which are hydrophobic and invariably non antigenic. In contrast, loops and turns are
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accessible and hydrophilic which are two characteristics of antigenic regions (Rose et 
al 1985). Loops are also flexible, as judged from the blurred electron density maps 
often observed around those regions.
Two main algorithms for predicting two-dimensional structure exist, namely 
those proposed by Fasman (1989) and Gamier et al (Gamier et al 1978). Tests made 
to assess the success rate of those two prediction algorithms show that, at most, 55- 
70% of two-dimensional elements are successfully predicted. (Kabsch and Sander 
1983; Fasman, 1989; Rooman and Wodak 1988).
The premise is that an antibody raised against a peptide from a surface area or a 
flexible area of the protein is more likely to cross-react with the native protein. Thus, 
the objective is to choose a region of the protein that is:
1. surface exposed, e.g. a hydrophilic region
2. conformationally flexible relative to the rest of the structure e.g., a loop 
region or a region predicted to form a (3-tum.
3.1.2 Results
A variety of predictive methods, developed by the authors quoted, have been 
used in this work to determine potential antigenic and immunogenic peptide sequences 
of bloodstream T. brucei DHHpDH. All prediction profiles for DHhpDH were obtained 
using PREDICT7, a programme developed by Carmenes et al (1989). This programme 
analyses hydrophilicity, surface probability, side chain flexibility, and secondary 
structure. (Fig. 9)
3.1.2.1 Ffvdrophilicitv
It can be seen from the results shown in Fig.9 that the top seven peaks of 
hydrophilicity occur at residues 56-66, 94-99, 115-122, 138-142 , 236-240 , 337-340 
and 375-382. It should be noted that, according to Hopp and Woods, only the highest 
peak of hydrophilicity was invariably found to correlate with antigenic sites in the 
model protein system they used. For bloodstream trypanosomal DHhpDH, the highest 
peak of hydrophilicity occurs between residues 236-240 (Fig. 9).
3.1.2.2 Surface probability (accessibility)
Seven major peaks are observed for surface probability occurring at residues 93-100, 
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Figure 9: A prediction profile for potential antigenic peptide sequences from bloodstream T.brucei 
DHlipDH determined by author using b.s T. brucei DHlipDH primary sequence data (Else et al, 1993) 











3.1.2.3 Side chain flexibility
The scale of Karplus and Shultz was used to construct a flexibility profile (Fig. 9). Six 
major peaks are observed for side chain flexibility occurring at residues 19-22, 95-98, 
137-141, 155-158, 235-241, 254-257, 375-379 and 447-449.
3.1.2.4 Secondary structure
Because turns and loops are both accessible and hydrophilic, two characteristics of 
antigenic regions, and are very often flexible, it was decided to predict regions of the 
primary sequence corresponding to a turn conformation according to Gamier et al 
(1978). Nine regions are predicted to have a turn conformation, namely residues 1-10, 
43-49 , 77-82 , 98-104, 133-136, 216-225, 236-240, 286-289, and 448-459
3.1.3 Conclusions
Four different predictive approaches, developed by the referenced authors, 
have been applied in this work, using the PREDICT7 programme, to compute the 
likely antigenic sites present on bloodstream T.brucei DHlipDH.
Predictions made by all four methods suggest that a region contained within 
residues 228-242 is likely to be an antigenic site. One further sequence (residues 130- 
144) is predicted by methods a, b and c, and is in a different region of the DHlipDH 
molecule..
The positions of both peptides were checked on a crystal model of 
Pseudomonas fluorescens DHlipDH by Dr. Rupert Russell, Department of Biology 
and Biochemistry, University of Bath.. This was the most accurate model available 
with a sequence identity of around 47% and a sequence similarity of 68%. Both 
sequences corresponded to surface loops on the crystal structure, so confirming their 
predicted position. Sequence alignments were performed by Dr. Russell to ensure that 
the two sequences were not homologous with trypanothione reductase (a very closely 
related enzyme in the cytosol of T. brucei) or rabbit mitochondrial DHlipDH ( a high 
sequence identity may mean that rabbits would fail to raise an immune response). No 
significant identity was found for either peptide.
At a later date, a homology model of bloodstream T.brucei, constructed by 
Simon WagstaffJ was made available. This homology model confirmed a surface 
location for both peptide sequences (Fig. 10), so strengthening the possibility of both 
sequences occurring on the surface of the native DHlipDH protein.
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Figure 10
Orthogonal views of the homology model of bloodstream T.b.brucei DHlipDH 
Constructed by Sim on W agstaff, Department o f  B iology and B iochem istry, University o f Bath. 
Putative epitopes DLD1 and D L D 2 are highlighted in blue and green respectively. Figure is generated 
by m olscript ( Kraulis, 1991)
Both peptides were synthesised, purified and used as both antigens and immunogens 
in this study. They were delegated short names (DLD1 and DLD2), as detailed 




Peptide synthesis was performed on a Milligen 9050 Pep synthesiser, using the 
fhiorenylmethoxycarhomyl-polyamide solid phase approach to peptide synthesis 
developed by Atherton and Sheppard (1987). The principle is the same as that first 
proposed by Merrifield (1963) Le. that a growing peptide chain is extended while it is 




Both peptides, DLD1 (residue no. 130-144) and DLD2 (residue no.228-242) 
were successfully synthesised (as detailed in section 2.16) and the yield of peptide 
estimated to be the final weight of resin after all the synthetic steps minus the initial 
weight of the resin used. Therefore for the lg of resin used initially for both peptides, 
DLD1 yielded a final mass of 0.8g and DLD2 yielded a final mass of 0.76g.
3.2.2.2 HPLC analysis and purification
A small scale trial cleavage and deprotection was performed on a 50 mg sample 
of peptide / resin prior to full scale preparation. The progress of the reaction was 
monitored by taking 200 pi aliquots of sample at various time intervals (see section
2.16.2). The peptide component was isolated and 100 pi used for analytical reverse- 
phase HPLC chromatography on a LKB Bromma Analytical HPLC.
3.2.2.2.1 Analytical trace for DLD1 ( Fig. 11)
The trace shows the presence, after one hour cleavage and deprotection, of 
three main peaks, eluting at 26%, 36% and 44% acetonitrile respectively (Fig. 11 (a)). 
There are some minor peaks occurring at low acetonitrile concentrations (between 12 
-18%) and these are probably due to peptide that is not fully assembled. The first 
major peak at 26% acetonitrile corresponds to the fully assembled peptide. The peak at 
36% elutes at a higher acetonitrile concentration (and is therefore more hydrophobic in 
nature) and decreases with incubation time, being at its lowest after 4 hrs incubation 
(Fig. 11 (b), Fig. 11 (c)). This suggests that this peak is probably caused by peptide still 
with hydrophobic deprotection groups attached. The peak decreases in quantity with 
time as the protection groups are finally cleaved and removed by scavengers, leaving 
the fully deprotected peptide after 4 hrs incubation with cleavage reagent ( Fig. 11 (c)).
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The peak at 44% acetonitrile increases with time until it is present in equal 
concentration to the peak at 26% (fully assembled peptide) indicating the possibility of 
dimerisation. This is confirmed by the trace of incubation with DTT overnight 
(Fig. 11(d)). The peak at 44% acetonitrile is completely absent while the peak at 26% is 
considerably larger, confirming the peak at 44% to be a peptide dimer which is 
reduced to the monomer form (26%) following reduction with DTT.
3.2.2.2.2 Analytical trace for DLD2 (Fig. 12)
The trace shows the presence, after two hours cleavage and deprotection, of 
three main peaks, eluting at 27%, 36% and 45% acetonitrile (Fig. 12 (a)). As before, 
the peak at 36% is eluted at a higher acetonitrile concentration and also decreases in 
size with time suggesting that this peak corresponds to peptide still with hydrophobic 
deprotection groups attached. The peak is completely absent in the sample taken after 
8 hrs (Fig 12 (c)), indicating that full cleavage of protection groups occurs after 8 hrs 
incubation with cleavage reagent. The peak at 45% acetonitrile remains fairly constant 
throughout the incubation and is due to an impurity. The peak eluted at 27% 
acetonitrile does not diminish but increases with time strongly indicating that this peak 
corresponds to the fully deprotected peptide. The trace ( Figs 12 (a) - (c)) clearly 
shows the emergence of a second peak (eluted at 34% acetonitrile) with time until 
eventually after eight hours it is present at the same level as the first peak. This 
indicates the possibility of peptide dimerisation and this is confirmed by the trace of 
crude peptide incubated with DTT for 8 hrs (Fig. 12 (d)). Only the peak at 27% 
acetonitrile is observed while the peak at 34% acetonitrile is completely absent, 
indicating that it has been fully reduced by the DTT. This shows that even at extremely 
low pH the peptide is able to exist in both a monomer and a dimer form.
3.2.3 Conclusions
DLD1 has an optimum cleavage time of 4 hrs while DLD2 has an optimum 
cleavage time of 8 hrs. Both peptides are capable of rapid dimerisation and 
consequently reduction of the peptides to their monomer forms using DTT was 
essential before a larger scale preparative run could be undertaken.
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Figure 11: Analytical hplc analysis of cleavage deprotection trial of peptide DLD1 from resin. Trace
A is the sample obtained 1 hr from the start of the trial, trace B = 2 hrs from the start, trace c = 4 hrs 
from the start and trace D is the sample obtained folowing incubation with DTT overnight The peak 
eluted at 26% acetonitrile (peak 1) corresponds to the fully assembled and deprotected peptide. The 
peak at 44% acetonitrile (peak 2) corresponds to the peptide dimer which is reduced to the monomer 
form foeak 1 at 26% acetonitrile) followina reduction bv DTT (trace D).
Q\
Figure 12: Analytical hplc analysis of cleavage deprotection trial of peptide DLD2 from resin. Trace 
A is the sample obtained 2 hrs from the start of the trial, trace B = 4 hrs from the start, trace c = 8 hrs 
from the start and trace D is the sample obtained folowing incubation with DTT overnight The peak 
eluted at 27% acetonitrile (peak 1) corresponds to the fully assembled and deprotected peptide. The 
emerging peak at 34% acetonitrile with time (peak 2) corresponds to the peptide dimer as  
confirmed bv its absence followina reduction bv DTT (trace D)
3.3 Purification Of Synthetic Peptides
3.3.1 Introduction
Several impurities were inevitably present in the crude peptide preparation; 
these included peptides lacking some of the amino acid residues or products of side 
reactions during the cleavage deprotection stage. These impurities were removed by 
preparative reversed phase HPLC to yield the pure peptide which should be the major 
constituent of the crude preparation.
3.3.1.1 Reversed - Phase High Performance Liquid Chromatography.
The reversed-phase HPLC (RP-HPLC) separation of any peptide mixture is 
dependent upon the strength of the hydrophobic interactions of each component in the 
mixture with the hydrophobic surface of the column matrix and the elution strength of 
the organic solvent in the mobile phase. Mobile phases normally consist of mixtures of 
organic solvents (e.g. acetonitrile) with water, often with the addition of other 
modifiers such as TFA. As the concentration of the organic solvent increases, the 
interactions between the peptides and the column matrix are diminished, and the 
elution of the polar species occurs first followed by the elution of nonpolar species. 
Peptide mixtures are applied to an RP column containing a chromatographic matrix 
with defined hydrophobic character. The adsorbed peptides are eluted in order of least 
to most strongly bound molecules by increasing the organic solvent concentration in 
the elution buffer, collected as individual chromatographic fractions, and analysed 
separately.
3.3.2 Results
3.3.2.1 Preparative HPLC of DLD1 and DLD2
Conditions for the preparative scale chromatography of both DLD1 and DLD2 
were comparable with those for the analytical scale, although the acetonitrile gradient 
was stepped at the point where the peptide was expected to elute, in order to give 
better discrimination between the eluted peaks. A stepped gradient between 20-30% 
acetonitrile was used for both peptides. HPLC, rotary evaporation and freeze drying 
were all performed under anaerobic conditions using nitrogen purged reagents, 
effectively preventing any oxidation of peptide in solution. Once freeze dried and in the 
solid state, peptide cannot undergo dimerisation.
After freeze drying under nitrogen, the masses of the peptides were 66.8 mg 
for the DLD1 peptide, i.e. an estimated yield of 18.79%, and 113 mg for the DLD2 
peptide, a yield of 32.. 17%. The yields are estimated from the amount of peptide 
assumed to be attached to 1 g of resin, calculated from the resin weight after all the 
synthetic steps were complete.
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3.4 General Summary
Using various predictive parameters, two peptide sequences corresponding to 
residues 130 - 144 and 228 - 242 (obtained from the primary sequence of the cloned 
bloodstream DHlipDH gene) were chosen in this study as probable surface epitopes on 
the native protein. These two synthetic peptides (DLD1 and DLD2), each of 15 amino 
acid residues, were successfully synthesised by the F-moc solid phase method . Before 
cleavage of the peptides from the resins, both peptides were extended with two more 
amino acid residues : glycine, which was used as a spacer, and cysteine. The cysteine 
residue was added to the amino terminus of the peptides to allow coupling to a protein 
carrier. The extended synthetic peptides were then cleaved from the resin and purified 
by reversed phase HPLC under anaerobic conditions to yield peptides in the reduced 
monomeric form.
CHAPTER 3 (B1 PREPARATION AND CHARACTERISATION OF ANTI-
PEPTIDE ANTIBODIES
3.5 Peptide coupling to carrier protein
3.5.1 Introduction
The extended, reduced peptides were coupled to the carrier protein keyhole 
limpet haemocyanin (KLH) using N-maleimidobenzoyl-N-hydroxysuccinimide ester 
(MBS) as a crosslinker. The carrier protein was first activated with MBS and 
subsequently coupled to the peptide through its cysteine residue (Green et al, 1982).
Because of high susceptibility to air oxidation, it was essential to have peptides 
in their reduced monomer form prior to use in order to achieve maximum coupling. 
Peptide reduction was achieved by carrying out the HPLC preparative step under 
anaerobic conditions as detailed above. The percentage of reduced peptide was 
determined by dissolving 1 mg of solid peptide into acetate buffer pH5 and testing 
100 pi aliquots with lOOpl DTNB ( Ellmans reagent) in 2 ml sodium phosphate buffer 
pH8. The % reduced peptide was determined by dividing the concentration of thiols 
present by the expected thiol concentration assuming complete reduction. DLD1 was 
found to be 62.7% reduced while DLD2 was 95.8% reduced.
3.5.2 Results
3.5.2.1 Preparation of activated KLH
Following activation of KLH with MBS (section 2.18.1), the reaction product 
was added to a P-30 Biorad column to remove any unreacted MBS. 1 ml fractions
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were collected and monitored at 280 nm and absorbancies were plotted to give an 
elution profile ( Fig. 13).
Collected Tractions from P-30 column
1.6  —
1.4
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Figure 13: Elution profile of activated KLH. 1ml fractions of activated KLH were collected from a P- 
30 column. Protein content was determined by measuring absorbancies at 280nm and plotted against 
fraction number to give an elution profile.
KLH - MBS conjugate was recovered by pooling fractions 4, 5 and 6 from the first 
peak o f the column eluate, giving 3 mis o f activated KLH.
The activated KLH was reacted with 1 ml o f a 5 mg / ml peptide solution in phosphate 
buffer pH 7.2. and the pH adjusted to pH 7.4 using sodium hydroxide. The reaction 
mixture was left continually stirring at room temperature for 3 hrs and then frozen at - 
20°C into 0.5 ml aliquots ( 1 mg peptide/ml) to be used for rabbit immunisation.
( section 2.19 )
3.6 A n ti-p ep tid e a n tib od y  characterisation  using enzym e-linked  im m u n osorb en t
assay (E L ISA )
3.6.1 M eth od
ELISA was used to screen for specificity and evaluate the antibody titre o f collected 
antiserum samples. Four rabbits (No.s 142-145) were immunised with 0.5 mg peptide 
( rabbits 142 and 143 were immunised with DLD1 while 144 and 145 were 
immmunised with DLD2) and the first bleeds were taken 4 weeks later. All subsequent 
boosts and bleeds were performed at 4 week intervals.
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Rabbit immune serum was tested for reactivity with the peptide antigen and 
carrier protein (KLH) using the ELISA method (see methods, section 2.21) The serum 
was also tested for cross-reactivity with the second unrelated peptide.
3.6.2 Results
The results were plotted as graphs of the optical density at 450nm against serial 
dilution, and tabulated as the fold-dilution of serum which gave 50% of the maximum 
absorbance at 450 nm. (table 6).
Table 6 : A summary of the antibody titres obtained for anti-DHDl (rabbits 142 
and 1431 and anti-DHD2 (rabbits 144 and 1451 serum.
RABBIT No. BLEED 1 BLEED 2 BLEED 3 BLEED 4
142 3200 12800 12800 1600
143 1600 1600 12400 1800
144 800 1600 800 800
145 1600 3200 3200 3200
The antibody titre is expressed as the fold-dilution of immune serum which gave 50% of the 
maximum absorbance at 450 nm
From these findings, the following bleeds were selected as anti-peptide sera for use in 
all subsequent studies:
• Anti DLD1 : Rabbit 142 - bleed 2
• Anti DLD2 : Rabbit 145 - bleed 2
Elisa analysis profiles for each of these bleeds, presented below (Figs 14 and 15) show 
that each antiserum exhibits a significant anti-peptide antibody response compared to 
pre-immune response. There is no cross-reactivity between peptides indicating that the 
raised antibodies are peptide-specific.
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Fig 14. BLEED (2) PROFILE FOR RABBIT 142 (immunised with peptide DLD1)
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Serum dilution
ra ( bleed 2 from Rabbit 
cross-reactivity with peptide DLD1 compared to the pre-immune:
ELISA analysis profile for DLD 1 antise 142 immunised with DLD 1 peptide antigen).The profile diows strongspecific
e serum response while no crossreactivity is observed with peptide DLD2.
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Serum dilution
ELISA analysis profile for DLD2 antisera ( bleed 2 from Rabbit 145 immunised with DLD2 peptide anti gen). The profile shows strongspecific 
cross-reactivity with peptide DLD2 compared to the pre-immune serum response while no crossreactivity is observed with peptide DLD1.
Key for Figs. 14 and 15
■  D L D l 
]  D L D l Pre-immune 
A  DLD2
A D LD2 Pre-immune 
▼  KLH
V  KLH Pre -immune
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CHAPTER 4
IM M U N O B L O T T IN G
4.1 Dot Immunobinding
A dot immunobinding assay ( methods section 2.24) was performed to confirm the 
previously obtained ELISA results (chapter 3, section 3.6) which indicated significant 
differences in peptide antigen binding between immune and preimmune sera. (Fig. 16). 
Additionally the assay was used as a preliminary investigation of antibody binding to 
trypanosomal proteins present in freshly sonicated procyclic T. brucei cell lysate.
4.1.1 Result
See Fig. 16 (over)
The blots show definitive binding to both KLH-peptide and free peptide with both anti- 
DLD1 and anti- DLD2 sera (as indicated by a strong blue colouration) which is absent 
with the corresponding pre-immune sera. Both antisera and pre-immune sera show 
some binding to free KLH, the binding being stronger for antisera, as would be 
expected from the ELISA results. Antisera and pre-immune sera also bind to sonicated 
trypanosome cell lysate apparantly with the same intensity.
7 2
DLD 1 Immune 
Serum
DLD 1 Pre-immune 
Serum
DLD 2 Immune 
Serum
DLD 2 Pre-immune 
Serum
d o t l :  KLH-peptide (ljig )  
dot 2: Free peptide (10|ig) 
dot 3: Cell sonicate (5 x 106 cells) 
dot 4: KLH (1 fig)
Figure 16: Dot immunoblot of DLDl and DLD2 immune/preimmune sera with a conjugated peptide 
antigen (KLH-peptide), free peptide antigen, T.brucei procyclic cell sonicate and KLH.
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4.1.2 Conclusion
This result verifies previous ELISA results in that it shows cross-reactivity of specific 
antisera with corresponding peptide antigen for both anti-DLDl and anti-DLD2 that is 
clearly absent in the corresponding pre-immune sera. In addition, the observed 
reactivity of both immune and pre-immune sera with cell lysate indicates that there are 
antibodies present in both which cross-react with native protein(s) present in sonicated 
trypanosome cells.
To investigate the nature of such trypanosome protein(s), a western blot analysis was 
carried out.
4.2 Western (protein) blotting
Western blotting combines the resolution of gel electrophoresis with the specificity of 
immunochemical detection and may be used to determine a number of important 
characteristics of protein antigens including the presence and quantity of an antigen 
and the relative molecular weight of the polypeptide chain. The western blotting 
procedure described in section 2.25 was used to confirm the above result, and to 
determine the molecular weight of any trypanosomal proteins which cross-reacted 
specifically with antiserum.(Fig. 17)
Antigen samples (50 pi sonicated cell lysate ( containing 4x106 cells per lane) 
were denatured using SDS, so increasing the number of exposed epitopes and hence 
increasing the chance of DHhpDH antibody binding
7 4
I4.2.2 Result
Wells 1, 4, 7, 10, 13 - Molecular weight markers
Wells 2, 5, 8, 11, 14 - cell sonicate
Figure 17 : Western blot of procyclic T.brucei cell lysate with DLDl and DLD2 immune/pre-immune 
serum. Cross-reactivity of both DLDl and DLD2 immune/ pre-immune is observed with 
trypanosomal protein bands between 66 and 97.4kD. Four additional bands are observed with anti- 
DLD1 immune serum only, occurring in the MW range of 47-65 kD.
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A calibration curve for the migration o f molecular weight markers was plotted (Fig. 
16) and used to determine the molecular weights o f bands o f interest.










2.1 2.2 2.31.4 1.5 1.6 1.7 1.8 1.9 2
Log MW
Figure 18: 60 pg per lane of protein molecular weight markers (table 5, section 2.25.1.4) were run 
on western blots together with samples. The migrated distances were used to plot a calibration curve 
(above) from which sample band molecular weights were calculated.
4.2.3 Conclusion
Western blots o f  procyclic T. brucei cell lysate with DLDl and DLD2 
immune/pre-immune serum were performed twice and the result presented as Fig. 17 
was found to be repeatable. There appear to be antibodies (IgG) present in both 
immune and pre-immune sera for DHD1 that cross-react with numerous trypanosomal 
proteins in the MW range 66-97.4 kD. This is also the case for antiserum raised against 
peptide 2 (DLD2). As whole sera contain the entire repertoire o f circulating antibodies 
found in the pre-immunised/immunised animal at the time the serum was collected, it is 
likely that whole serum may contain antibodies that recognise spurious trypanosomal 
antigens. This may explain the generally high level o f reactivity o f both pre-immune 
and immune sera with trypanosomal sonicate.
However, additional bands are observed with anti-DHDl immune serum only, 
occurring in the MW range o f 47 - 65 kD ( ie. 47.9, 52.3, 56.2 and 64.6 kD). These
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are comparable with previously determined subunit molecular weights for DHhpDH 
from various species as detailed in table 7 (below).
Table 7: Molecular weights of DHlipDH from various organisms






Rat liver 6 56.5
1 Jackman (1991);2 Otulakowski & Robinson (1987);3 Browning et al (1988); 4Lohrer & Krauth- 
Siegal (1990);5 Schmincke-Ott & Bisswanger (1981); 6Reed (1973)
These bands are not observed with pre-immune serum indicating that these bands may 
be due to raised antibodies specific for DHlipDH.
If this is indeed the case and antiserum raised for the DLDl epitope also cross-reacts 
with the denatured enzyme, the question of cross-reactivity with intact native enzyme 
still remains. This was investigated by a series of immunoprecipitation experiments as 
detailed in chapter 5.
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CHAPTER 5
I \1  M  U N O P R E C IP IT  A T I O N
5.1 Introduction
Immunoprecipitation is the immunochemical method of choice to isolate specific 
proteins and was employed in this study to investigate raised peptide antisera (DLDl 
and DLD2) binding to native DHhpDH in sonicated procyclic T. brucei. The 
procedure has three main stages:
1. Lysis of the cells to release the antigen
2. Formation of the antibody-antigen complexes
3. Purification of the immun e complexes
Formation of antigen-antibody immune complexes, on incubation with specific 
antiserum, was detected by measuring the corresponding decrease in DHhpDH activity 
compared to controls incubated with PBS only. Ah assays were performed in 
duphcate.
Section 1
5.2 Direct inhibition of enzyme activity
Neither peptide antisera DLDl or DLD2 were raised to peptide sequences occurring at 
the catalytic active site of the DHhpDH enzyme, as determined by the homology model 
presented in Fig. 10 (chapter 3). However, because of the polyclonal nature of the 
antisera and also for thoroughness of investigation, it was decided to determine 
whether there was any direct cross-reactivity of antiserum with the enzyme’s active 
site which would be observed as a direct inhibition of enzyme activity
5.2.1 Method
Frozen cell pellets (6 x 107 cells in 0.5 mis PBS) were thawed and sonicated on ice as 
detailed in section 2.23. 30pi samples of freshly sonicated trypanosome cell lysate were 
incubated with equal volumes of DLDl and DLD2 immune/pre-immune serum or PBS 
(control) on ice for two time intervals, 6 hr and 24 hours (Figs 19 and 20). 20pl from 
each sample were assayed for DHhpDH enzyme activity (see methods, section 
2.27.3.1) 5.2.2 Results
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Figure 19: 6 x 107 procyclic T.brucei cells were sonicated in 0.5 mis PBS. 30 pi samples were 
incubated for 6 hours on ice with equal volumes of DLD1/DLD2 immune and preimmune sera. 




















Figure 20: 6 x 107 procyclic T.brucei cells were sonicated in 0.5 mis PBS. 30 pi samples were 
incubated for 24 hours on ice with equal volumes of DLD1/DLD2 immune and preimmune sera. 
Incubation with PBS was carried out as a control. 20pl samples were assayed for DHlipDH activity
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5.2.3 Conclusion
There is no significant reduction in enzyme activity for either the 6 hr or 24 hr 
incubation, indicating that any DHhpDH-specific antibodies present do not bind to the 
enzyme’s active site. Antibody binding to other parts of the dimeric enzyme were 
investigated as detailed in section 2 (below).
Section 2
5.3: Indirect immunoprecipitation of enzyme activity : Adsorption of immune 
complexes using goat anti-rabbit IgG
Any immune complexes, formed by polyclonal rabbit antiserum binding to DHhpDH, 
can theoretically be bound to by anti-rabbit immunoglobulin. It was assumed that any 
raised anti-DHhpDH antibody would be IgG in nature and so immobilised goat anti­
rabbit IgG was used to adsorb out any formed immune complexes.
5.3.1 Adsorption of immune complexes with various concentrations of goat anti­
rabbit IgG
5.3.1.1 Method
Microtitre wells were coated with 100pi of lOpg/ml goat anti-rabbit IgG diluted in 
coating buffer (see section 2.21) at 4°C overnight. Control wells containing no goat 
anti-rabbit IgG were set up also.Wells were washed three times with PBS/tween. 
Equal volumes of cell lysate and anti-DLDl immune serum were incubated for 24 
hrs at 4°C. 40 pi of incubated lysate/antibody samples were added to each well and 
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Figure 21: Microtitre wells were coated with 100fil of 10 ug/ml gt antirabbit IgG in coating buffer at 
4 °C overnight. Control wells containing no gt antirabbit IgG were also set up. Equal volumes of 
sonicated cell lysate and anti-DLDl immune serum were incubated for 24 hours at 4 °C T. 40pl of 
this incubated lysate/immune serum were added to each well and left for 6 hours at room temperature 
before being assayed for DHlipDH activity.
There appears to be a 5% reduction in enzyme activity. Although small, the reduction 
appears to be real as indicated by very low standard deviations (see error bars) 
obtainined in each duplicate assay. The experiment was repeated using 100 pg/ml o f gt 
anti-rabbit IgG in an attempt to improve upon this slight reduction (Fig 22).
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Adsorption of immune complexes using goat anti-rabbit IgG
MOOuq/mn
0.0016
control gt anti-rabbit IgG
Figure 22: Microtitre wells were coated with 100|j.l of 100 ug/ml gt antirabbit IgG in coating buffer at 
4 °C overnight. Control wells containing no gt antirabbit IgG were also set up. Equal volumes of 
sonicated cell lysate and anti-DLDl immune serum were incubated for 24 hours at 4 °C. 40pl of this 
incubated lysate/immune serum were added to each well and left for 6 hours at room temperature 
before being assayed for DHlipDH activity.
Reduction o f enzyme activity appears to improve very slightly, with an 8% reduction 
being observed.
5.3.1.3 Conclusions
Adsorption o f immune complexes with immobilised goat anti-rabbit IgG resulted in 
a possible very small reduction in enzyme activity. However, this reduction is so 
small that immune complex formation is open to question.
5.3.2 Adsorption with successive goat anti-rabbit IgG
A possibility remained that the amount o f goat anti-rabbit IgG coating the well surface 
was insufficient to bind all formed immune complexes. To determine if  this was the 
case, incubated supernatants were exposed to a succession o f wells, each coated with 
gt anti-rabbit IgG (lOjig/well)
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5.3.2.1 Method
Five wells were coated with goat anti-rabbit IgG (10 pg/w ell) overnight at 4°C. A 
series o f five uncoated control wells were also set up. Equal volumes (50pl) 1 o f  
immune serum (anti-DHDl / anti-DHD2) and freshly sonicated cell lysate were 
incubated together overnight at 4°C. The samples were diluted with lOOpl PBS and 
mixed thoroughly. Samples (200 pi) were added successively to each series o f wells
( coated and uncoated ) and were left to incubate for 3 hrs at room temperature per 
well before being transferred to the next. After incubation in the final well, 20pl 
samples were taken and assayed for enzyme activity (Fig. 23).
5.3.2.2 Results







control anti-DLD1 control anti-DLD2
Figure 23 : Five microtitre wells were coated with lOOpl of 10 ug/ml gt anti rabbit IgG in coating 
buffer at 4 °C overnight. Five control wells containing no gt antirabbit IgG were also set up. Equal 
volumes of sonicated cell lysate and anti-DLDl immune serum were incubated overnight at 4 °C. 
200pl of this incubated lysate/immune serum were added successively to each series of wells (coated 
and uncoated) and left for 3 hours at room temperature per well before transference to the next. 20 (il 
samples were taken following incubation in final well and assayed for DHlipDH activity.
There is a 11% reduction in enzyme activity compared to control for anti-DHDl 
immune serum while there is no significant reduction in activity with anti-DHD2 
immune serum. This is in agreement with western blot results shown previously 
(section 4.2.2) which indicate that anti-DLDl contains antibodies specific for T. brucei
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DHlipDH while anti-DLD2 seems to contain no such DHlipDH-specific antibodies. 
Although small, this reduction in DHlipDH activity appears to be significant and may 
be a real effect of specific anti-DHhpDH antibody binding. However, a greater 
reduction in activity was desired for this to be conclusive and further investigations 
were carried out using PEG and Protein A from the Cowan strain of Staphylococcus 
aureus to adsorb any immun e complexes formed.
Section 3
5.4 Immunoprecipitation of immune complexes using polyethylene glycol (PEG)
PEG precipitates proteins in proportion to their molecular size and concentration. Thus 
free IgG is soluble in 2% w/v PEG, but is insoluble when part of an immune complex.
5.4.1 Method
Equal volumes of sonicated cell lysate were incubated with DLD1/DLD2 immune 
serum or PBS (control) overnight at 4°C. A polyethylene glycol 6000 (PEG) solution 
(20% w/v in saline solution) was adjusted to the working concentration by mixing 6 ml 
of 20 % PEG with 3 ml 0.2 M EDTA (pH 7.6) and 1 ml saline (0.15M). This was then 
added to the incubated sample to give a final PEG concentration of 2%. Samples were 
mixed and left overnight at 4°C. Samples were centriguged at 20,000 rpm for 30 mins 
at 4°C and 20pl of each sample was assayed for enzyme activity (Fig. 24).
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5.4.2 Results












Figure 24: Equal volumes of sonicated lysate and DLD1/DLD2 antiserum ( or PBS for control) were 
incubated overnight at 4°C. PEG solution was added to a final PEG concentration of 2%. Samples 
were mixed and left overnight at 4°C . Samples were centrifuged and 20pl of each sample assayed for 
DHlipDH activity.
Although there is considerable reduction in enyme activity, compared to the PBS 
control, for both anti-DLDl and anti-DLD2 antisera, the effect does not appear to be 
immune serum specific ie. large reductions in enzyme activity were observed following 
incubation with the corresponding pre-immune sera.
5.4.3 Conclusions
Polyclonal antibodies are often used in immunoprecipitations as they tend to produce 
stable multivalent interactions. However, their use also tends to yield high nonspecific 
backgrounds as multiple interactions that lead to forming large complexes are more apt 
to trap or bind nonspecific proteins. It may be possible that the DHlipDH is still 
associated with the mitochondrial multienzyme complex in which it is normally found 
together with enzymes E l and E2. These large enzyme complexes, rather than any 
specific DHlipDH immune complexes, are perhaps directly precipitated out by the PEG 
so explaining the unexpected pre-immune serum results obtained above.
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Alternatively, it may be that antibodies are present in both pre-immune and 
immune sera which are cross-reactive with trypanosomal proteins, but not necessarily 
specific for DHlipDH This would be in agreement with the western blot result (section
4.2.2). Such antibodies may cause large complex formation which could trap free 
DHlipDH enzyme molecules, so bringing about non specific precipitation of DHlipDH 
activity
To overcome the problem of non-specific large complex precipitation by PEG, 
it was decided to try an IgG specific precipitating compound, Staphylococcus aureus 
Protein A. This would ensure that any observable reduction in enzyme activity was due 
to precipitation of immune complexes as opposed to general large complexes.
The problem of non-specific precipitation of DHlipDH activity was tackled by the 
inclusion of a preclearing step using non-immune, commercially available rabbit serum 
(‘neutral serum’). If rabbit serum naturally contains strong cross-reactive antibodies, as 
appears to be the case, addition of commercially obtained rabbit serum to the lysate 
will result in large non-DHhpDH immune complex formation. Such complexes may 
then be removed by centrifugation, prior to treatment with DHlipDH-specific 
antiserum.
PEG precipitates large complexes only, hence if a single DHlipDH specific IgG 
antibody molecule is bound to the enzyme, it is unlikely that it will be precipitated. 
Protein A from Staphylococcus aureus binds to and precipitates all IgG molecules, and 
so maximal immunoprecipitation would be expected.
Section 4
5.5 Immunoprecipitation using Staphylococcus aureus Protein A
The protein A incorporated into the cell wall of some strains of Staphylococcus aureus 
bacteria has the property of binding strongly and specifically to the Fc portion of 
certain mammalian Ig classes and subclasses, especially IgG (Kronvall et al., 1970 a,b ; 
Goding, 1978 ). The bacteria provide a solid phase that may be easily manipulated. 
Because the binding site on the antibody is found in the Fc region, the interaction with 
protein A does not change the ability of the antibody to combine with the antigen.
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Protein A, a 42 kDa polypeptide is bifunctional, allowing multimeric complexes to be 
formed
The problem of non-specific precipitation of DHlipDH activity (as observed with 
preimmune sera in PEG immunoprecipitation) was tackled by including a preclearing 
step as detailed below.
5.5.1 Method 
Preclearing the lysate
Non-specific binding was lessened by ‘pre-clearing’ freshly prepared procyclic T. 
brucei sonicate with commercially obtained neutral rabbit serum This will contain any 
general cross-reactive antibodies present normally in rabbit serum Any large non­
specific complexes so formed were removed by centrifugation prior to addition of 
DHlipDH-specific antibodies. Control precipitations with pre-immune serum were 
carried out, as were absolute controls containing PBS.
0.5 mis of freshly sonicated cell lysate was pre cleared by the addition of 25 pi 
normal rabbit serum with incubation for 1 hr on ice. A washed pellet of 250 pi 
Staphylococcus aureus protein A (10 % solution, washed in sterile PBS) was added to 
the lysate and incubated for 30 mins at 4°C. Protein A and any complexed rabbit IgG 
molecules were removed by centrifugation for 15 mins at 4°C.
Various volumes of test serum ( 5 , 50 and lOOpl of anti-DHDl immune and pre- 
immune ( or PBS for control)), were added to 100 pi of the lysate for one hour on ice 
to allow formation of any immune complexes. 50pl of a suspended pre-washed 
Staphylococcus aureus Protein A pellet in PBS was added and incubated for 30 mins 
on ice to allow adsorption of antibody ( and hence any formed immune complexes). 
Any adsorbed complexes were removed by centrifugation for 10 minutes at 10,000 g 
in a bench centrifuge. The remaining supernatant was removed and 20pl samples 
assayed for DHlipDH activity (Fig. 25). All assays were performed in duplicate.
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5.5.2 Results
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Figure 25: 5 pi , 50pl and lOOpl aliquots of DLD1 immune/preimmune (or PBS for control) were 
added to lOOpl procyclic T.brucei cell lysate (previously cleared with neutral rabbit serum) for 1 hr on 
ice. 50|il of Staph, aureus Protein A suspension was added and left to incubate for 30 minutes on ice. 
Adsorbed immune complexes were removed by centrifugation at 10,000g for 10 minutes. Samples of 
the supernatant (20pl) were assayed for DHlipDH activity.
Treatment with pre-immune serum resulted in no significant difference in enzyme 
activity from the PBS control, whereas incubation with immune serum resulted in a 
significant reduction in enzyme activity. A 17% reduction in enzyme activity was 
observed, compared to control, after incubation with 50 j l l 1 anti-DHDl immune serum, 
while lOOpl immune serum resulted in a reduction of 15 %. No significant decrease in 
activity was observed on treating with 5pi immune serum.
In an attempt to maximise this observed decrease in enzyme activity further, 
incubation with 50pi DLD1/DLD2 test serum (or PBS) was performed followed by 
the protein A immune complex adsorption step which was repeated three times, adding 
fresh immune/preimmune serum (50pl) and fresh protein A (50pl) with each repeat 
step (Figs. 26 and 27) This experiment was repeated twice to verify the result. Anti- 
DLD2 ( and DLD2 preimmune serum) was included as a negative control.
In experiment 1 (Fig. 26), a 26% reduction in DHlipDH activity was observed with 
DLD1 immune serum compared to control, while no significant reduction in activity 
was observed with DLD1 pre-immune serum Similarly, experiment 2 (Fig. 27) 
resulted in a 25% reduction in DHlipDH activity with DLD1 immune serum while no 
significant reduction was observed following incubation with DLD1 pre-immune 
serum No significant reduction in activity was observed in either experiments for 
DLD2 immune or preimmune serum
8 9
Figure 26 Experiment 1




















Figure 27 Experiment 2
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Figures 26 and 27: 50|il of test serum (DLD1/DLD2 immune and preimmune serum) or PBS 
(control) were added to lOOpl of T.brucei cell lysate (previously cleared with neutral rabbit serum) for 
1 hour on ice. 50pl of Staph., aureus Protein A suspension was added and left to incubate for 30 
minutes on ice. Adsorbed immune complexes were removed by centrifugation for 10 minutes at 
10,000g. This adsorption step was repeated three times, adding fresh immune/preimmune serum 




This result shows a significant, reproducible large reduction in DHlipDH activity on 
treatment of trypanosomal cell lysate with anti-DHDl immune serum The absence of 
any reduction in activity with DLD1 pre-immune sera indicates that non-specific 
precipitation of enzyme activity is elucidated by the preclearing step using neutral 
rabbit serum These results show the presence of a DHlipDH-specific antibody in 
antiserum raised against peptide 1 (DLD1) and absence of such an antibody in 
antiserum raised against peptide 2 (DLD2) and hence verify immunoblot results 
presented previously (section 4.2.2).
For use in immunogold localisation studies, an antibody has to he both strongly 
specific for the native enzyme and tightly binding to withstand the rigorous washing 
procedures inherent in this method. It was therefore decided to proceed with 
preliminary immunofluorescence studies to decide if anti-DLDl immune serum was 






Indirect immunofluorescence was employed as the method of choice to 
determine if the raised antiserum bound specifically to internal structures in intact 
trypanosome cells. Tmmunofluoresence analysis entails the use of a fluorescent-labelled 
antibody to localize antigens in intact permeabilised cells. Indirect immunofluorescence 
involves the use of a “middle layer” of non-fluorescent primary antibody (antiserum) 
followed, after washing, with fluorescent-labelled reagent (secondary antibody). This 
reagent is usually an antibody directed against the middle
layer. The indirect assay is very sensitive since the layering of reagents increases the 
total number of determinants available to the fluorescent reagent, and the total number 
of fluorochromes bound to the specimen is subsequently increased. However, the 
indirect method is difficult to control, and the increases in background may be a poor- 
trade off for the increased sensitivity.
6.1.2 Controls
The heterogenous and undefined nature of polyclonal antisera makes the choice 
of controls in immunocytochemical experiments critical. Adequate controls, both 
positive and negative, were hence performed to ensure validity of any observed 
staining. Negative controls included the use of pre-immune serum, obtained from the 
original rabbit prior to immunisation with peptide antigen and used at an equivalent 
dilution to immune sera, in all experiments. An additional negative control involving 
omission of the middle primary antibody layer ( ie. using PBS buffer instead of 
immune serum) was carried out in all experiments to ensure that the fluorescent tracer 
(secondary antibody) in the final layer was specific for binding to the middle layer only, 
and not to other components of the specimen. In addition, a positive control using the 
mouse monoclonal antibody ROD1, which has been shown to specifically bind to the 
paraflagellar rod in T.brucei (Woods et al, 1989), was performed to ensure the validity
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of the immunofluoresence procedure. Finally, the assay was performed with various 
concentrations of primary and secondary antiserum in an effort to “dilute out” potential 
non-specific staining.
The inclusion of a blocking step, in which blocking agents such as BSA or a 
commercially available neutral serum such as foetal calf serum (FCS) are normally 
used, was employed to reduce background staining due to non-specific binding of both 
primary and secondary antisera. Surfactants such as Tween further reduce non-specific 
background staining. Pre-incubation of cells with 10% FCS in PBS/tween (PBS with 
0.1 % v/v tween-20) was used as a blocking step in all experiments.
6.2 Results
6.2.1 Section 1: Initial conditions
6.2.1.1 Method
A 1/15 dilution ofimmune/pre-immune serum for both DLD1 and DLD2 was 
used as a starting primary antibody serum dilution. A control of undiluted ROD1 (a 
fully characterised monoclonal antibody) was also used to test that the system was 
working. Normally, commercial immunoconjugates (secondary antibody) work at a 
1:100 dilution, although this is a very general starting concentration. Hence, a dilution 
series of secondary antibody was performed. Secondary antibody, goat anti-rabbit- 
FITC, was used at 1/50, 1/100, 1/500 ,1/1000 and 1/10,000 dilutions and added to all 
wells previously incubated with primary antibody (immune or pre-immune) including a 
control well treated with no primary antibody. Rabbit antimouse-FITC was used at a 
range of dilutions from 1/50 through to 1/10,000 in wells previously incubated with 
ROD1. A control well treated with no primary antibody was also incubated with rabbit 
antimouse-FITC.
6.2.1.2 Result
Cells incubated with ROD1 as primary antibody showed good 
immunofluoresence with 1/50 rabbit antimouse-FITC. Staining diminished with 
successive dilution of secondary antibody, giving a weak signal at 1/100 dilution and 
no signal at higher dilutions. Staining appeared as a thin line down the length of the
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trypanosome cell, corresponding to specific staining of the paraflagellar rod. No 
immnn ofluoresen ce was observed in the absence of primary antibody (negative 
control). Strong immunofluorescence over the entire trypanosome cell was observed 
with both DLD1 and DLD2 preimmune and immune serum at both 1/50 and 1/100 
dilutions of secondary antibody, while 1/500 and 1/1000 dilutions resulted in 
increasingly weaker immunofluoresence. No immunofluoresence was observed at 
1/10,000 dilutions of secondary antibody. No immunofluoresence was observed with 
the negative control in the absence of primary antibody.
6.2.1.3 Conclusions
The distinctive fluorescent staining observed after treatment with ROD1 was as 
expected, being similar to staining observed by Woods et al (1989) and confirmed that 
the immunofluoresence procedure employed was a viable one. The negative control 
showed that the flouresence staining was due to primary antibody binding and that no 
cross-reactivity of antimouse secondary antibody with trypanosomal antigen had 
occurred.
The very strong uniform immunofluorescence observed for DLD1 and DLD2 
immune and pre-immune serum was thought to be due to the very low primary 
antiserum dilution (1/15) used, resulting in high background immunofluoresence. The 
good immunofluoresence obtained with 1/100 dilution of anti-rabbit-FITC, together 
with the negative control, indicated that 1/100 dilution of secondary antibody was a 
reasonable working dilution. This dilution of secondary antibody was used in all 
subsequent experiments.
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6.2.2 Section 2: Reduction of non specific background staining
Excessive background non-specific antibody interactions arising from spurious 
antibody activities in the serum are a common problem in cell staining with polyclonal 
sera. Because such antibodies will normally not account for the major activities in the 
serum, their binding can often be reduced below the levels of detection by careful 
titration of the polyclonal antibodies
6.3.2.1 Dilution of primary antibody
6.2.2.1.1 Method
a) The procedure was repeated as described in “general method” for both immune and 
preimmune serum for DLD1 and DLD2 except that various primary antibody dilutions 
were performed (1/10,1/00, 1/1000, 1/10,000) in an effort to dilute out any non 
specific background binding.
b) The experiment was repeated using a range of dilutions (1/100 - 1/1000) for anti- 
DLDl and 1/50-1/100 for anti-DLD2.
6.2.2.1.2 Result
see over ( Figs 28 and 29)
Good immunofluorescene staining was observed for DLD1 immune and preimmune 
serum (Fig.28). Although a general staining of the whole trypanosome cell was 
evident, areas of intense nuclear staining were evident for both immune and preimmune 
serum A similar staining pattern, with intense nuclear staining, was observed for 
DLD2 immune and preimmune serum (Fig. 29).
6.2.2.1.3 Conclusions
a)Good immunofluorescence staining was observed at 1/10 , 1/50 and 1/100 dilutions 
of DLD1 (Fig. 28 (a)) while staining was noticably weaker at 1/1000 dilutions and 
absent at 1/2000. Good staining was observed for DLD2 at 1/10 and 1/50 while 
becoming weak at 1/100 (Fig. 29 (a)) and absent at 1/1000. Surprisingly, pre-immune 
and immune sera (for both DLD1 and DLD2) were found to stain the whole cell with 
approximately the same intensity ( as observed by eye; Fig.s 28 (b) and 29(b)) at each
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dilution, indicating that attempts to reduce any nonspecific background staining by 
dilution of primary antibody had failed.
b)Optimal fluorescence was found at 1/100 dilution of DLD1, while 1/50 gave optimal 
fluorescence for DLD2. However, there was no noticeable difference between 
antiserum and preimmune serum at these dilutions.
Although dilution of primary antibody failed to resolve the problem of background 
immunofluoresence staining, there is a clear difference in staining intensity between the 
two antisera. Incubation with DLD 1 immune serum (1/100 dulution) results in much 
higher fluorescence than incubation with DLD 2 immmune serum (1/100 dilution), 
appearing to support previous results (western blot, 4.2.2; immunoprecipitation,
5.3.2.2) that indicate the presence of a DHlipDH-specific antibody present in DLD1 
immune serum only.
Attempts to reduce background staining were investigated further.
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Figure 28 (a) Anti-DLD1 immune serum
1/100 dilution As viewed under phase contrast
Figure 28 (b) Pre-immune serum
1/100 dilution
light microscope
As viewed under fluorescent 
microscope
Figure 29 (a) Anti-DLD2 immune serum
Antiserum 1/50 dilution
Antiserum 1/100 dilution
Figure 29 (b) Pre-immune serum
Pre-immune serum 1/50 dilution
Pre-immune serum 1/100 dilution
6.2.2.2 Use of neutral serum to reduce non specific background staining.
Commercially obtained serum (or ‘neutral’ serum) was used in an attempt to remove 
non-specific background staining. Cells were pre-incubated with blocking buffer 
containing neutral serum (1-10%) prior to labelling with primary antibody.
6.2.2.2.1 The use of commercially obtained neutral rabbit serum in both blocking 
buffer and primary antibody dilution
6.2.2.2.1.1 Method
a) Procedure was as described in section 2.26 except that blocking was performed 
with 10% FCS in PBS-tween overnight and various dilutions (1-10%) of neutral 
rabbit serum were added to the blocking buffer. Wells were incubated with 1/100 
dilution of DLD 1 immune/ preimmune serum and 1/50 dilution of DLD2 immune / 
pre-immune serum A negative control in the absence of primary antibody was 
performed.
6.2.2.2.1.2 Result
Although strong immunofluorescence was observed both for DLD1 and DLD2, 
again no difference between immune and pre-immune sera was evident. On repeating 
the experiment, using 5% rabbit serum in blocking buffer and using 1/100, 1/200, 
1/500, 1/1000 dilutions of both DLD1 and DLD2 (immune and preimmune) primary 
antibody, the same result was obtained ie. no observable difference in fluoresence 
between immune and pre-immune sera. Interestingly, there was no obvious sequential 
lowering in fluorescence intensity with primary antibody dilution as previously 
observed (section 6.3.2.1) and strong fluorescence was detected at dilutions as low as 
1/1000 for both immune and pre-immune sera. The negative control ( no primary 
antibody) performed following overnight incubation with blocking buffer containing 
rabbit serum resulted in a marked uniform immunofluorescence.
6.2.2.2.1.3 Conclusions
Not only is treatment with the normal rabbit serum having no effect in reducing 
background staining and creating an observable difference between immune and
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preimmune sera, but appears to contribute to background immunofluoresence.This was 
confirmed by the negative control which showed uniform immunofluoresence 
following preincubation with blocking buffer containing neutral rabbit serum. This 
confirms the presence of strong cross-reactive antibody(s) in commercially obtained 
rabbit serum as indicated in previous immunoprecipitation experiments (chapter 5 
section 5.5). Indeed, cross-reactive antibodies appear to be a common occurrence in 
rabbit serum in general (Keith Gull, personal communication).
6.2.2.2.2 Use of commercially obtained neutral goat serum in both blocking 
buffer and primary anitbodv dilution
6.2.2.2.2.1 Method
Procedure was followed as described above (section 6.3.2.2.1.1) except that neutral 
rabbit serum was replaced by neutral goat serum. Cells were preincubated overnight in 
blocking buffer containing 1-10% normal goat serum prior to labelling with a 1 /100 - 
1/2000 dilution of DLD1 primary antibody ( immune and pre-immune) or 1/50 - 
1/1000 dilution DLD2 (immune and preimmune serum). The use of goat serum as 
blocking antibody ensures that there is no recognition by secondary antibody as the 
blocking serum is from the same animal species as that used to make the secondary 
antibody. A negative control in the absence of primary antibody was performed.
6.2.2.2.2.2 Results
Uniform immunofluorescence was observed with both DLD1 and DLD2 at all 
concentrations of goat serum used in blocking buffer. No difference between immune 
and preimmune serum was observed in either case. However, contrary to results using 
neutral rabbit serum, on repeating the experiment using 5% goat serum in blocking 
buffer and using 1/100, 1/200, 1/500 and 1/1000 dilutions of both DLD1 and DLD2, 
staining became weaker with increased dilution. However, no difference between 
immune and preimmune staining was observed at any dilution. The negative control 
(no primary antibody) resulted in no observable immunofluorescence.
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6.2.1.2.2.3 Conclusions
Hence, although not able to reduce background staining, preincubation with goat 
serum does not result in additional non specific binding of secondary antibody as 
observed with neutral rabbit serum
6.2.2.3 Investigation of incubation time and temperature to reduce non specific 
background staining
Many antibody solutions contain a small proportion of antibodies that will bind non 
specifically to certain antigens (e.g. to charged residues) in a cell. Such non specific 
interactions may be reduced by shortening incubation times and/or lowering 
temperature.
6.2.2.3.1 1 hr primary antibody incubation at different temperatures for neutral 
rabbit/goat serum
6.2.2.3.1.1 Method
A series of wells were blocked overnight with 10% FCS in PBS/Tween and then 
treated with normal rabbit serum (1/10, 1/100, 1/1000 and 1/10,000 dilutions) while a 
further series were treated similarly with commercially obtained goat serum ( These 
wells were treated with rabbit anti goat-FITC as secondary antibody). Primary 
antibody incubation was carried out for a) 1 hour at 26 °C and b) for 1 hour at 4 °C
6.2.2.3.1.2 Results
a) 1 hour at 26 °C (Fig. 30)
Good immunofluorescence was observed for normal rabbit serum up to 1/1000 
dilution (Fig. 30 (a)). No immunofluorescence was observed with normal goat serum
b) 1 hour at 4 °C (Fig. 31)
No immunofluorescence was observed for either rabbit or goat serum
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(a) 1 hr incubation (26 degrees) with neutral rabbit serum 
(1/1000 dilution)
(b) 1 hr incubation (26 degrees) with neutral goat serum 
(1/10 dilution)
(a) 1 hour incubation (4 degrees) \N\ih nevitraX vatobW sernm 
(1/10 dilution)
(b) 1 hr incubation (4 degrees) with neutral goat serum 
1/10 dilution
6.2.2.3.1.3 Conclusion
This clearly shows that no background binding from neutral serum of either 
species occurs on incubation for one hour on ice. These conditions are therefore 
favourable for the removal of background binding
6.2.2.3.2 Primary antibody incubation for 1 hr (4°C) for immune / preimmune 
sera
6.2.2.3.2.1 Method
The general method was followed as described above, with wells being blocked 
overnight in 10% FCS in PBS/tween. However, primary antibody, anti-DLDl immune 
and pre-immune sera (1/50, 1/100, 1/200 and 1/500 dilutions) were incubated with 
cells for 1 hr on ice before incubation with secondary antibody.
6.2.2.3.2.2 Result
No immunofluorescence was observed at any of the dilutions.
6.2.2.3.2.3 Conclusions
Incubation for lhr on ice is not sufficient for primary antibody binding of test immune 
serum and is hence not a viable solution for the reduction of background staining.
The failure of both dilutions of primary antibody (section 6.3.2.1) and the use 
of neutral goat goat serum (section 6.3.2.2.2) to reduce background 
immunofluorescence suggests that observed staining is not due to non-specific binding 
of primary or secondary antibody, but rather that the rabbit polyclonal antiserum, and 
rabbit serum in general, contains strong cross-reactive antibodies which may mask the 
reactivity of raised DHlipDH- specific antibodies. Non-specific labeling of this type may 
best be avoided by affinity purification of the antibody
6.2.3 Section 3 Preliminary to affinity purification : adsorption of serum IgG 
component bv Staph. aureus protein A
The strong, seemingly specific, staining of pre-immune serum was investigated further 
to determine if the observed reactivity was due to IgG or other serum antibodies
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rincluding IgM and IgA. The IgG content of the pre-immune serum was precipitated 
out using Staphylococcus aureus containing Protein A (see immunoprecipitation 
method, Chapter 5, 5.5 section 5) to observe if any staining occurred using IgG 
deficient pre-immune serum.
6.2.4.1 Method
Pre-treatment of immune serum
150 fil of pre-immune serum from rabbit 142 was incubated with a pellet of 1ml 10% 
Staph, aureus ( washed twice in sterile PBS) for 30 mins on ice. The suspension was 
centrifuged and the supernatant removed and used as described below.
The method was followed as previously described ( “general method.”) except that 
1/50, 1/100,1/200 and 1/500 dilutions ofDHDl immune, pre-immune and treated pre­
immune sera were incubated in wells for I hr at 26°C before adding diluted goat 
antirabbit-FITC (1/100 dilution).
6.2.3.2 Result
Fig. 32 (See over)
Immunofluorescence staining occurred with all three primary antibody samples. 
Fluorescence intensity was dilution dependent between 1/50 to 1/200. No fluorescence 
was detected at 1/500 for any of the samples. There was no difference in intensity 
between immune and pre-immune serum (in accordance with previous findings), 
however “ treated “ (ie. IgG-deficient) preimmune serum appeared to show a slight 
reduction in flourescence intensity. Even with “treated “ serum, however, background 
staining was still prevalent, indicating the strong presence of trypanosome-specific 
non-IgG antibodies.
6.2.3.3 Conclusion
The high background staining for all three samples (immune, preimmune and treated) 
indicates the presence of cross-reactive antibodies other than IgG types which are 
masking any specific IgG-DHhpDH interaction.
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IFigure 32
Com parison of im m une and treated pre-im m une serum
DLD1 Immune serum 
1/50 dilution
Treated pre-immune serum 
1/50 dilution
1/100 dilution 1/100 dilution
1/200 dilution 1/200 dilution
r6.3 Discussion
Although satisfactory cell staining experiments may be conducted using polyclonal 
antibodies, their use requires careful controL The results described in this section show 
that strong specific background staining is present and this staining may be resposible 
for masking any DHHpDH-specific binding. All attempts to reduce specific background 
staining, including diluting out of any specific spurious antibodies ( 6.3.2.1) and 
attempts to reduce non specific binding of primary or secondary antibodies using 
neutral rabbit serum and goat serum (6.3.2.2.1) were unsuccessful. Similarly, attempts 
to reduce non specific background staining by reducing temperature and incubation 
time (6.3.3) were also unsuccessful. Staining observed following the removal ( or at 
least reduction) of the IgG fraction of preimmune serum using protein A (6.3.4) 
indicates that antibodies other than IgG molecules (probably IgM or IgA) are involved 
in this background binding.
Affinity purification of both DLD1 and DLD2, using synthetic peptides DLD1 
and DLD2, was carried out at Keith Gull’s laboratory, University of Manchester, by 
Kit Tyler. The purified antibodies were tested for cross-reactivity in T. brucei 
bloodstream, stumpy and procyclic cells. DLD2 antibodies appeared not to cross-react 
at all with any cell type, while DLD1 antibodies were found to weakly bind to the 
mitochondrion of procyclic and stumpy cell and no crossreactivity was observed with 
bloodstream cells (Tyler, personal communication). This result was verified by Tyler et 
al (1997) using polyclonal antibody to T. cruzi DHlipDH provided by Lohrer and 
Krauth-Siegel (1990). Immunofluorescence studies, performed by Tyler et al using 
Lohrer and Krauth-Siegel’s polyclonal antiserum, resulted in staining that localised 
DHlipDH to the mitochondrion of the stumpy and procyclic forms, while failing to 
detect the protein in the slender form Hence although it seems that at least one of the 
antisera raised (antiDLDl) was active, binding was weak and hence unlikely to 
withstand the rigorous procedures involved in immunogold localisation studies. It was 
therefore decided to abandon plans for immunolocalisation of DHlipDH in T. brucei 
using peptide antisera.
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Peptide antisera suffer, in general, from one major drawback- an 
antiserum with a high titre against the free peptide will not necessarily have a high 
affinity for the native protein (Beesley, 1993). Although the peptide sequence can be 
chosen to include regions which are likely to be antigenic determinants, it is impossible 
to predict with certainty that the selected region will be at the surface of the native 
protein and therefore accessible to antibodies, or if this region of the native protein is 
in a similar conformation to that of the peptide.
Although immunolocalisation of DHlipDH in other members of the 
Trypanosomatidae family using DHhpDH-specific antibodies was hence no longer an 
option, it was decided to continue localisation studies of DHlipDH in other 
trypanosomes, specifically C.fasciculata and Phytomonas sp. using cell fractionation 
techniques. The presence of DHlipDH in both cells was established by assaying cell 
lysates, and enzyme localisation investigated further by analysis of plasma membrane 
isolates obtained following fractionation of both C.fasciculata and Phytomonas sp.
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CHAPTER 7
INVESTIGATION OF DHLIPDH IN Crithidia fasciculata AND 
Phytomonas sp.
7.1 Introduction
There are no reports in the literature to date concerning investigations of DHlipDH in 
either Crithidia fasciculata ox Phytomonas sp. Verification of the presence of 
DHlipDH in both cell types was therefore an essential pre-requisite to any localisation 
studies of the enzyme.
7.2 DHlipDH in Phytomonas sp. and Crithidia fasciculata cell sonicates
7.2.1 Methods
A number of control enzyme assays were perfomed to ensure that any rise in 
absorbance observed at 340 nm was due to DHlipDH activity.
7.2.1.1 Alcohol dehydrogenase
Assay for NAD-dependent alcohol dehydrogenase in Phytomonas sp. and Crithidia 
fasciculata cell sonicates under conditions suitable for DHlipDH assay, as detailed in 
methods section 2.28.3.1, resulted in no observed increase in absorbance at 340 nm 
over a ten minute assay period.
7.2.1.2 ‘No substrate9 controls
‘No substrate’ controls were performed routinely (methods section 2.28.3.1.) and any 
observed endogenous activity subtracted from experimental results.
7.2.1.3 NADH oxidising activity
Phytomonas sp. sonicates exhibited some endogenous NADH oxidising activity, 
probably due to the presence of NADH oxidase, observed as a decrease in absorbance 
at 340 nm when assayed.( see methods section 2.28.3.2.). Hence, it was recognised 
that assays measuring NADH formation in Phytomonas sp. including the assay for 
DHhpDH would not reflect full enzyme activity. Crithidia fasciculata cell sonicates 
exhibited no NADH oxidase activity.
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7.2.2 Results
7.2.2.1 Assay of DHlipDH in Phytomonas sp.
2.25 x 108 cells were sonicated in 1 ml PBS. 20pl, 30pl and 50pl aliquots were 
assayed as described in methods section 2.28.3.1. A good linear relation between 
activity and sonicate volume (Fig. 33) was obtained. Protein assays were performed by 
standard coomassie blue assay, and the mean specific activity was determined to be
0.06 pmol /min/mg protein. Because of the endogenous NADH oxidising activity in 
Phytomonas sp. sonicate ( previously mentioned), it may be suggested that this is not 
the absolute specific activity but rather the minimum specific activity.
Figure 33
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225E8 cells were sonicated in 800ul PBS 20,30 and 50 ul aliquots of sonicate were taken and assayed for DHlipDH activity.
Protein determinations were carried out by coomassie blue protein assay, using BS4 a s a  protein standard, mean specific actvity 
was calculated to be 0.0.6 urn / min / mg protein_____________________________________________________________________
7.2.2.2 Assay of DHlipDH in Crithidia fasciculata
DHlipDH activity was assayed in both logarithmic (log) and stationary growth phase 
cells of Crithidia fasciculata.
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7.2.2.2.1 Assay of DHlipDH in log phase Crithidia fasciculata
o
6.15 x 10 cells were sonicated in 1ml PBS. 20 pi, 30pl and 40 pi sonicate aliquots 
were assayed for dihydrolipoamide dehydrogenase activity. A good linear relation 
between activity and sonicate volume (Fig. 34) was observed. Protein assays were 
performed by standard coomassie blue assay, and the mean specific activity was 
determined to be 0.29 pmol /min/mg protein.
Figure 34
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6.15E8 cells were sonicated in 1ml PBS 20.30 and 40 ul aliquotsof sonicated cell extract were assayed for DHlipDH activity 
Protein determinations were carried out by coomassie blue protein assay, using BSA as a protein standard. M ean specific activity 
was calculated to be QjffiaM / min /  mg protein.______________________________________________________________________
122.2.2 Assay of DHlipDH in stationary phase Crithidia fasciculata
5.3 x 107 cells were sonicated in 1ml PBS. 20pl, 30pl, and 40pl sonicate aliquots
were assayed for DHlipDH activity. A good linear plot was obtained between activity
and sonicate volume (Fig. 35). Protein assays were performed by standard coomassie
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7.2.3 Summary
Table 8; Specific activities in cell free extracts :Comparison of DEDipDH- 
specific activities (in uM of NADH produced/minute/mg protein) from T. brucei, 
C.fasciculata and Phytomonas sp.
Trypanosome species Specific activity 
pmol/min/mg protein
Phytomonas sp. 0.06
Log Crithidia fasciculata 0.29
Stationary Crithidia fasciculata 0.11
T.b. brucei bloodstream * 0.03
T. b. brucei procyclics* 0.4
* Taken from Cook et al, 1990.
7.2.4 Conclusions
The presence o f DHlipDH in mitochondrially active log phase Crithidia fasciculata is 
5 times the level in mitochondrially repressed Phytomonas sp. This is comparable to
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DHlipDH activity in T.b. brucei where Cook et al (1990) reported increased levels of 
DHlipDH in nhtochondrially active procyclic forms ten times those measured in 
mitochondrially inactive bloodstream forms. Both results may be accounted for by the 
activity of DHlipDH-containing mitochondrial 2-oxo acid dehydrogenase complexes 
which are absent in mitochondrially repressed forms, although it is impossible to say 
whether the increase in mitochondrially active forms is due entirely to these complexes.
The difference in DHlipDH levels between log and stationary phase Crithidia 
fasciculata is an interesting one. Differences in enzyme activity may be a consequence 
of differing metabolic rates, with log phase cells being the most metabolically active 
stage. Rapid glycolysis in dividing logarithmic cells would result in excretion of 
carboxylic acids e.g. acetic, pyruvic and succinic acid which may cause acidification of 
the media. Acidification tends to slow and then terminate growth of Crithidial cells in 
traditional media (Shim and Fairlamb, 1988), so explaining the observed metabolic 
inactivity of stationary phase Crithidia fasciculata.
Interestingly, Page and Lagnado (1998) found that Crithidia fasciculata, 
under certain conditions, form large bundles oftrans-cytoplasmic filaments that are 
distinct from both microtubules, the only major cytoskeletal element identified to date 
in the cell body of trypanosomes, and actin microfilaments. These filaments were never 
seen in log-phase cells or lower density stationary-phase cultures of Crithidia 
fasciculata. Thus, filament formation appears to be linked to conditions of limited 
nutrient availability, such as are associated with dense stationary-phase cultures of the 
parasite ( Shim and Fairlamb, 1988). Changes in DHlipDH activity between log- and 
stationary- phase Crithidia fasciculata may hence be a biochemical reflection of the 
general cell growth cycle.
7.2.5 Future work
Future work should focus on assays for the pyruvate dehydrogenase, 2-oxoglutarate 
dehydrogenase and branched chain 2-oxo acid dehydrogenase complexes in both cell 
types. Such assays are essential to consolidate further the findings of Sanchez-Moreno 
et al (1991) and Fernandez Beccerra et al (1997) who reported that Phytomonas sp. 
were incapable of oxidising 2-oxoglutarate and pyruvate and had fully repressed 
mitochondria that were similar to bloodstream T. brucei mitochondria. DHlipDH -
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containing 2-oxo acid dehydrogenase complexes are intra-mitochondrial in other 
eukaryotes, and therefore their presence might be expected in mitochondrially-active 
cells such as Crithidia fasciculata where both oc-ketoglutarate and pyruvate 
dehydrogenase complex activity have been reported (Diaz and Komuniecki, 1995).
7.3 Determination of DHlipDH Km,pp and Vmax*pp in Phytomonas sp. cell 
sonicate, (see methods section 2.27.5)
7.3.1 Method
DHlipDH assays were performed on crude Phytomonas sp. cell sonicates (obtained by 
sonicating 1 x 108 cells in 1 ml PBS as described in methods section 2.23 ) in order to 
investigate the kinetic properties of Phytomonas DHlipDH. NAD+ was present at a 
constant high concentration (10 mM) while varying concentrations of 
dihydrolipoamide ( from 0.5 mM to 0.05 mM ) were assayed in the presence of 50 pi 
of Phytomonas sp. cell sonicate. The concentration of the dihydrolip o amide was 
determined by titration with 5,5’-dithiobis-(2-nitrobenzoic acid).
7.3.2 Result
An increase in DHlipDH activity with increasing DHHp substrate concentration was 
observed. This result is presented as a Hanes-Woolf plot (Fig. 36).
The plot shows the close fitting of all the points to a straight line, and indicates 
that that the kinetics of the reaction are steady state. The kinetic parameters Kmapp and 
Vmaxapp were determined from direct linear plot analysis of the data using ‘Enzpak’ 
software and found to be 0.23 +/- 0.03mM and 3.6xl0'3 +/- 0.001 s'1 respectively.
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Figure 36: The kinetics of DHlipDH, represented as a Hanes-Woolf plot as DHlip concentration 
varied at a constant NAD+ concentration of lOmM.







T. b. brucei (bloodstream)b 29




T. b. brucei (procyclic)3 400
T. b. brucei (procyclic) c 400
C. fasciculata (choanomastigote)d 300
Phytomonas sp. (promastigote) 61
* Else et al 1994 bDanson et al(1987) cCook et al (1990) dAndy McClennan, Bath University.
7.3.3 Conclusion
All three T. brucei species in the above table show higher levels of activity in procyclic 
than in bloodstream forms. This difference varied between species, being 
approximately 13 fold with T.b. brucei, 6-fold with T.b.gambiense and 1.25-fold with 
T.b.rhodesiense. Comparison of the mitochondrially active Crithidia fasciculata with 
the inactive Phytomonas sp. renders an analogous situation, with Crithidia fasciculata 
DHlipDH levels 5 times those observed in Phytomonas sp.
The level of DHlipDH in sonic extracts of Phytomonas sp. (0.06 pmol/min/mg 
protein) is twice the level of DHlipDH found in bloodstream T. brucei sonicates 
(0.03 pmol/min/mg protein) as determined by Danson et al (1987). The level compares 
favourably, however, with that found in Halobacterium halobium ( Danson et al,
1986) which also lacks the 2-oxo acid dehydrogenase complexes and with some 
cyanobacterium which lack 2 oxoacid dehydrogenase complexes. While filamentous 
cyanobacterium Anabaena sp., lacking pyruvate and 2 oxoglutarate dehydrogenase 
activities, contains DHlipDH with specific activity 190pmol /min/mg protein 
(Serrano, 1992), DHlipDH from unicellular cyanobacterium Synechoccus sp. has a 
specific activity of 0.05-0.08 pmol/min/mg protein (Serrano et al,1992) while 
DHlipDH in another cyanobacterium, Synechocystis, was found to have a specific 
activity of 0.075 pmol /min/mg protein ( Engels et al, 1997).
The level of DHlipDH in Crithidia fasciculata (0.3 pmol/min/mg protein) is 
comparable with the mitochondrially active T. brucei procyclic (0.4pmol/min/mg 
protein). The specific activity is 3-fold higher than in the epimastigotes of T. cruzi 
(Lohrer & Krauth-Siegal, 1990) and in Saccharomyces cerevisiae (Wren and Massey, 
1965), which possess active citric acid cycles, and 5-fold higher than the activity in 




ENZYME MARKERS FOR THE DETERMINATION OF 
PLASMA MEMBRANE PREPARATION PURITY
Prior to isolation and investigation of trypanosomal plasma membranes, it was 
a necessary to be able to determine the purity of the isolated plasma membrane 
fractions. Contamination of plasma-membrane preparations may occur in three ways. 
First, particles such as mitochondria may co-sediment with the fraction. Second, in the 
case of large sheets of plasma membrane, particles may be trapped inside the 
membrane and will be released only if the membrane is fragmented. Third, proteins or 
small vesicles may adhere to the membrane, often by electrostatic interaction.
The purity of plasma-membrane preparations may be assessed in two main
ways;
1. by morphological examination, with either the light or electron microscope
2. by measurement o f ‘marker’ enzymes for other cell organelles
Four enzyme markers, specific to various trypanosomal organelles, were 
chosen for use in determining plasma membrane purity following cell fractionation of 
Crithidia fasciculata and Phytomonas sp. cells. The chosen marker enzymes were:
• NAD-dependent isocitrate dehydrogenase (mitochondrial marker),
• NAD-dependent glycerol - 3 - phosphate dehydrogenase (glycosomal marker),
• pyruvate kinase (cytosolic marker)
• 5’nucleotidase (plasma membrane marker).
Preliminary enzyme assays were performed on cell sonicates to determine the 
suitability of each enzyme assay in Crithidia fasciculata and Phytomonas sp.
Catalytic activity was assayed spectrophotometrically at 30 °C using a Perkin Elmer 
Lambda Bio or Lambda 11 spectrophotometer. Initial enzyme rates were calculated 
using the Perkin-Elmer Computer Spectroscopy Software (PECSS) version 4.31 
supplied with the instrument. All assays were performed in duplicate unless otherwise 
stated.
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8.1 NADH oxidising activity
While Crithidia fasciculata sonicates exhibited no endogenous NADH 
oxidising activity, Phytomonas sp. sonicates showed a decrease in absorbance at 340 
nm when assayed (see methods section 2.28.3.2). Routine ‘no substrate’ controls to 
determine endogenous NADH oxidase activity in Phytomonas sp. (for each marker 
enzyme assay measuring NAD+ formation) were therefore essential. All such rates 
were routinely subtracted from experimental rates. It was recognised that assays 
measuring NADH formation would not reflect full enzyme activity.
Routine ‘no substrate’ controls were performed as negative controls in Crithidia 
fasciculata.
Endogenous controls, in the absence of cell sonicate, were performed in all assays and 
subtracted from experimental rates where appropriate.
8.2 Isocitrate dehydrogenase
Isocitrate dehydrogenase catalyses the nicotinamide nucleotide-dependent 
oxidative decarboxylation of isocitrate to 2-oxoglutarate. Eukaryotes contain both 
NAD- and NADP- specific isocitrate dehydrogenases; the NAD-linked enzyme is 
confined to mitochondria and is allosterically regulated in line with its regulatory role 
of the energy-yielding citric acid cycle (Colman, 1983; Plaut and Gabriel, 1983) while 
the NADP-linked enzyme is found both in the mitochondria and the cytoplasm and is 
not allosterically regulated.
8.2.1 Assay of NAD-dependent isocitrate dehydrogenase in Phytomonas sp
2.25 x  108 cells were sonicated in PBS and assayed as described previously 
(methods section 2.28.3.1). No isocitrate dehydrogenase activity was observed.
8.2.2 Assay of NAD-dependent isocitrate dehydrogenase in Crithidia fasciculata
1.66 x 108 cells were sonicated in 1 ml PBS. 50pl, 75pl and 100 pi aliquots 
were taken and assayed for isocitrate dehydrogenase activity as detailed in methods 
section 2.28.3.1. Blank rates in the absence of substrate were deducted from all 
observed initial rates ( and all controls) which were then plotted giving a good linear
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plot ( Fig. 37). Control assays were performed in the absence o f NAD+ and in the 
absence o f Mg2+ ( no magnesium was added to assay buffer and 0.5 mM EGTA was 
added to buffer to bind any Mg2+ in the cell sonicate). Both controls were negative, 
confirming that the observed activity was specific to isocitrate dehydrogenase.
Figure 37
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8.2.3 Conclusions
The absence o f isocitrate dehydrogenase in Phytomonas sp is in keeping with 
its biochemical similarity to bloodstream T. brucei. Both have repressed mitochondrial 
activity ( Durieux et al, 1991; Sanchez-moreno et al, 1995) and hence lack enzymes 
involved in the mitochondrial TCA cycle. The TCA cycle enzyme NAD+-isocitrate 
dehydrogenase is not detectable in bloodstream T. brucei trypomastigotes 
(Duriex et al 1991) but is detectable in the procyclic form which, like Crithidia 
fasciculata , has a fully functional mitochondrial TCA cycle. Interestingly, NAD- 
dependent isocitrate dehydrogenase is not found in the insect trypanosome 
Herpetomonas muscarum ingenoplastis or T. cruzi (Francisco - Javier et al, 1988) 
where the presence o f  mitochondrial NADP-dependent isocitrate dehydrogenase was 
observed.
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8.3 NAD+-dependent glycerol-3-phosphate dehydrogenase
NAD+- linked glycerol-3-phosphate dehydrogenase catalyses the reduction of 
dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate and vice-versa within 
the glycosome where it is firmly particle bound. ( Opperdoes and Nwagwu, 1980).
Its main function is to guarantee the reoxidation of the glycolytically produced NADH 
by the glyceraldehyde-3-phosphate dehydrogenase reaction.
8.3.1 Assay of NAD+-dependent gIycerol-3-phosphate dehydrogenase in 
Phytomonas sp.
1.05 x 107 cells were sonicated in 1 ml PBS. 2 0 p l, 40pl ,60pl ,100pl and 120pl 
aliquots were assayed for glycerol-3-phosphate dehydrogenase activity as detailed in 
methods section 2.28.3.2. Control assays were performed in the absence of DHAP. 
The decrease in absorbance, following oxidation of NADH, was measured at 340 nm.
Control assays resulted in a comparatively small decrease in absorbance at 340 
nm compared to experimental rates. This is probably due to NADH oxidase activity 
which has been previously reported to be present in Phytomonas sp cell sonicate. 
These rates were subtracted from experimental values to give a linear plot of activity 
with sonicate volume (Fig. 38).
Results 
Figure 38
Assay of NAD - dependent glycerol -3-phosphate 















Mirrber of cels per nrl
105E7 ceils v^re sonicated in 1ml PBS 20 ,40 ,601D0 and 120 ul aliquots of sonicate were assayed for 
glycerol-3-phosphate dehydrogenase activity. A control assay containing no DHA P substrate was performed and 
the resulting background activity deducted from all assay rates.
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8.3.2 Glycerol-3-phosphate dehydrogenase in Crithidia fasciculata
1.53 x 108 cells were sonicated in 1 ml PBS. lOOpl, 150(il and 200pl aliquots 
were assayed as described in methods section 2.28.3.2. Control assays, in the absence 
of DHAP, were performed, resulting in no change in absorbance at 340 nm.
Figure 39
Assay of NAD - dependent glycerol-3-phosphate 
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153E8 cells \*ere sonicated in Im lPB S IX), 150 and 200 ul aliquots were taken and assayed for glycerol-3-phosphate dehydrogenase 
activity. A 'no substrate* (no DHA P) control was perform ed and the resulting endogenous rate subtracted from all assay rates______
8.3.3 Conclusions
These results confirm the presence of the glycosomal marker glycerol-3- 
phosphate dehydrogenase in both Crithidia fasciculata and Phytomonas sp cell 
sonicates. This is in accordance to previous reports which have detected glycerol-3 
phosphate dehydrogenase in both Phytomonas sp and Crithidia sp, and went on to 
localise this activity to glycosomes (Sanchez-moreno et al, 1992).
These findings may be compared to Opperdoes’ findings (Opperdoes et al, 
1981) where both bloodstream and procyclic forms of T. brucei were found to 
possess glycerol-3-phosphate activity, which was only slightly reduced in the 
bloodstream form compared to procyclic forms. Glycerol-3-phosphate dehydrogenase 
( G3P) functions as part of the G3P:DHAP shuttle which is essential for aerobic 
metabolism of bloodstream form T. brucei, but is also operational in procylic cells 
(Opperdoes, 1987).
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Glycerol-3-phosphate activity is sufficiently high in Phytomonas sp to be 
detectable after subtraction of background NADH oxidase activity, so confirming 
previously reported high levels of glycerol-3-phosphate dehydrogenase in a number of 
Phytomonas sp. isolates (Femandez-Becerra et al, 1997).
Glycerol-3-phosphate dehydrogenase was hence found to be a suitable 
glycosomal enzyme marker in cell fractionations of both Phytomonas sp and Crithidia 
fasciculata
8.4 Pyruvate Kinase
Pyruvate kinases have been isolated from many organisms, including bacteria, 
protists, fungi, plants and animals ( Kayne, 1973) In almost all cases, the enzyme is a 
tetramer composed of identical subunits with a molecular mass of approximately 60 
kDa ( Kayne, 1973) In prokaryotes and lower eukaryotes, generally one form of 
pyruvate kinase is found which is allosterically controlled (Kayne 1973). This is also 
the case in trypanosomes, where the role of the enzyme in metabolism is crucial.
8.4.1 Pyruvate kinase in Phytomonas sp.
3.35 x 107 cells were sonicated in 0.5 ml PBS. 40pl, 50pl and 60 pi aliquots 
were taken and assayed as described previously (methods section 2.28.3.3). 
Experimental rates, detected by a decrease in absorbance at 340nm, were observed 
which were sonicate volume-dependent and which appeared to be due to pyruvate 
kinase activity.(data not shown for the reasons below). However, ‘no substrate’ 
controls gave much higher decreases in A340nm than expected and were not 
significantly different from the experimental rates. This was confirmed by a second 
control experiment, in the absence of lactate dehydrogenase, where similar initial rates 
were observed.(data not shown). The observed experimental rates were therefore 
likely not to be attributable to pyruvate kinase activity, but were more likely the result 
of NADH oxidase activity inherent in Phytomonas sp sonicate.
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8.4.2 Pyruvate kinase in Crithidia fasciculata
9.6 x 107 cells were sonicated in 1 ml PBS and assayed as described previously 
( methods section). Control assays were performed in the absence of PEP substrate 
and in the absence of sonicate as for Phytomonas sp (above). Both control assays gave 
similarly very low assay rates which were deducted from experimental rates, giving a 
good linear plot (Fig. 40)
Figure 40
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9.6E7 cells were sonicated in 1 ml PBStD, f j and 20 ul aliquots were taken and assayed for pyruvate 
kinase activity. Controls ( see text) were performed to determine endogenous NA DH oxidase activity 
and such background levels were deducted from all assayed rates.______________________________
8.4.3 Conclusion
It would be expected that pyruvate kinase activity is present in Phytomonas sp. 
considering its important role in glycolysis and especially considering the 
biochemical similarity to bloodstream T.brucei where pyruvate kinase is an abundant 
enzyme of the cytosol, appearing to comprise 1.6% of the total cytosolic protein 
(Barnard et al, 1988). Additionally, it would be expected that pyruvate kinase would 
be present in significant amounts as compared to Crithidia fasciculata which is less 
dependent on glycolysis for energy. Barnard et al (1994) have shown that pyruvate 
kinase levels are higher in procyclic T. brucei than bloodstream forms and that both 
are detectable in the absence of activators, as in this assay.
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However, the observed experimental rates for Phytomonas sp appear to be the 
result of NADH oxidase activity present in the cell sonicate, as determined by 
performing control assays in the absence of PEP substrate. A second control in which 
lactate dehydrogenase was omitted from assays resulted in the same high rates, so 
confirming the activity of NADH oxidase. In a similar control experiment using 
sonicate from bloodstream T. brucei, Van Schaftingen (Van Schaftingen et al, 1985) 
failed to detect any NADH oxidase activity in T. brucei cells. Phytomonas therefore 
appears to have an unusual NADH oxidase activity which seems to mask the effect of 
any pyruvate kinase present. Pyruvate kinase, therefore, is an unsatisfactory enzyme 
marker for use in fractionation studies of Phytomonas sp
8.5 5’ nucleotidase
Phosphomonoesterases specific for nucleotides ie. nucleotidases, are known 
from a wide variety of eukaryotic and prokaryotic sources (Drummond and 
Yamamoto, 1971). 5' nucleotidase activity has been reported from a wide variety of 
cell types, and it is generally considered as a constituent o£ and a useful marker for, 
plasma membranes (De Pierre and Kamovsky, 1973; Riordan and Forstner, 1978; 
Trams and Lauter, 1974; Evans, 1978) although some intracellular activity has been 
demonstrated in membranes of the endoplasmic reticulum (Widnell, 1972) and in the 
Golgi apparatus (Farquhar et al, 1974), and a soluble form of the enzyme has been 
reported in certain tissues (Naito et al, 1974). The enzyme is also found in association 
with the cell surface membrane of various eukaryotic and prokaryotic microorganisms 
(Bengis-garber and Kushner, 1981; Armant et al, 1980).
5' nucleotidase activity has been investigated in some trypanosomatids. The 
enzyme has been found present in Leishmania (Gottlieb and Dwyer 1981; 1983; 
Konigk et al, 1978) and bloodstream forms of T. brucei (Voorheis et al, 1979), while 
Morgado Diaz et al (1996) confirmed the presence of 5'-nucleotidase in the plasma 
membrane of T. foetus (Queiroz et al, 1991; Morgado Diaz et al, 1996). Hunt and 
Ellar (1974) reported a very low level of 5'-nucleotidase in Leptomonas collosoma. 
Gottlieb and Dwyer(1983) confirmed the presence of 5’nucleotidase in L donovani 
while clearly differentiating the 5’ nucleotidase from the non-specific membrane-bound 
acid phosphatase of the promastigotes.
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3-nucleotidase activities have been localised to the surface membrane of 
several members of the protozoan family Trypanosomatidae. These members include 
species of Leishmania ( Steiger and Steiger, 1977; Marr and Berens, 1983; Gottlieb 
and Dwyer, 1983), African trypanosomes (Gottlieb and Dwyer, 1988) and Crithidia 
spp. (Dwyer and Gottlieb (1983 ;1984;1985). However, 3 ’nucleotidase does not occur 
in all trypanosomatids for it was not detected in T. cruzi (Gottlieb et al 1986) and has 
been reported absent from other protozoal parasites such as Babesia divergens 
(Hassan and Coombs, 1987a), Acanthamoeba species (Hassan and Coombs, 1987b) 
and T.vaginalis (Miller and Lindstead (1983).
5’Nucleotidase appears to be generally more widely distributed in protozoal 
parasites (Hassan and Coombs (1987) and so it was decided to assay for 
5’nucleotidase as a potential plasma membrane marker in both Crithidia fasciculata 
and Phytomonas sp.
8.5.1 General assay of 5’nucleotidase in Crithidia fasciculata
Hydrolysis of [3H]AMP by 5 ’nucleotidase was measured in both cell lysates 
and isolated plasma membrane fractions from Crithidia fasciculata. Typically, 50 pi 
aliquots of sample ( see individual results section) were incubated with 0.5 ml of a 
‘working substrate solution’ which contained [3H|AMP, 12mM glycerophosphate and 
0.12mM cold AMP in a 60 mM piperazine - HC1 buffer (pH 9.0) as detailed in 
methods section 2.28.3.5. The reaction was allowed to run at 37°C for various time 
periods (as detailed in individual results sections), at the end of which time 0.2 mis of 
0.15M zinc sulphate (ZnS04) was added. Samples were vortexed and placed on ice. 0.5 
mis of 0.15M barium hydroxide (Ba(OH)2) was then added and left to incubate for 30 
minutes on ice. These reagents served to both stop the reaction and to separate 
unreacted substrate from the product, [3H]adenosine , which remained in solution. The 
tubes were microfuged at 13,000 rpm(4 °C) for 10 minutes and 10 pi aliquots of 
supernatant were removed for counting.
Controls were performed for each assay in which substrate and enzyme sonicate/ 
plasma membrane fraction was absent. These values were subtracted as background 
from the experimental samples. The release of adenosine was calculated in relation to 
the measured [3H] activity of the working substrate solution.
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Various modifications of this general assay procedure were carried out as 
detailed in individual results sections.
8.5.2 Verification of experimental conditions
Before any assays could be performed, some initial experimental conditions 
needed to be characterised. The first of these was the determination of the percentage 
precipitation of [3H]AMP by Ba(OH)2 in the absence of 5’nucleotidase enzyme.
8.5.2.1 Initial experimental conditions
8.5.2.1.1 Determination of % precipitation of f3U]AMP
Recovery of [3H] adenosine and precipitation of AMP were ascertained by 
performing a mock 5’nucleotidase assay ( methods section 2.28.3.5) in the absence of 
cell sonicate. The procedure was followed as described above (section 9.5.1). 3 x lOpl 
supernatant samples were taken both before and after incubation with barium 
hydroxide and counted for [3H]adenosine. Counts were adjusted to take the change in 
volume into consideration, and the percentage of [3H] adenosine in the supernatant 
following precipitation with Ba(OH)2 was calculated to be 15.4%. This means that 
barium hydroxide maximally precipitates 85% of [3H] AMP under these assay 
conditions.
8.5.2.1.2 Determination of optimal Ba (OH)? incubation time for maximum f3H]AMP 
precipitation
The procedure was repeated as described before ( section 9.5.2.1.1) except that 
samples were incubated with Ba(OH)2 for various time periods in an attempt to 
improve upon the percentage of [3H]AMP precipitated at this step. 3 x 10pl samples of 
supernatant were taken before and after the addition of Ba(OH)2 for five incubation 
periods in the range of 30 to 150 minutes and counted for [3H]adenosine (Fig. 41).
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8.5.2.1.2.1 Results
% of tritia ted  AMP precip itated  by Barium 
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Figure 41 : ‘Mock’ 5’nucleotidase assays were performed in the absence of enzyme as described 
above in section 9.5.1. Various barium hydroxide incubation times ( 0 - 150 minutes) were tested in an 
attempt to maximise precipitation of [3H] AMP. 3 x 10gl supernatant samples were taken both before 
and after incubation with 0.5 ml Ba (OH>2 (0 .15M) and counted for [3H]adenosine.
No significant differences in % [3H]AMP precipitated with Ba(OH)2 was observed 
between incubations times.
8.5.2.1.2.2 Conclusion
There is no advantage to be gained by extending Ba(OH)2 precipitation time 
beyond the 30 minutes detailed in the original method. 30 minutes is hence an 
appropriate precipitation time and was used in all subsequent experiments.
8.5.3 5’ Nucleotidase assays ( see methods section 2.27.3.5)
All assays were performed in triphcate ( unless otherwise stated). Cell 
sonication (methods section 2.24) was performed in a stainless steel vessel at 4 °C to 
minimise 5’nucleotidase degradation with heat.
8.5.3.1 Time course for 5’ nucleotidase assay
2.3 x 107 Crithidia fasciculata cells were freshly harvested, washed and 
sonicated (methods sections 2.2 & 2.24) in 1 ml PBS.. lOfil o f sonicated extract was 
added to 0.5 mis o f  working substrate solution and left to incubate for various time 
periods between 0 and 60 minutes. Reactions were ended by the addition o f 0.5mls
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ZnS04 and [3H]adenosine product was precipitated using Ba(OH)2 and assayed as 
described previously. ‘No glycerophosphate’ control assays were performed 
simultaneously using 0.5 ml working substrate solution deficient in 12mM 
glyceropho sphate.
8.5.3.1.1 Results
No significant increase in [3H] adenosine product was observed with time in either the
presence or absence o f  (3-glyceropho sphate, an inhibitor o f non-specific alkaline 
phosphatase (data not shown). The experiment was repeated with 50pl sonicate 
aliquots and the same result obtained (Fig. 42).
Figure 42: 2.3 x 107 Crithidia fasciculata cells were freshly harvested, washed and sonicated 
in 1 ml PBS. 50 pi of sonicated extract was added to 0.5 mis of working substrate solution mixture 
and left to incubate for various time periods between 0 and 60 minutes before the reaction was stopped 
with 0.2 mis of ZnS04 (0.15M). Precipitation and counting of [3H] adenosine product was performed 
as detailed previously. Control assays for alkaline phosphatase were performed simultaneously in the 
absence of glycerophosphate using 0.5 mis working substrate solution deficient in 12mM 
glycerophosphate.
8.5.3.1.2 Conclusion
This result may indicate the absence o f 5’nucleotidase activity in Crithidia 
fasciculata. Alternatively, the amount o f cold AMP present in the assay (in the 
working substrate solution) may be too high and may be masking any hydrolysis o f 
trace [3H]AMP by 5’nucleotidase.
8.5.3.2 Investigation of possible masking effect of cold AMP.
The working substrate solution was modified in an attempt to overcome 
possible masking o f enzyme activity. Cold AMP was omitted and a lower dilution o f
5' n u c leo tid ase  a ssa y  of Crithidia fasc icu la ta  
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stock [3H]AMP (1 (j.1 stock [3H]AMP (250pCi; specific activity 18.9 Ci/  mmole) in 10 
mis reaction mixture) was used in an attempt to increase assay sensitivity.
lx l  08 Crithidia fasciculata cells were harvested, washed and sonicated in 1 ml 
PBS (section 2.23 & 2.24). lOOpl aliquots were incubated with 0.5 mis o f modified 
working substrate solution in both the presence and absence o f 12mM 
glycerophosphate for various time intervals (10 - 60 minutes). The reaction was 
stopped by the addition o f ZnS04 and the assay procedure followed as before 
(methods section 2.28.3.5). >
8.5.3.2.1 Results
Again, no rise in [3H]adenosine formed with incubation time (Fig. 43) was 
observed, with no significant difference in the hydrolysis o f  [3H]AMP observed in the 
presence and absence o f  glycerophosphate.
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Figure 43: 1x10s Crithidia .fasciculata cells were harvested, washed and sonicated in 1 ml PBS 100 
pi aliquots of cell sonicate were assayed both in the presence and absence of 12mM glycerophosphate 
using modified working substrate solution which was deficient in cold AMP and contained a higher 
concentration of [3H] AMP in an attempt to increase assay sensitivity. The reaction was stopped by the 
addition of 0.2 mis ZnS04 (0 .15M) and the formation of [3H]adenosine product assayed as described 
previously.
8.5.3.2.2 Conclusions
Even in the absence o f cold AMP, no significant hydrolysis o f [3H] AMP was observed 
over the hour time course. This suggests that either 5’nucleotidase activity is absent in 
Crithidia fasciculata cell sonicate, or is present in such low amounts as to be 
undetectable after one hour. To investigate the latter possibility further, a 36 hour time 
course was performed.
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8.5.3.3 36 hour time course for Crithidia fasciculata sonicate 
A 36 hr time course experiment was carried out using modified working substrate 
solution (see section 9.5.3.2.1) in order to see if any 5’nucleotidase activity could be 
detected over a prolonged time period (Fig. 44). 1.2 x 108 Crithidia fasciculata cells 
were harvested, washed and then sonicated in 1 ml PBS. 50pl o f sonicate were assayed 
in 0.5 mis modified working substrate solution both with and without 12mM 
glycerophosphate. The reaction was terminated by the addition o f Z nS04 and 
unreacted substrate separated from reaction product by precipitation using Ba(OH)2 as 
previously described
8.5.3.3.1 Results
36 hr time course of 5* nucleotidase activity 













Figure 44: 1.2 x 10* Crithidia fasciculata cells were harvested, washed and then sonicated in 1 ml PBS. 50pl of 
sonicate were assayed in 0.5 mis modified working substrate in the presence and absence o f 12mM 
glycerophosphate over a 36 hour time course. The reaction was terminated by the addition of ZnS04 and 
unreacted substrate separated from reaction product by precipitation using Ba(OH>2 as previously 
described.
An increase in [3H]adenosine formed with time was observed, which indicates 
5’nucleotidase activity in the cell sonicate. There was no significant difference between 
reactions carried out in the presence and absence o f glycerophosphate, so confirming 
that the observed activity is due to 5’nucleotidase and not a result o f  nonspecific 
alkaline phosphatase activity.
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8 .5 .3 .3 .2  C on clu sion s
The time - dependent increase in [3H]adenosine formed following incubation with 
Crithidia fasciculata sonicate indicates the presence o f  a small amount o f  
5’nucleotidase activity. However, the activity appears to be so low as to render the use 
o f this enzyme as a membrane marker impractical and unreliable as a quantitative 
assay.
8 .5 .3 .4  36 h our tim e course for isolated  C rithid ia fascicu lata  iso lated  plasm a>  
m em brane fraction  (see C hapter 9)
The above experiment was repeated using 50 pi o f isolated Crithidia fasciculata 
plasma membrane instead o f cell lysate (Fig. 42). The plasma membrane fraction from 
Crithidia fasciculata was isolated as detailed in Chapter 9 and methods section 2.28. 
Isolated plasma membrane was washed and suspended in 0.5 ml PBS prior to assay. 
50pl o f plasma membrane isolate was incubated with 0.5mls o f modified working 
substrate solution (section 9.5.3.2) in the presence and absence o f 12mM 
glycerophosphate over a 36hr timecourse. The reaction was stopped by the addition o f  
ZnS04 and the assay carried out in the usual was as described previously.
8.5.3.4.1 R esu lts
36 hr tim ecourse for 5 'nucleo tidase in stored 














Figure 45: 50 pi of Crithidia fasciculata plasma membrane isolate, obtained following cell fractionation (see 
chapter 9), was assayed for 5 ’nucleotidase activity over a 36 hour time course. The isolate w as incubated  
with 0.5m ls o f  m odified w orking substrate solution (section 9 .5 .3 .2 ) in the presence and absence o f  
12mM glycerophosphate over a 36hr timecourse. The reaction w as stopped by the addition o f  Z n S 0 4 
and the assay carried out in the usual was as described previously.
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There appears to be no significant 5’nucleotidase activity in the plasma 
membrane fraction with time. As in the cell sonicate time course, there is no significant 
difference in activity between reactions carried out in the presence and absence of 
glycerophosphate, indicating the absence of non specific alkaline phosphatase in the 
isolated fraction.
8.5.3.4.2 Conclusions
There appears to be no 5’nucleotidase activity in the plasma membrane fraction. This is 
an unusual finding, considering the activity observed for the cell sonicate, as 
5’nucleotidase is a common plasma membrane enzyme.
It is possible that 5’nucleotidase may be present in other parts of the cell other 
than the plasma membrane. 5’nucleotidase activity has been demonstrated in 
membranes of the endoplasmic reticulum (Widnell, 1972) and in the Golgi apparatus 
(Farquhar et al, 1974) of some cells, and a soluble form of the enzyme has been 
reported in certain tissues (Naito et al, 1974). Hassan and Coombs (1987) reported 
that 5’nucleotidase in L.mexicana mexicana occurs both membrane bound and in the 
cell matrix. A proportionally high level of cell matrix 5’nucleotidase activity compared 
to plasma membrane-located enzyme might explain the activity observed in cell 
sonicate and the apparent absence in the plasma membrane isolate.
8.5.4 Discussion
It appears that there is a very low 5’nucleotidase activity present in Crithidia 
fasciculata cell sonicate, detectable after a minimum 12 hours reaction time under 
optimally sensitive assay conditions. Although it is possible that the 5’nucleotidase 
does not have a plasma membrane location and is located in other organelle 
membranes, this is unlikely as in previous studies of trypanosomal 5’nucleotidase, the 
enzyme, if detected at all, has been shown to have a plasma membrane location 
(Morgado Diaz et al, 1996; Gottlieb and Dwyer, 1983; Voorheis et al, 1979; Hunt and 
Ellar,1974). It is possible that a weak association with the plasma membrane, as 
suggested by Voorheis et al (1979) in T. brucei, may result in detachment of the 
enzyme during homogenisation. The enzyme has been found to be discontinuously 
distributed over the external surface of Leishmania donovani (Dwyer and Gottlieb,
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1984) by means of a GPI anchor which renders the enzyme highly labile and this may 
be the case for Crithidia fasciculata. A weak plasma membrane association was also 
found for 3 ’nucleotidase in procyclic T. brucei. (Cook et al,1990), rendering the assay 
of nucleotidase in fractionation studies to be relatively inaccurate.
Hence, owing to the generally very low activity observed in cell sonicate 
experiments together with the possibility of considerable loss during fractionation 
experiments, it was decided to abandon 5’nucleotidase as a plasma membrane marker 
for use in fractionation studies.
8.5.5 Future work
Trypanosomes are dependent on an exogenous supply of preformed purines because 
they are incapable of de novo purine synthesis (Kidder and Dutta, 1958) and it has 
been widely reported in the literature that 5’nucleotidase ( and 3’nucleotidase) 
expression in trypanosomes may vary dramatically depending on the culture medium 
Nucleotidase activity has been observed to increase dramatically in some Crithidia sp. 
in the absence of purines and/or phosphate in the culture medium (Dwyer and Gottlieb, 
1984 ; Gottlieb and Zlotnick, 1987). In Crithidia fasciculata, the level of 
5’nucleotidase has been found to increase 5 fold when grown in medium containing 
low adenosine ( i.e. under conditions of purine starvation) as compared to cells grown 
in adenosine-enriched medium (Gottlieb, 1985). The striking induction of 
5’nucleotidase activity in response to clearly defined and easily manipulated nutrient 
signals may hence be explored further in order to gain higher 5’nucleotidase activity in 
Crithidia fasciculata cells for use in fractionation studies.
It has been reported in the literature that 5 ’nucleotidase activity varies 
depending on the growth stage of Crithidia fasciculata, with nucleotidase activity 
observed to be twice as high in late log-phase cells compared to early log- phase cells 
(Gottlieb, 1985). Furthermore, it has been reported that the level of 3’nucleotidase in 
Leishmania donovani does not remain constant throughout the growth curve, but is 
transiently elevated during the lag- and early log- phases of growth (Sacci et al, 1990). 
Cells used in the experiments detailed in this thesis may have been harvested during a 
phase of the growth cycle in which low levels of 5 ’nucleotidase were exhibited. Future
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work involving cells from different phases of the growth curve should hence be 
performed in an attempt to maximise 5’nucleotidase activity in cells used for assay.
8.6 General conclusions
While isocitrate dehydrogenase, glycerol-3-phosphate dehydrogenase and 
pyruvate kinase appear to be suitable enzyme markers for mitochondrial, glycosomal 
and cytosolic contamination in plasma membrane isolates from Crithidia fasciculata, 
5’nucleotidase was found to be an unsuitable plasma membrane marker. Only glycerol- 
3-phosphate dehydrogenase was found to be a suitable enzyme marker in Phytomonas 
sp., with isocitrate dehydrogenase activity found to be absent and pyruvate kinase un- 
assayable due to masking by endogenous NADH oxidase activity. Time constraints did 
not permit an exhaustive investigation of enzyme markers for both cell types and it was 
decided to assess plasma membrane isolate purity for both cells by morphological 
examination of isolates by electron microscopy. Although non-quantitative, this 
method may be used effectively to determine whether plasma membrane enrichment 
has occurred following the isolation procedure.
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CHAPTER 9
INVESTIGATION OF A PLASMA MEMBRANE LOCATION 
FOR DHLIPDH IN CRITHIDIA FASCICULATA AND 
PHYTOMONASSP
9.1 Plasma membrane preparations of Phytomonas sp. and Crithidia fasciculata
A method of plasma membrane preparation, based on the procedure described by 
Dwyer (1980) who reported the isolation of highly enriched (> 95% purity) fractions 
of pellicular membrane-microtubule complexes from L donovani promastigotes, was 
used to obtain plasma membrane - enriched isolates for both Phytomonas sp. and 
Crithidia fasciculata (methods section 2.27; Fig. 43). Cells were grown to a cell 
density of 1.5 x 108 cells per ml for Crithidia fasciculata and 4 x 107 cells per ml for 
Phytomonas sp., and harvested by centrifugation at 4°C (methods section 2.23). 
Washed, pelleted cells were resuspended in 1 ml ice cold swelling buffer (tris-EDTA 
buffer (pH 7.8) containing leupeptin (2pg/ml) and PMSF (ImM)) and transferred to a 
chilled mortar. Chilled silicon carbide abrasive grain was added to the mortar (60:40 
gm carbide/ gm wet weight) and the cell paste ground manually using a chilled pestle. 
The suspension was diluted with 5 ml chilled isolation buffer and spun for 3 minutes at 
120g to remove the carbide ( see Fig. 43). The supernatant was removed and 
centrifuged a further 10 minutes at 4,000 g at 4°C. The pelleted material was 
suspended in 6ml 0.146 M sucrose solution (dissolved in tris-EDTA containing 1 mM 
PMSF) and the pellet disrupted by 2 passages through a 22 gauge needle. The 
suspension was overlaid onto a discontinuous sucrose gradient consisting of a 1.61 M 
sucrose cushion (5 ml) and a 1.17M sucrose layer (15ml), and spun in a Beckman L5- 
50B ultracentrifuge at 27,000 rpm (4 °C ), for 2 hours using an SW27 rotor (Dwyer, 
1980).
Following sucrose gradient centrifugation, a dense white band on the 
discontinuous sucrose gradient (corresponding to a plasma membrane enriched 
fraction) at the interface between 1.17M and 1.6M sucrose, was obtained. Fig. 46 
shows a photograph of this band. A small amount of white material was observed at 
the interface between the 0.146M and 1.17M sucrose layers and corresponds to a very 
small microsomal fraction. The dark pellet at the bottom of the gradient was found to 
contain mainly unbroken cells and flagella, as observed under a light microscope. The
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‘plasma membrane’ band was collected by careful removal o f  gradient layers using a 
pipette and then diluted with Tris-EDTA buffer before ultracentrifuging for a further 2 
hours at 27,000 rpm. The resulting pelleted membranes were washed twice in PBS by 
centrifugation as described above and finally suspended in 1 ml PBS for analysis.
Figure 46 : Isolation of a plasma membrane fraction, observed as a dense white band at the interface 
between 1.17M and 1.6M sucrose, on a discontinuous sucrose gradient.
9.2 Investigation of DBQipDH activity during plasma membrane preparation
0.5 ml fractions taken from stages during the purification o f  the trypanosome 
plasma membranes were stored on ice until tested for protein content and DHhpDH 
activity. Fractions assayed were the homogenate (H), the supernatant (SI), the pellet in 
suspension (PI) and the final plasma membrane enriched pellet (P 2) (Fig. 47). 30 pi 
aliquots were taken from each fraction and DHhpDH was assayed as described in 
methods 2.27.3.1. NADH oxidase activity was measured as a control in each fraction 
( methods section 2.27.3.2). To provide some correction for the depression o f  
measured NADH in the DHhpDH assay, the measured rate o f any NADH oxidase was 
added to observed rates.
Total protein content and corrected DHhpDH activity was determined for all 
isolated fractions. Total enzyme activities are expressed in p moles NADH formed per 
minute. Specific activities were determined and are expressed as p moles o f NADH  
formed /per minute/ per mg o f protein. Tables 10 and 11 summarise the specific
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activities, total activities and percentage o f the total enzyme activity, taking the 
homogenate value as the 100% value. Figs 48 and 49 show bar charts o f  total enzyme 
activity and specific activities for easy comparison.
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Figure 47: Plasma membrane isolation procedure used to isolate plasma membrane fractions in 
both Crithidia fasciculata and Phytomonas sp. Fractions were taken and assayed for protein content 
and DHlipDH activity at various stages of the isolation procedure as denoted in the schedule.
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Table 10 (a) Total protein content for Crithidia fasciculata fractions
Total protein 




Table 10 (b) Dihvdrolipoamide dehydrogenase activity in Crithidia fasciculata
H 0.49 100 0.273
SI 0,26 54 0.24
PI —
P2 0.193 39.3 0.6
Table 11 (a) Total protein content for Phytomonas sp. fractions
Sample
Total protein content (mg/ml)




Table 11 (b) Dihvdrolipoamide dehydrogenase activity in Phytomonas sp.
MM
H 0.22 100 0.079
SI 0.022 10 0..0018
PI -
P2 0.08 36.4 0.41
137
Figure 48: Comparison of total DHlipDH activity in Crithidia fasciculata and
Phytomonas sp. fractions










Figure 48(a) 500 mis of Crithidia fasciculata cell suspension with a cell density of 1.5 x 108cells per 
ml were rapidly chilled on ice and then harvested by centrifuging for 10 minutes at 2,000 g. Cells 
were washed twice in ice cold PBS. The washed , pelleted cells were weighed and resuspended in 1 
ml Tris-EDTA isolation buffer (pH 7.8) containing leupeptin (2pg/ml) and PMSF (ImM), and 
transferred to a chilled mortar. Silicon carbide abrasive grain was added to mortar (approx. 60:40 
ratio of grain to cell wet weight) and the cell paste ground manually using a chilled pestle. 
Fractionation procedure was carried out as detailed in methods section 2.27 and isolated fractions (see 
fig. 47) were assayed for DHlipDH activity as described previously (methods section 2.27.3.1)
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Figure 48(b) 2,500 mis of Phytomonas sp. cell suspension with a cell density of 4 x 107 cells per ml 
were rapidly chilled on ice and then harvested by centrifuging for 10 minutes at 2,000 g. Cells were 
washed twice in ice cold PBS. The washed , pelleted cells were weighed and resuspended in 1 ml 
Tris-EDTA isolation buffer (pH 7.8) containing leupeptin (2pg/ml) and PMSF (ImM), and 
transferred to a chilled mortar. Silicon carbide abrasive grain was added to mortar (approx. 60:40 
ratio of grain to cell wet weight) and the cell paste ground manually using a chilled pestle. 
Fractionation procedure was carried out as detailed in methods section 2.27 and isolated fractions 
(see fig 47) were assayed for DHlipDH activity as described previously (methods section 2.27.3.1)
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Figure 49: Comparison of DHlipDH specific activity in Crithidia fasciculata and
Phytomonas sp. fractions




Figure 49 (a): Total DHlipDH activities were determined for each isolated fraction (Fig. 48 (a); table 10(b)). 
Protein determinations were performed using a modified Lowry method ( methods section 2.27.2, table 10(a)) 
and DHlipDH specific activity for each fraction calculated.
DHlipDH specific activity in isolated fractions of Phytom onas sp
H S1 P2
Fraction
Figure 49(b): Total DHlipDH activities were determined for each isolated fraction (Fig. 48(b); table 11(b)). 
Protein determinations were performed using a modified Lowry method ( methods section 2.27.2, table 11(a)) 
and DHlipDH specific activity for each fraction calculated.
9.2.1 DHlipDH activity in Crithidia fasciculata
The specific activity o f DHlipDH in C. fasciculata cell homogenate was found to be 
0.273 pM/min'Vmg protein1 and was comparable to the specific activity o f  
0.29pM/miu'Vmg protein1 previously determined for the cell sonicate (section
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7.1.3.1). 54% of the total DHlipDH activity was found in the supernatant, SI, 
following centrifugation of homogenate. The specific activity in the supernatant was 
decreased to 88% of the homogenate value. However, the isolated plasma membrane- 
enriched fraction, after washing and pelleting to form P2, had a total activity 40% of 
the homogenate value. The specific activity of the final plasma membrane pellet, P2, 
was 0.6pM . This signified a 2 fold increase in specific activity over the homogenate, 
indicating some retention of enzyme activity in the plasma membrane-enriched fraction
9.2.2 Dihydrolipoamide dehydrogenase activity in Phytomonas sp.
The specific activity of DHlipDH in Phytomonas sp. cell homogenate was found to be 
0.079 pM/min'Vmg protein'1 and was comparable to the specific activity of 
0.06pM/min'Vmg protein'1 previously determined for the cell sonicate (section 7.1.2). 
10 % of the total enzyme activity was found in the supernatant (SI) following 
centrifugation of homogenate. This is approximately 40% less than that observed for 
Crithidia fasciculata. The specific activity in the supernatant was decreased to 23% of 
the homogenate value. 36.4 % of the total homogenate activity was observed in the 
plasma membrane pellet, with a high specific activity 5.2 times the homogenate 
activity. This result shows that the plasma membrane enriched fraction is also enriched 
with DHlipDH, suggesting some degree of copurification of DHhpDH with 
Phytomonas sp. plasma membrane.
Fig. 50 (a) and (b) are electron micrographs of the final plasma membrane fraction of 
Crithidia fasciculata, while Fig. 51 (a) and (b) are micrographs of the plasma 
membrane fraction of Phytomonas sp. Both clearly show cross sections through the 
pellicular microtubule array which is characteristically attached to the plasma 
membrane in trypanosomes (Vickerman and Preston (1976)). Hence the presence of 
these structures is definitive proof of plasma membrane enrichment in isolated plasma 




Figure 50 (a and b): electron micrographs of plasma membrane-enriched fractions isolated from 
Crithida fasciculata by sucrose gradient ultracentrifugation. Arrow heads indicate microtubules 




Figure 51 (a and b): electron micrographs of plasma membrane-enriched fractions isolated from 
Phytomonas sp by sucrose gradient ultracentrifugation. Arrow heads indicate microtubules 
characteristically attached to the plasma membrane (PM). Fig. 51 (b) shows microtubules, in both 
transverse (arrow head) and longitudinal (large arrow) section.
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9.2.3 Mitochondrial contamination of plasma membrane fractions
9.2.3.1 Indicated by NADH oxidase in Phytomonas sp.
NADH oxidase activity was found to be absent in the isolated Crithidia fasciculata 
plasma membrane fraction but present in low levels in Phytomonas sp. plasma 
membrane fraction. The presence of NADH oxidase may be an indication of 
contamination by membranes from other organelles in the plasma membrane 
preparation. Such membranes may be mitochondrial, or possibly glycosomal (Conroy, 
1988; Jackman 1991)
In the method of Voorheis (1979) (used by Danson et al (1987)) to purify 
bloodstream plasma membranes, and the method described by Dwyer (1980) used in 
this work, there is no way of determining whether DHhpDH is present at a plasma 
membrane location only within the cell. This is important as the possibility of 
contamination of the plasma membrane preparation with other cellular membranes, e.g. 
mitochondrial membranes, is a very real one. There is substantial evidence for the 
absence of functional citric acid cycle enzymes in Phytomonas sp. , with mitochondria 
incapable of oxidising pyruvate, succinate, 2-oxoglutarate, malate or proline 
(Femandez-Beccerra et al, 1997; Sanchez-Moreno et al, 1992). However, residual 
amounts of citric acid cycle enzymes have been detected in the inactive bloodstream T. 
brucei promitochondrion by Jenkins et al (1988) and Durieux et al (1991) and a 
mitochondrial location of DHhpDH cannot be entirely dismissed. Hence it may be 
possible that the observed DHhpDH recovery with Phytomonas plasma membranes 
could be a result of contamination or adventitious adherence.
9.2.3.2 Indicated by NAD -dependent isocitrate dehydrogenase in Crithidia 
fasciculata
NAD-dependent isocitrate dehydrogenase, a previously characterised 
mitochondrial marker (chapter 8, section 8.2), was assayed during the fractionation of 
Crithidia fasciculata to determine the extent of any mitochondrial contamination in the 
plasma membrane preparation. Isocitrate dehydrogenase, together with DHhpDH, 
activity was measured in the unfractionated homogenate and isolated plasma 
membrane pellet and specific activities determined (Fig. 52). There was a four fold
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decrease in isocitrate dehydrogenase specific activity , from 0.029 U/mg protein"1 in 
homogenate to 0.007 U/mg protein'1 in the isolated plasma membrane fraction, 
indicating a significant though low level o f mitochondrial contamination in the isolated 
plasma membrane fraction.
Purification of plasm a mem brane sheets  of Crithidia fasciculata and cellular location of
dihvdrolipoamide dehydrogenase and isocitrate dehydrogenase
S' Homogenate Homogenate PLasma PLasma
111 DHlipDH I CD membrane membrane
DHlipDH I CD
Figure 52: Plasma membrane sheets from Crithidia fasciculata were purified, and the enzymic 
activities of DHlipDH and isocitrate dehydrogenase were assayed, as described in methods section 
2.28.3. The enzymic activities are expressed as a percentage of their specific activity in the 
unfractionated cell homogenate (DHlipDH, 0.273 |iM/NADH produced min'Vmg protein'1; isocitrate 
dehydrogenase 0.029 pM/NADH produced min'Vmg protein'1)
9.3 Discussion
The DHhpDH o f the bloodstream form o f T. brucei was first identified and 
localised to the plasma membrane o f the organism by Danson et al (1987) using the 
method o f Voorheis et al (1979) to purify plasma membranes. Contrary to the method 
described here, cells, swollen to turgidity, were homogenised with a tight-fitting 
Dounce homogeniser and then treated with leupeptin and DNAase before being 
subjected to sucrose-density-gradient centrifugation (Voorheis et al., 1979). A  
prominent dense band was extracted from the gradient and examination by electron 
microscopy revealed it to be enriched with plasma membranes, as evidenced by then- 
characteristic subpellicular microtubular array. Enzymatic analysis o f these membrane 
fractions indicated that they contained the majority of the DHhpDH (only 10% being 
found in the initial supernatant), up to 60% o f a plasma membrane marker (the 
ouabain-sensitive Na+ + K+ stimulated ATPase), and a neghgible amount o f malate 
dehydrogenase contamination (<2%) (Danson et al, 1987). Further work by Jackman
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et al (1990), based on full subcellular fractionation studies, reported that DHlipDH was 
located over the entire surface of the plasma membrane, including the flagellar pocket 
region in bloodstream forms. Jackman et al performed a subcellular fractionation 
according to the method of Gbenle et al, 1986. Cells were homogenised with silicon 
carbide, and subjected to differential centrifugation followed by isopycnic 
centrifugation of the post-large-granule extract on a linear sucrose gradient in which 
the plasma membrane migrated to a characteristic density. Fractions were taken and 
assayed for DHlipDH together with marker enzymes a-glucosidase (plasma 
membrane), acid phosphatase (flagellar pocket), 3 ’nucleotidase (plasma membrane), 
isocitrate dehydrogenase (mitochondria), a-mannosidase (lysosomes), hexokinase 
(glycosomes) and adenylate cyclase (flagellar pocket).
Both Crithidia fasciculata and Phytomonas sp. have specific activities in the 
plasma membrane fractions which are higher than the homogenate value, initially 
indicating some copurification of DHlipDH with plasma membrane in both cell types. 
This retention of enzyme activity in plasma membrane fraction appears to be more 
pronounced in Phytomonas sp. , where specific activity is over five times that of the 
homogenate value. Interestingly, only 10% of total DHhpDH activity was lost in the 
supernatant in Phytomonas sp. ( as compared to a considerable 54% in Crithidia 
fasciculata ) which compares directly with the 10 % loss found in the initial 
supernatant found by Danson et al (1987) in their preparation of bloodstream T. brucei 
plasma membrane preparations.
The two fold increase in specific activity over homogenate observed in the 
plasma membrane fraction of Crithidia fasciculata appears to indicate some 
copurification of DHhpDH with plasma membrane. However, in view of the 
mitochondrial contamination of the plasma membrane fraction ( section 9.2.3.3), it is 
possible that the observed increase in activity is due to mitochondrial DHhpDH, which 
is certainly present in the mitochondriaUy active Crithidia fasciculata. Cook et al 
(1990) reported the possible presence of DHhpDH in the plasma membrane of 
procychc T. brucei following kinetic analysis of DHhpDH in sonicate and plasma 
membrane isolates. However, a full subcellular fractionation study performed by
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Jackman (1991) indicated the probable absence of an extra mitochondrial DHhpDH in 
procyclic T. brucei, although a plasma membrane location could not be entirely ruled 
out. Hence, although there is a possibility of an extra-mitochondrial DHhpDH in 
Crithidia fasciculata, it is unlikely and further investigations are essential.
The five fold increase in DHhpDH in Phytomonas sp. is comparable to the 
findings of Danson et al (1987) where the specific activity of T. brucei DHhpDH was 
8-fold greater in plasma membrane preparations than that observed in the cell lysate. 
This increase in specific activity compares with reported values of 15-fold for ouabain- 
sensitive Na+ + K+-stimulated ATPase and 5-fold for adenylate cyclase in blood stream 
T. brucei (Voorheis et al, 1979). However, owing to the unavailability of a suitable 
mitochondrial enzyme marker, it was impossible to determine the degree, if any, of 
mitochondrial contamination in Phytomonas sp. However, the presence of NADH 
oxidase in the plasma membrane isolate may indicate some mitochondrial 
contamination although the considerable five-fold increase does seem to suggest the 
presence of an extra-mitochondrial plasma membrane DHhpDH.
One obvious difference between Crithidia fasciculata and Phytomonas sp. in 
the results presented above is the notable loss of DHhpDH in supernatant (SI) in 
Crithidia fasciculata as compared to Phytomonas sp. (Figs 48 and 49). This may be 
explained by suggesting that rupturing of the highly developed Crithidia fasciculata 
mitochondria during grinding with silicon carbide could easily take place, and enzymes 
present in the mitochondrial matrix could leak out. DHhpDH may be free in the 
mitochondrial matrix of Crithidia fasciculata and therefore able to leak out.
9.4 Future work
Future work should focus on the elucidation of reliable organelle enzyme 
markers which could be used in a full subcellular fractionation study of both 
Phytomonas sp. and Crithidia fasciculata, similar to that performed by Jackman et al 
(1990) on bloodstream T. brucei, in which ah cellular locations of DHhpDH could be 
investigated. Assays for the pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase 
and branched chain 2-oxo acid dehydrogenase complexes should also be performed, as 
suggested in Chapter 7 (section 7.1.6) as should an investigation of the presence of a 
glycine cleavage system in both cell types.
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A plasma membrane location of DHlipDH could be investigated further by 
latency studies on whole cells to determine if the enzyme is located at the cytoplasmic 
or external face of the plasma membrane, as described by Steiger et al (1980). Assays 
for the presence of lipoic acid ( Jackman et al, 1991) is another line of future 
investigation. Lipoic acid is a coenzyme for pyruvate dehydrogenase, a  ketoglutarate 
dehydrogenase, branched chain-ketoacid dehydrogenase, and the glycine cleavage 
system. DHlipDH is an essential component of all these complexes and hence 
confirmation of the presence or absence of lipoic acid would be advantageous, 
especially in Phytomonas sp. where the possibility exists of a novel and possibly 
uncomplexed plasma membrane enzyme.
9.5 Summary
The discovery of DHlipDH in mitochondrially inactive Phytomonas sp., and the 
possible plasma membrane location, is an exciting one and is comparable to the 
findings of Danson et al (1987) and Jackman et al (1991) of DHhpDH in the 
mitochondrially inactive bloodstream form of T. brucei. Their findings were important 
as it was the first and only known example of an extra-mitochondrial eukaryotic 
DHhpDH. The results reported here suggest that the previously reported presence of 
DHhpDH in mitochondrially inactive bloodstream T. brucei, and the unusual plasma 
membrane location, may be common to Phytomonas sp. and possibly other members 




The work presented here in this thesis was inspired by the findings of Danson 
et al (1987) who reported the presence of dihydrolipoamide dehydrogenase 
(DHlipDH) in the bloodstream form of T. brucei in the absence of pyruvate (PDHC), 2- 
oxoglutarate, and branched chain 2-oxoacid dehydrogenase complexes (BCOADC). 
They also presented evidence for an unusual plasma membrane location, suggesting 
that DHlipDH might have a cellular function in addition to its established role in these 
dehydrogenase complexes. The finding of a plasma membrane associated DHlipDH 
was very exciting as it was the first reported incidence of an extra-mitochondrial 
DHlipDH in a eukaryotic cell
Jackman et al (1991) continued investigations into the nature and localisation 
of DHhpDH in both bloodstream and procyclic forms of T. brucei. Using subcellular 
fractionation techniques and latency studies where DHlipDH activity was measured in 
the presence and absence of 0.1% triton X-100 according to the method described by 
Gbenle et al (Gbenle et al, 1986)., they confirmed that mitochondrially-inactive 
bloodstream T. brucei possessed a DHhpDH which was solely located in loose 
association over the inner surface of the plasma membrane. The mitochondrially- active 
procychc form was shown to possess mitochondrial DHipDH, which would be 
expected owing to the presence of 2-oxo acid dehydrogenase complexes, although it 
was not possible to determine if there was also a plasma membrane location using the 
methods employed.
The aim of this study has been to determine unequivocally if a plasma 
membrane DHhpDH occurs in procychc T.brucei cells and to extend the investigation 
of DHhpDH to other members of the Trypanosomatid family in which mitochondria 
may be either active or repressed, namely Crithidia fasciculata and Phytomonas sp. 
respectively.
Attempts to utilise DHhpDH-specific polyclonal antibodies, raised using 
synthetic peptide sequences, in immunolocahsation experiments proved largely 
unsuccessful owing to weak antibody binding to both the denatured enzyme, as seen in 
western blots, and the native DHhpDH protein as found in immunofluorescence
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experiments (chapter 6). However, although unable to show conclusively whether 
DHhpDH was to be found in the plasma membrane of procychc T. brucei cells by 
immunochemical means, this project presents convincing preliminary evidence, based 
on subcellular fractionation experiments, for an unusual plasma membrane associated 
DHhpDH in Phytomonas sp.
10.1 DHlipDH in members of the subgenus Trypanozoon 
DHhpDH activity has been detected in both bloodstream and procychc forms of 
T.b.brucei, T.b.rhodesiense ,T.b.gambiense and T.evansi (Else et al, 1994) while 
antibodies to T.cruzi DHhpDH, provided by Krauth-Siegel ( Lohrer & Krauth- Siegel,
1990) have been shown to cross-react with a band of Mr 55 000, corresponding to 
DHhpDH, in western blots of ah bloodstream and procychc cell extracts (Else et al, 
1994).
Tyler et al (1997) used the same polyclonal antibody to screen for DHhpDH in 
the differentiation of mitochondrially repressed slender T.b.brucei bloodstream to 
partially mitochondrially active stumpy forms. Western blots showed weak 
crossreactivity with bloodstream forms while pronounced reactivity was observed with 
stumqpy and procychc forms. Immunofluorescence, using Krauth Siegel’s antibody, and 
NAD-diaphorase assays conclusively localised the enzyme to the mitochondrion of 
stumpy and procychc forms while showing no plasma membrane localisation of 
DHhpDH in bloodstream forms. These results directly contradict the findings of 
Danson et al (1987) and Jackman et al (1991). Tyler et al’s western blot results, using 
the DHhpDH-specific antibodies that they went on to use in their immunofluorescence 
experiments, clearly show a cross-reactive band with long slender T. brucei cell 
homogenates that corresponds to DHhpDH. They went on to report that there was an 
increase in DHhpDH expression in the stumpy form and procychc form relative to the 
slender form, so confirming the unusual presence of DHhpDH in long slender T. brucei 
cells. It is most likely that their failure to detect a plasma membrane location of 
DHhpDH in long slender T. brucei using immunofluorescence is due to the 
insensitivity of this locahsation method for the small amounts of DHhpDH that would 
be expected to be present at the trypanosome plasma membrane. It was for this reason 
that in the work presented here, very sensitive immunogold locahsation techniques
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were originally the method of choice for the investigation of a plasma membrane 
associated DHhpDH in procychc T. brucei cells ( see section 1.4, study aims).
It may also be possible that during cell fixation and immunofluorescence 
studies, as described by Sherwin et al (1987) and used in this work and by Tyler et al, a 
loosely associated plasma-membrane DHhpDH may have been lost during stringent 
washing steps.
Cellular locahsation studies in T.cruzi epimastigotes (Portela and Stopopani,
1991) showed no evidence for association of DHhpDH with the plasma membrane 
and the authors suggested that ah T.cruzi DHhpDH was present in the mitochondrion. 
However, T.cruzi differs from T.brucei in that there is a functional mitochondrion 
present in ah stages of the parasite’s life cycle. T.cruzi DHhpDH is therefore probably 
a component of the 2-oxoacid dehydrogenase complexes (Fairlamb 1982;1989) and as 
such would be expected to have a mitochondrial locahsation.
10.2 Genetics of trypanosomal DHlipDH
In T. brucei, it appears that both the plasma-membrane and mitochondrial forms are 
encoded by the same gene and that there is little if any difference between the two 
proteins (Else at al, 1994). DNA probes have revealed only a single gene and the N- 
termini of both proteins are identical and correspond to the cloned gene sequence, but 
with a nine amino acid truncation. The enzymes are kinetically indistinguishable and 
have identical subunit molecular sizes on SDS-PAGE and identical native molecular 
sizes by gel filtration, (Else at al, 1994).
10.3 Intracellular mitochondrial targeting of DHlipDH in trypanosomes
The majority of constituent trypanosomal polypeptides are encoded in the nucleus and 
are synthesised on free ribosomes in the cytosol (De Marcucci et al, 1988), with 
kinetoplast DNA encoding only cytochromes, ATPase and a few other polypeptides 
(Simpson, 1987). In ah mitochondriahy-active trypanosomes, as in ah other 
eukaryotes, DHhpDH is coded in the nucleus and then targeted to the mitochondrion 
by means of a protein signal peptide (Kim et al, 1991). N-terminal peptide extensions, 
which are removed during translocation, have been demonstrated for the mammalian 
PDHC and OGDHC components, with pre-E3 having an extra 15-20 amino acids in
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each case (De Marcucci et al, 1988). The N-terminal extension to the pre-E3 is cleaved 
by a specific matrix protease during or shortly after entry into the mitochondrial matrix 
( Hunter and Lindsay, 1986). The dimeric DHhpDH then interacts with the E2 or 
protein X components of the 2-oxo acid dehydrogenase complexes.
A nine amino acid N-terminal pre-sequence determined for T. brucei DHhpDH 
contains two positively-charged amino acids and none that are hydroxylated (Else et al, 
1994) (table 12). DHhpDH has also been characterised (Lohrer and krauth-Siegel, 
1990), and the gene cloned and sequenced (Schoneck et al, 1997) in T.cruzi 
epimastigotes.
Similar to T.brucei, the DNA-derived amino acid sequence of T.cruzi DHhpDH shows 
an N-terminal extension of nine residues which contains basic residues and does not 
contain acidic amino acids. The T.cruzi terminal sequence, which is absent from the 
protein, shows a high degree of similarity with both the T. brucei presequence and 
other mitochondrial targeting sequences of proteins from other eukaryotes including 
the trypanosome Crithidia fasciculata (table 12). At the protein level, the T.cruzi 
enzyme shows 81% identity with the T. brucei enzyme (Schoneck et al, 1997)
Table 12: N-terminal nonapeptide of mitochondrial proteins from Kinetoplastida
Species Sequences
-9 -1
T.cruzi DHlipDH3 M F R R C A V K L
T.bmcei DHhpDH3 M F R R C F P I F
C.fasciculata Pol B b M F R R T F L  T R
C.fasciculata p 16 c M L R F V P R R L
C.fasciculata p l 7 c M L R R S P T L L
C.fasciculata p 18 0 M L R R T V S N F
a Else etal (1994)
b mitPol b, mitochondrial DNA polymerase B (Torn and Englund, 1995) 
c pl6-pl8, kinetoplast-DNA-associated proteins (Xu and Ray, 1993)
A general three-amino-acid motif common to leader peptides of mitochondrial 
proteins has been identified by Hendrick et al, (1989). Such sequences are cleaved off 
in a 2-step process: an Arg-10 (counting upstream from the N-terminus of the mature
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protein), a hydrophobic residue (usually Phe or Leu) at position -8, and a Ser, Thr, or 
Gly at position -5. A first cleavage event, N-terminal to residue -8, results in an 
intermediate with an N-terminal octapeptide. Removal of this peptide in the second 
cleavage step yields the mature protein. The trypanosomal presequences are similar to 
this intermediate octapeptide. They also possess a small, mostly hydrophilic residue at 
position -5 and Phe or Leu at position -8. In addition, the trypanosomal precursor 
proteins show two conserved Arg residues at the positions -6 and -7. The 
mitochondrially-targeted Rieske iron-sulphur proteins from T. brucei and Crithidia 
fasciculata (Priest and Hajduk, 1995) have nine amino acid presequences which 
contain this motif twice: once within the presequences itself and then secondly 
upstream from the mature protein. Furthermore, it has recently been shown that that 
the N-terminal presequence of T.brucei DHhpDH mediates the import of dihydrofolate 
reductase as fusion protein into mitochondria ofLeishmania tarentolae, T.brucei and 
yeast (Hauser et al, 1996).
The presence of DHhpDH in bloodstream T.b.brucei, T.b.rhodesiense, 
T.b.gambiense and T.evansi, ah of which were shown to lack mitochondrial 2- 
oxoglutarate and pyruvate dehydrogenase enzyme complexes ( Else et al, 1994) 
indicate that the DHhpDH of bloodstream trypanosomes is the result of normal 
expression and is not the result of faulty or leaky expression dependent on the strain of 
organism studied. However, whether the presence of an extramitochondrial DHhpDH 
in bloodstream forms is due to its expression not being fully suppressed and/or to 
diminished mitochondrial import or if the enzyme exerts a specific function remains 
unknown. Interestingly, the pre-sequence appears to be processed identicahy in both 
bloodstream and procychc forms, even though the enzyme is not thought to be 
mitochondrially targeted in the bloodstream form. Targeting to the plasma membrane 
is reasonably well understood for secretory and integral membrane proteins, although 
the situation remains unclear for proteins that are loosely associated with membranes.
It is thought, however, that cytoplasmic factors such as chaperones are essential for 
plasma membrane targeting of proteins (Rhee and Hunter, 1990; Ellis and van der 
Vies, 1991)
152
10.4 Possible DHlipDH plasma membrane functions
DHlipDH is found as an integral component in four main multienzyme complexes : 
pyruvate dehydrogenase complex (PDHC), 2-oxoglutarate dehydrogenase complex 
and branched-chain 2-oxoacid dehydrogenase multienzyme complexes (Mattevi et al, 
1992; Perham, 1991) and the glycine cleavage system (Kikuchi and EGraga, 1982). 
DHhpDH traditionally functions in the mitochondrion in association with a 
multienzyme complex. DHhpDH in bloodstream T.brucei has been shown to be 
extramitochondrial and operating independently of the mitochondrial 2-oxo-acid 
dehydrogenase components with which it is usually associated. Such an extra­
mitochondrial plasma membrane DHhpDH in T.brucei and now possibly Phytomonas 
sp. (chapter 9), may be similarly present as a complexed enzyme, or else it may exist in 
a free, uncomplexed form, possibly with a novel function. There is some evidence to 
suggest that the bloodstream T.brucei DHhpDH is indeed complexed at the plasma 
membrane (Else et al, 1994) as in terms of its size, stability and kinetics, T.brucei 
bloodstream form DHhpDH appears to be similar to DHhpDHs associated with the 2- 
oxo acid dehydrogenase complexes of other species. Furthermore, although the level 
of DHhpDH and its substrate hpoic acid has been found to be higher in procychc cells 
compared to bloodstream forms, they are both expressed in a ratio of 1:1 in both cell 
types. While procychc DHhpDH would be expected to be a component of 
mitochondrial 2-oxo acid dehydrogenase complexes, this suggests that the bloodstream 
form DHhpDH may exist in a similar enzyme complex at the plasma membrane. 
However, the possibility of an uncomplexed DHhpDH in bloodstream T.brucei cannot 
be entirely ruled out and the nature of the membrane-associated DHhpDH in 
Phytomonas sp. remains to be determined.
10.4.1 Multienzyme complex functions
There are examples of plasma membrane DHhpDHs involved in multienzyme 
complexes in various cells. Plasma membrane-associated DHhpDH has been found in 
the glycine cleavage system in the purinolytic Clostridium cylindrosporum (Dietrichs 
et al, 1991) and the glycine-utilising Eubacterium acidaminophilum (Freudenberg et 
al, 1989). However, these are both prokaryotic cells, and the GCS has never been 
found outside the mitochondrion in a eukaryotic cell. DHhpDH involvement in a
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plasma membrane GCS in either bloodstream T.brucei or Phytomonas sp. is therefore 
highly unlikely.
The DHhpDH-containing pyruvate dehydrogenase enzyme complex (PDHC) 
has been localised to plasma membranes of many species. PDHC enzyme activity has 
been detected in the mycoplasma Acholeplasma laidlawi (Manolukas et al, 1988; 
McGarrity et al, 1984) and has been shown to be at least partially associated with the 
membrane fraction (Wallbrandt et al, 1992). A laidlawi ferments glucose to lactate, 
pyruvate and acetate but lacks the tricarboxylic acid cycle and cytochromes 
(Manolukas et al, 1988, Pollack et al, 1983). In this respect, it exhibits metabolic 
characteristics similar to Phytomonas sp., suggesting that a similar plasma membrane - 
associated PDH may possibly be present in Phytomonas sp.
Other DHlipDH-containing complexes include the lactate-degrading system of 
Butyribacterium rettgeri (Wittenberger and Haa£ 1964) and the acetoin 
dehydrogenase system of Pelobacter carbinolicus (Oppermann et al, 1991). Both of 
these are rather specialised, but they do demonstrate that DHhpDH is not confined to 
the four most common complexes, but could be part of a complex catalysing a 
completely different dehydrogenase reaction
10.4.2 Thiol:protein disulphide interchange
DHhpDH and hpoic acid form part of an active system of flavoenzymes that maintains 
redox balance and catalyses reductive processes in many cell types (Freedman, 1979). 
Lipoic acid has been used therapeutically in a number of diseases, including liver 
cirrhosis, heavy metal intoxication, and diabetic polyneuropathy, and in 1988 it was 
proposed that the antioxidant activity of hpoic acid might play an important role in its 
therapeutic efficacy (Bast and Haenen, 1988). Lipoic acid is reduced to dihydrohpoic 
acid (DHLA) in vivo, and it thought that it is the DHLA which is primarily responsible 
for antioxidant activity (Haenen and Bast, 1991; Scott et al, 1994; Kagan et al, 1995). 
In contrast to many other antioxidants, dihydrohpoate may function as a universal free 
radical quencher that scavenges peroxyl radicals both in the aqueous cytosol and the 
hydrophobic membrane environment ( Kegan et al, 1992, Matsugo et al, 1995,
Schohch et al, 1989). In this context, a plasma membrane location of DHhpDH in 
T.brucei and Phytomonas sp. is particularly interesting.
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It has been suggested that dithiol-disulphide interchanges play a general role in 
membrane-related processes including receptor signal transduction and solute transport 
(Robillard and Konings, 1982; Malbon et al, 1987). Furthermore, it has been suggested 
that DHlipDH and hpoic acid may be directly or indirectly involved in these 
phenomena, giving rise to further possible functions of a plasma membrane DHhpDH
10.4.3 Solute transport
DHhpDH has been directly implicated in the transport of various sugars, mediated 
through its cofactor dihydrohpoamide. African trypanosomes are totally dependent on 
glycolysis for ATP production and it is conceivable that a plasma-membrane- 
associated DHhpDH may be involved in the very high glucose uptake of African 
trypanosomes which exceeds that of erythrocytes by a factor of approximately 300.
A hpoic acid-dependent import of sugars has been suggested for E.coli and 
adipocytes (Richarme and Heine, 1986; Frost and Lane, 1986). E.coli has been found 
to express both a mitochondrial enzyme associated with the 2-oxoacid dehydrogenase 
complexes (reviewed by Carothers et al, 1989) and an extramitochondrial, possibly 
plasma membrane located DHhpDH thought to be involved in sugar transport 
(Richarme, 1989). A strong link between DHhpDH-containing multienzyme complex 
activity and binding protein-dependent transport of maltose, ribose and galactose has 
been clearly demonstrated in E.coli (Richarme 1985;1987; Richarme and Heine, 1986).
E.coli has two different genes encoding DHhpDH, specific for the intra and 
extramitochondrial enzyme (Richarme, 1989). However, this does not seem to be the 
case in T.brucei where it appears that both the plasma membrane and mitochondrial 
forms are encoded by the same gene and that there is little, if any, difference between 
the two proteins.(Else et al, 1993, 1994).
10.4.4 Other possible roles of DHlipDH
Evidence of additional roles for DHhpDH may be seen in archaebacteria, 
where 2-oxoacids are metabohsed by a different mechanism, employing 
oxidoreductases that do not use hpoic acid (Plaga et al, 1992 ; Kersher and Oesterhelt,
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1982), and where DHlipDH is still found but as a non-complexed enzyme (Danson, 
1988). The role of such a DHlipDH remains undetermined.
DHlipDH from H. volcanii appears not to be involved in sugar transport (Jolly 
et al, 1996) nor to play a role in a glycine cleavage enzyme complex. It has been 
suggested that dihydrolipoic acid, which is also present in H.volcanii and is known to 
possess antioxidant properties (Suzuki et al, 1994), may play a role in the repair of 
membrane thiol groups in mitochondria (Zimmer et al, 1991). Hence the role of lipoic 
acid and DHlipDH in the halophilic bacteria may be in protection and repair.
10.5 Trypanosomal DHlipDH : role in oxidative stress and potential drug target
Lipoic acid is able to reduce the major intracellular thiol, glutathione (Bast and 
Haenan, 1988) and thereby contributes to the maintenance of redox balance and to 
reduction of oxidative stress (Meister and Anderson, 1983) in many eukaryotic cells. 
Kinetoplastida appear to possess an antioxidative thiol metabolism which differs 
qualitatively from that of other eukaryotes. In the trypanosome, glutathione is replaced 
by trypanothione, and the cell is much more vulnerable to reactive oxygen species 
(Boveris et al, 1980; Camieri et al, 1993) Similar in structure to trypanothione 
reductase (TR), a key enzyme of the parasite’s thiol metabolism, DHlipDH may also 
have a general function in creating and oxidising free intracellular thiol groups. Hence 
in the trypanosome environment, lipoic acid and DHlipDH may have considerable 
influence upon redox levels and may well be an effective drug target as many anti­
trypanosomal drugs act as oxidative stressors and/or interfere with the defence 
mechanisms of the parasite (Fairlamb et al, 1992; Krauth-Siegel and Schoneck, 1995). 
In this context DHlipDH may be additionally attractive as a drug target because of its 
plasma membrane location in bloodstream T. brucei and now Phytomonas sp.
DHlipDH appears to be a target for a number of drugs which are already being 
used against trypanosomal infections. Melarsenoxide, an arsenical used in the 
treatment of sleeping sickness, covalently inhibits reduced DHlipDH (Fairlamb et al,
1992) while DHlipDH is implicated in the chemotherapeutic effect of Nifurtimox. 
DHlipDH triggers the production of 0 2’ and H2O2 by reducing Nifurtimox, the most 
effective drug against T.cruzi ( Docampo and Stoppani, 1979).
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10.6 DHlipDH in Crithidiafasciculata
Although DHlipDH activity was found to be present in Crithidia fasciculata 
cell homogenates (chapter 7), it must be assumed that most of this DHlipDH is 
associated with 2-oxoacid dehydrogenase enzyme complexes in the active 
mitochondrion. To this effect, the enzyme has recently been characterised in the 
pyruvate dehydrogenase complex of C. fasciculata (Diaz and Komuniecki, 1995).
Subcellular fractionation studies were unable to determine conclusively a 
plasma membrane location for DHlipDH in Crithidia fasciculata in this study 
(chapter 9), paralleling findings by Jackman et al (1991) who were unable to show by 
subcellular fractionation whether a small proportion of the DHlipDH was present at 
the plasma membrane of T.brucei procyclic cells. A plasma membrane location in 
either of these cell types would be highly unusual as there are few enzymes located in 
both the mitochondrion and the plasma membrane of an organism However, recent 
findings of normally mitochondrial dihydrolip oamide succinyltransferase (the core 
enzyme of the 2-oxoacid dehydrogenase complex) located both in the mitochondrion 
and plasma membrane of skeletal muscle cells ( Matuda et al, 1997) confirm that, 
although unusual, the possibility of a plasma membrane location of DHlipDH in these 
cells is possible.
Interestingly, immunofluorescence studies performed by Tyler et al (1997) 
using antibodies specific for T.cruzi DHlipDH localised DHlipDH to the 
mitochondrion of procyclic forms of T.brucei but failed to detect the enzyme in the 
plasma membrane of procyclic cells. However, Tyler et al failed to detect the protein in 
the plasma membrane of T.brucei bloodstream cells using these antibodies, a finding 
which directly contradicts a number of reports (Danson et al, 1987, Jackman et al, 
1991, Else et al, 1994). The negative result reported by Tyler et al is most likely due to 
insensitivity of the immunofluorescence assay used for the detection of very small 
amounts of enzyme expected to be present at the plasma membrane, as discussed 
earlier (section 10.1). This limited sensitivity could be overcome by using the more 
sensitive immunogold labelling method of localisation.
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10.7 DHlipDH in Phytomonas sp.
Phytomonas sp. cells are highly specialised for glycolysis, with mainly glucose being 
consumed as energy and carbon source during logarithmic growth in culture 
(Chaumont et al, 1994). No evidence has been found for the presence of functional 
citric acid cycle enzymes in any species of Phytomonas studied to date (Femandez- 
Beccerra et al, 1997; Chaumont et al, 1994; Sanchez-Moreno et al, 1992). When 
mitochondria were supplemented with a-oxoglutarate, pyruvate, malate or proline, 
none of these substrates increased endogenous respiration (Femandez-Beccerra et al, 
1997). The absence of detectable cytochromes and the fact that respiration is not 
inhibited by the classical inhibitors of the mitochondrial respiratory chain, such as 
cyanide and antimycin (Sanchez-Moreno et al, 1992) indicates that in Phytomonas sp. 
the mitochondrion is metabolically inactive and the glycolytic pathway serves as the 
major, if not the only, source of ATP within the cell
The capacity for reoxidation of the glycolytically produced NADH by a 
putative glycerol-3-phosphate dihydroxyacetone cycle (involving a mitochondrial 
glycerol-3-phosphate oxidase and a glycosomal NAD-dependent glycerol-3-phosphate 
dehydrogenase) is not sufficient and some of the NADH is reoxidised by the reduction 
of acetate to ethanol following the decarboxylation of pyruvate ( Femandez-Becerra, 
1997)
There have been no reports in the literature for the activity of any of the 
mitochondrial multienzyme complexes with which DHlipDH is normally associated. 
While preliminary work, presented here, suggests an extramitochondrial plasma 
membrane location for DHlipDH in Phytomonas sp., the function of such an enzyme 
remains unknown at present, mirroring the situation in bloodstream T.brucei.
10.8 Future work
10.8.1 Further characterisation of Phytomonas sp. DHlipDH
Further studies should be performed to identify and characterise DHlipDH conclusively 
in Phytomonas sp. Size, stability and kinetics of Phytomonas DHlipDH should be 
thoroughly investigated and compared with DHhpDHs associated with the 2-oxo acid 
dehydrogenase complexes o f other species to elucidate whether the enzyme is present 
as part of a multienzyme complex (as has been suggested for bloodstream T. brucei) or
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uncomplexed (as in some species of prokaryotes including archaebacteria),. When 
DHlipDH functions in the 2-oxo acid dehydrogenase complexes, its substrate, 
dihydrolipoic acid, is attached to the transacetylase component of the multienzyme.
The question hence arises as to whether lipoic acid is still the substrate of the 
apparently extra-mitochondrial DHlipDH in Phytomonas sp. Elucidation of the ratio 
of lipoic acid to DHlipDH would help to determine if DHlipDH is present in a 
complexed or uncomplexed form Hence, future work should focus on a 
determination of this cofactor in Phytomonas sp.
Additionally, purification of the enzyme and N-terminal sequencing could 
provide information on the possible mechanism of plasma membrane targeting in this 
trypanosome.
10.8.2 Study of DHlipDH in other trypanosomatids
As well as Phytomonas sp. and bloodstream T.brucei, a complete suppression of 
mitochondrial activity and a total absence of cytochromes has been reported in another 
trypanosomatid Herpetomonas muscaeum ingenoplastis. (Coombs., 1989). 
Furthermore, a recent report that in the culture-adapted trypanosomatid Leishmania 
tarentolae most o f the guide RNAs required for the editing of mitochondrial 
transcripts have been lost (Simpson et al, 1993), suggests also that this organism is 
able to survive in the absence of mitochondrial activity.
Hence utilisation of the glycolytic pathway as the sole carbon and energy 
source, together with a complete suppression of mitochondrial activity, appears to be 
found in at least three distantly-related representatives within the trypanosomatid 
family. Evidence for an unusual plasma-membrane associated DHlipDH in bloodstream 
T.brucei (Danson et al, 1987) and now Phytomonas sp. (chapter 9) suggests that such 
a DHlipDH may be a common feature of mitochondrially-inactive trypanosomatids. It 
would be therefore of interest to determine if such a DHlipDH may be found in the 
plasma membrane of Herpetomonas muscarum ingenoplastis and Leishmania 
tarentolae.
The separation of the African trypanosome from the main line of 
trypanosomatid evolution took place several hundreds of millions of years ago, well 
before the other representatives of the family Trypanosomatidae diverged (Fernandes
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et al, 1993). The utilisation of glycolysis as the sole carbon and energy source in 
various diverse members of the trypanosomatid family indicates that such metabolic 
flexibility must represent an ancestral property, rather than a recent adaptation to life in 
a specific host. It may well be that this metabolic flexibility has allowed descendants of 
the ancestral trypanosomatid to adapt to the great variety of metazoan hosts, ranging 
from plants via insects, fishes, amphibians and reptiles to mammals, that are all 
parasitised today by trypanosomatids.
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